<html lang="en" data-critters-container=""><head><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin="">
  <meta charset="UTF-8">
  <script type="text/javascript" async="" src="https://www.googletagmanager.com/gtag/js?id=G-DP2X732JSX&amp;l=pingerDataLayer&amp;cx=c&amp;gtm=45He5421v847342615za200&amp;tag_exp=102788824~102803279~102813109~102887799~102926062~102975949~103016951~103021830~103027016"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-PC9B6M3&amp;l=pingerDataLayer" id="pingerInjectedGTM"></script><script type="text/javascript">
    window.ncbi_startTime = new Date();
  </script>
  <meta http-equiv="X-UA-Compatible" content="IE=edge">

  <!-- Mobile properties -->
  <meta name="HandheldFriendly" content="True">
  <meta name="MobileOptimized" content="320">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1">

  <style>@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3GUBGEe.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3iUBGEe.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3CUBGEe.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3-UBGEe.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMawCUBGEe.woff2) format('woff2');unicode-range:U+0302-0303, U+0305, U+0307-0308, U+0310, U+0312, U+0315, U+031A, U+0326-0327, U+032C, U+032F-0330, U+0332-0333, U+0338, U+033A, U+0346, U+034D, U+0391-03A1, U+03A3-03A9, U+03B1-03C9, U+03D1, U+03D5-03D6, U+03F0-03F1, U+03F4-03F5, U+2016-2017, U+2034-2038, U+203C, U+2040, U+2043, U+2047, U+2050, U+2057, U+205F, U+2070-2071, U+2074-208E, U+2090-209C, U+20D0-20DC, U+20E1, U+20E5-20EF, U+2100-2112, U+2114-2115, U+2117-2121, U+2123-214F, U+2190, U+2192, U+2194-21AE, U+21B0-21E5, U+21F1-21F2, U+21F4-2211, U+2213-2214, U+2216-22FF, U+2308-230B, U+2310, U+2319, U+231C-2321, U+2336-237A, U+237C, U+2395, U+239B-23B7, U+23D0, U+23DC-23E1, U+2474-2475, U+25AF, U+25B3, U+25B7, U+25BD, U+25C1, U+25CA, U+25CC, U+25FB, U+266D-266F, U+27C0-27FF, U+2900-2AFF, U+2B0E-2B11, U+2B30-2B4C, U+2BFE, U+3030, U+FF5B, U+FF5D, U+1D400-1D7FF, U+1EE00-1EEFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMaxKUBGEe.woff2) format('woff2');unicode-range:U+0001-000C, U+000E-001F, U+007F-009F, U+20DD-20E0, U+20E2-20E4, U+2150-218F, U+2190, U+2192, U+2194-2199, U+21AF, U+21E6-21F0, U+21F3, U+2218-2219, U+2299, U+22C4-22C6, U+2300-243F, U+2440-244A, U+2460-24FF, U+25A0-27BF, U+2800-28FF, U+2921-2922, U+2981, U+29BF, U+29EB, U+2B00-2BFF, U+4DC0-4DFF, U+FFF9-FFFB, U+10140-1018E, U+10190-1019C, U+101A0, U+101D0-101FD, U+102E0-102FB, U+10E60-10E7E, U+1D2C0-1D2D3, U+1D2E0-1D37F, U+1F000-1F0FF, U+1F100-1F1AD, U+1F1E6-1F1FF, U+1F30D-1F30F, U+1F315, U+1F31C, U+1F31E, U+1F320-1F32C, U+1F336, U+1F378, U+1F37D, U+1F382, U+1F393-1F39F, U+1F3A7-1F3A8, U+1F3AC-1F3AF, U+1F3C2, U+1F3C4-1F3C6, U+1F3CA-1F3CE, U+1F3D4-1F3E0, U+1F3ED, U+1F3F1-1F3F3, U+1F3F5-1F3F7, U+1F408, U+1F415, U+1F41F, U+1F426, U+1F43F, U+1F441-1F442, U+1F444, U+1F446-1F449, U+1F44C-1F44E, U+1F453, U+1F46A, U+1F47D, U+1F4A3, U+1F4B0, U+1F4B3, U+1F4B9, U+1F4BB, U+1F4BF, U+1F4C8-1F4CB, U+1F4D6, U+1F4DA, U+1F4DF, U+1F4E3-1F4E6, U+1F4EA-1F4ED, U+1F4F7, U+1F4F9-1F4FB, U+1F4FD-1F4FE, U+1F503, U+1F507-1F50B, U+1F50D, U+1F512-1F513, U+1F53E-1F54A, U+1F54F-1F5FA, U+1F610, U+1F650-1F67F, U+1F687, U+1F68D, U+1F691, U+1F694, U+1F698, U+1F6AD, U+1F6B2, U+1F6B9-1F6BA, U+1F6BC, U+1F6C6-1F6CF, U+1F6D3-1F6D7, U+1F6E0-1F6EA, U+1F6F0-1F6F3, U+1F6F7-1F6FC, U+1F700-1F7FF, U+1F800-1F80B, U+1F810-1F847, U+1F850-1F859, U+1F860-1F887, U+1F890-1F8AD, U+1F8B0-1F8BB, U+1F8C0-1F8C1, U+1F900-1F90B, U+1F93B, U+1F946, U+1F984, U+1F996, U+1F9E9, U+1FA00-1FA6F, U+1FA70-1FA7C, U+1FA80-1FA89, U+1FA8F-1FAC6, U+1FACE-1FADC, U+1FADF-1FAE9, U+1FAF0-1FAF8, U+1FB00-1FBFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3OUBGEe.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3KUBGEe.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3yUBA.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3GUBGEe.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3iUBGEe.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3CUBGEe.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3-UBGEe.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMawCUBGEe.woff2) format('woff2');unicode-range:U+0302-0303, U+0305, U+0307-0308, U+0310, U+0312, U+0315, U+031A, U+0326-0327, U+032C, U+032F-0330, U+0332-0333, U+0338, U+033A, U+0346, U+034D, U+0391-03A1, U+03A3-03A9, U+03B1-03C9, U+03D1, U+03D5-03D6, U+03F0-03F1, U+03F4-03F5, U+2016-2017, U+2034-2038, U+203C, U+2040, U+2043, U+2047, U+2050, U+2057, U+205F, U+2070-2071, U+2074-208E, U+2090-209C, U+20D0-20DC, U+20E1, U+20E5-20EF, U+2100-2112, U+2114-2115, U+2117-2121, U+2123-214F, U+2190, U+2192, U+2194-21AE, U+21B0-21E5, U+21F1-21F2, U+21F4-2211, U+2213-2214, U+2216-22FF, U+2308-230B, U+2310, U+2319, U+231C-2321, U+2336-237A, U+237C, U+2395, U+239B-23B7, U+23D0, U+23DC-23E1, U+2474-2475, U+25AF, U+25B3, U+25B7, U+25BD, U+25C1, U+25CA, U+25CC, U+25FB, U+266D-266F, U+27C0-27FF, U+2900-2AFF, U+2B0E-2B11, U+2B30-2B4C, U+2BFE, U+3030, U+FF5B, U+FF5D, U+1D400-1D7FF, U+1EE00-1EEFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMaxKUBGEe.woff2) format('woff2');unicode-range:U+0001-000C, U+000E-001F, U+007F-009F, U+20DD-20E0, U+20E2-20E4, U+2150-218F, U+2190, U+2192, U+2194-2199, U+21AF, U+21E6-21F0, U+21F3, U+2218-2219, U+2299, U+22C4-22C6, U+2300-243F, U+2440-244A, U+2460-24FF, U+25A0-27BF, U+2800-28FF, U+2921-2922, U+2981, U+29BF, U+29EB, U+2B00-2BFF, U+4DC0-4DFF, U+FFF9-FFFB, U+10140-1018E, U+10190-1019C, U+101A0, U+101D0-101FD, U+102E0-102FB, U+10E60-10E7E, U+1D2C0-1D2D3, U+1D2E0-1D37F, U+1F000-1F0FF, U+1F100-1F1AD, U+1F1E6-1F1FF, U+1F30D-1F30F, U+1F315, U+1F31C, U+1F31E, U+1F320-1F32C, U+1F336, U+1F378, U+1F37D, U+1F382, U+1F393-1F39F, U+1F3A7-1F3A8, U+1F3AC-1F3AF, U+1F3C2, U+1F3C4-1F3C6, U+1F3CA-1F3CE, U+1F3D4-1F3E0, U+1F3ED, U+1F3F1-1F3F3, U+1F3F5-1F3F7, U+1F408, U+1F415, U+1F41F, U+1F426, U+1F43F, U+1F441-1F442, U+1F444, U+1F446-1F449, U+1F44C-1F44E, U+1F453, U+1F46A, U+1F47D, U+1F4A3, U+1F4B0, U+1F4B3, U+1F4B9, U+1F4BB, U+1F4BF, U+1F4C8-1F4CB, U+1F4D6, U+1F4DA, U+1F4DF, U+1F4E3-1F4E6, U+1F4EA-1F4ED, U+1F4F7, U+1F4F9-1F4FB, U+1F4FD-1F4FE, U+1F503, U+1F507-1F50B, U+1F50D, U+1F512-1F513, U+1F53E-1F54A, U+1F54F-1F5FA, U+1F610, U+1F650-1F67F, U+1F687, U+1F68D, U+1F691, U+1F694, U+1F698, U+1F6AD, U+1F6B2, U+1F6B9-1F6BA, U+1F6BC, U+1F6C6-1F6CF, U+1F6D3-1F6D7, U+1F6E0-1F6EA, U+1F6F0-1F6F3, U+1F6F7-1F6FC, U+1F700-1F7FF, U+1F800-1F80B, U+1F810-1F847, U+1F850-1F859, U+1F860-1F887, U+1F890-1F8AD, U+1F8B0-1F8BB, U+1F8C0-1F8C1, U+1F900-1F90B, U+1F93B, U+1F946, U+1F984, U+1F996, U+1F9E9, U+1FA00-1FA6F, U+1FA70-1FA7C, U+1FA80-1FA89, U+1FA8F-1FAC6, U+1FACE-1FADC, U+1FADF-1FAE9, U+1FAF0-1FAF8, U+1FB00-1FBFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3OUBGEe.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3KUBGEe.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3yUBA.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3GUBGEe.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3iUBGEe.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3CUBGEe.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3-UBGEe.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMawCUBGEe.woff2) format('woff2');unicode-range:U+0302-0303, U+0305, U+0307-0308, U+0310, U+0312, U+0315, U+031A, U+0326-0327, U+032C, U+032F-0330, U+0332-0333, U+0338, U+033A, U+0346, U+034D, U+0391-03A1, U+03A3-03A9, U+03B1-03C9, U+03D1, U+03D5-03D6, U+03F0-03F1, U+03F4-03F5, U+2016-2017, U+2034-2038, U+203C, U+2040, U+2043, U+2047, U+2050, U+2057, U+205F, U+2070-2071, U+2074-208E, U+2090-209C, U+20D0-20DC, U+20E1, U+20E5-20EF, U+2100-2112, U+2114-2115, U+2117-2121, U+2123-214F, U+2190, U+2192, U+2194-21AE, U+21B0-21E5, U+21F1-21F2, U+21F4-2211, U+2213-2214, U+2216-22FF, U+2308-230B, U+2310, U+2319, U+231C-2321, U+2336-237A, U+237C, U+2395, U+239B-23B7, U+23D0, U+23DC-23E1, U+2474-2475, U+25AF, U+25B3, U+25B7, U+25BD, U+25C1, U+25CA, U+25CC, U+25FB, U+266D-266F, U+27C0-27FF, U+2900-2AFF, U+2B0E-2B11, U+2B30-2B4C, U+2BFE, U+3030, U+FF5B, U+FF5D, U+1D400-1D7FF, U+1EE00-1EEFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMaxKUBGEe.woff2) format('woff2');unicode-range:U+0001-000C, U+000E-001F, U+007F-009F, U+20DD-20E0, U+20E2-20E4, U+2150-218F, U+2190, U+2192, U+2194-2199, U+21AF, U+21E6-21F0, U+21F3, U+2218-2219, U+2299, U+22C4-22C6, U+2300-243F, U+2440-244A, U+2460-24FF, U+25A0-27BF, U+2800-28FF, U+2921-2922, U+2981, U+29BF, U+29EB, U+2B00-2BFF, U+4DC0-4DFF, U+FFF9-FFFB, U+10140-1018E, U+10190-1019C, U+101A0, U+101D0-101FD, U+102E0-102FB, U+10E60-10E7E, U+1D2C0-1D2D3, U+1D2E0-1D37F, U+1F000-1F0FF, U+1F100-1F1AD, U+1F1E6-1F1FF, U+1F30D-1F30F, U+1F315, U+1F31C, U+1F31E, U+1F320-1F32C, U+1F336, U+1F378, U+1F37D, U+1F382, U+1F393-1F39F, U+1F3A7-1F3A8, U+1F3AC-1F3AF, U+1F3C2, U+1F3C4-1F3C6, U+1F3CA-1F3CE, U+1F3D4-1F3E0, U+1F3ED, U+1F3F1-1F3F3, U+1F3F5-1F3F7, U+1F408, U+1F415, U+1F41F, U+1F426, U+1F43F, U+1F441-1F442, U+1F444, U+1F446-1F449, U+1F44C-1F44E, U+1F453, U+1F46A, U+1F47D, U+1F4A3, U+1F4B0, U+1F4B3, U+1F4B9, U+1F4BB, U+1F4BF, U+1F4C8-1F4CB, U+1F4D6, U+1F4DA, U+1F4DF, U+1F4E3-1F4E6, U+1F4EA-1F4ED, U+1F4F7, U+1F4F9-1F4FB, U+1F4FD-1F4FE, U+1F503, U+1F507-1F50B, U+1F50D, U+1F512-1F513, U+1F53E-1F54A, U+1F54F-1F5FA, U+1F610, U+1F650-1F67F, U+1F687, U+1F68D, U+1F691, U+1F694, U+1F698, U+1F6AD, U+1F6B2, U+1F6B9-1F6BA, U+1F6BC, U+1F6C6-1F6CF, U+1F6D3-1F6D7, U+1F6E0-1F6EA, U+1F6F0-1F6F3, U+1F6F7-1F6FC, U+1F700-1F7FF, U+1F800-1F80B, U+1F810-1F847, U+1F850-1F859, U+1F860-1F887, U+1F890-1F8AD, U+1F8B0-1F8BB, U+1F8C0-1F8C1, U+1F900-1F90B, U+1F93B, U+1F946, U+1F984, U+1F996, U+1F9E9, U+1FA00-1FA6F, U+1FA70-1FA7C, U+1FA80-1FA89, U+1FA8F-1FAC6, U+1FACE-1FADC, U+1FADF-1FAE9, U+1FAF0-1FAF8, U+1FB00-1FBFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3OUBGEe.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3KUBGEe.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3yUBA.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3GUBGEe.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3iUBGEe.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3CUBGEe.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3-UBGEe.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMawCUBGEe.woff2) format('woff2');unicode-range:U+0302-0303, U+0305, U+0307-0308, U+0310, U+0312, U+0315, U+031A, U+0326-0327, U+032C, U+032F-0330, U+0332-0333, U+0338, U+033A, U+0346, U+034D, U+0391-03A1, U+03A3-03A9, U+03B1-03C9, U+03D1, U+03D5-03D6, U+03F0-03F1, U+03F4-03F5, U+2016-2017, U+2034-2038, U+203C, U+2040, U+2043, U+2047, U+2050, U+2057, U+205F, U+2070-2071, U+2074-208E, U+2090-209C, U+20D0-20DC, U+20E1, U+20E5-20EF, U+2100-2112, U+2114-2115, U+2117-2121, U+2123-214F, U+2190, U+2192, U+2194-21AE, U+21B0-21E5, U+21F1-21F2, U+21F4-2211, U+2213-2214, U+2216-22FF, U+2308-230B, U+2310, U+2319, U+231C-2321, U+2336-237A, U+237C, U+2395, U+239B-23B7, U+23D0, U+23DC-23E1, U+2474-2475, U+25AF, U+25B3, U+25B7, U+25BD, U+25C1, U+25CA, U+25CC, U+25FB, U+266D-266F, U+27C0-27FF, U+2900-2AFF, U+2B0E-2B11, U+2B30-2B4C, U+2BFE, U+3030, U+FF5B, U+FF5D, U+1D400-1D7FF, U+1EE00-1EEFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMaxKUBGEe.woff2) format('woff2');unicode-range:U+0001-000C, U+000E-001F, U+007F-009F, U+20DD-20E0, U+20E2-20E4, U+2150-218F, U+2190, U+2192, U+2194-2199, U+21AF, U+21E6-21F0, U+21F3, U+2218-2219, U+2299, U+22C4-22C6, U+2300-243F, U+2440-244A, U+2460-24FF, U+25A0-27BF, U+2800-28FF, U+2921-2922, U+2981, U+29BF, U+29EB, U+2B00-2BFF, U+4DC0-4DFF, U+FFF9-FFFB, U+10140-1018E, U+10190-1019C, U+101A0, U+101D0-101FD, U+102E0-102FB, U+10E60-10E7E, U+1D2C0-1D2D3, U+1D2E0-1D37F, U+1F000-1F0FF, U+1F100-1F1AD, U+1F1E6-1F1FF, U+1F30D-1F30F, U+1F315, U+1F31C, U+1F31E, U+1F320-1F32C, U+1F336, U+1F378, U+1F37D, U+1F382, U+1F393-1F39F, U+1F3A7-1F3A8, U+1F3AC-1F3AF, U+1F3C2, U+1F3C4-1F3C6, U+1F3CA-1F3CE, U+1F3D4-1F3E0, U+1F3ED, U+1F3F1-1F3F3, U+1F3F5-1F3F7, U+1F408, U+1F415, U+1F41F, U+1F426, U+1F43F, U+1F441-1F442, U+1F444, U+1F446-1F449, U+1F44C-1F44E, U+1F453, U+1F46A, U+1F47D, U+1F4A3, U+1F4B0, U+1F4B3, U+1F4B9, U+1F4BB, U+1F4BF, U+1F4C8-1F4CB, U+1F4D6, U+1F4DA, U+1F4DF, U+1F4E3-1F4E6, U+1F4EA-1F4ED, U+1F4F7, U+1F4F9-1F4FB, U+1F4FD-1F4FE, U+1F503, U+1F507-1F50B, U+1F50D, U+1F512-1F513, U+1F53E-1F54A, U+1F54F-1F5FA, U+1F610, U+1F650-1F67F, U+1F687, U+1F68D, U+1F691, U+1F694, U+1F698, U+1F6AD, U+1F6B2, U+1F6B9-1F6BA, U+1F6BC, U+1F6C6-1F6CF, U+1F6D3-1F6D7, U+1F6E0-1F6EA, U+1F6F0-1F6F3, U+1F6F7-1F6FC, U+1F700-1F7FF, U+1F800-1F80B, U+1F810-1F847, U+1F850-1F859, U+1F860-1F887, U+1F890-1F8AD, U+1F8B0-1F8BB, U+1F8C0-1F8C1, U+1F900-1F90B, U+1F93B, U+1F946, U+1F984, U+1F996, U+1F9E9, U+1FA00-1FA6F, U+1FA70-1FA7C, U+1FA80-1FA89, U+1FA8F-1FAC6, U+1FACE-1FADC, U+1FADF-1FAE9, U+1FAF0-1FAF8, U+1FB00-1FBFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3OUBGEe.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3KUBGEe.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:700;font-stretch:100%;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v47/KFO7CnqEu92Fr1ME7kSn66aGLdTylUAMa3yUBA.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}</style>
  <style>@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v143/flUhRq6tzZclQEJ-Vdg-IuiaDsNc.woff2) format('woff2');}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased;}</style>
  <script src="https://maps.googleapis.com/maps/api/js?key=AIzaSyC3PtSiQNBORX_rM0MRLHNA9VybME6zF1A&amp;libraries=places&amp;region=US&amp;language=en"></script>

  <title>Study Details |  | ClinicalTrials.gov</title>
  <base href="/">

  <!-- Favicons -->
  <link rel="shortcut icon" type="image/svg" href="assets/favicons/favicon.svg">
  <link rel="icon" type="image/svg" href="assets/favicons/favicon.svg">

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/svg" sizes="192x192" href="assets/favicons/favicon.svg">

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="assets/favicons/favicon.svg">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/favicons/favicon.svg">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/favicons/favicon.svg">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/favicons/favicon.svg">


  <!-- Page description -->
  <meta name="description" content="">

  <meta property="og:title" content="">
  <meta property="og:description" content="">

  <meta name="twitter:title" content="">
  <meta name="twitter:description" content="">
  <meta name="twitter:card" content="summary">

  <!-- robots -->
  <meta name="robots" content="index, follow">

  <!-- Pinger -->
  <meta name="ncbi_app" content="ctgov2">
  <meta name="ncbi_db" content="">
  <meta name="ncbi_pinger_track_stat" content="false">
  <meta name="ncbi_pinger_ga_track" content="true">
  <meta name="ncbi_pinger_ga_tracking_id" content="UA-68648221-4">
  <meta name="ncbi_pinger_url_query_strip" content="lat,lng,locStr">
  <meta name="ncbi_pinger_click_use_capture" content="true">
  <meta name="ncbi_pinger_gtm_track" content="true">

  <meta name="ncbi_app_version" content="v2.14.4">
<style>:root{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji",Segoe UI Symbol;--font-family:-apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol";--surface-a:#ffffff;--surface-b:#f8f9fa;--surface-c:#e9ecef;--surface-d:#dee2e6;--surface-e:#ffffff;--surface-f:#ffffff;--text-color:#495057;--text-color-secondary:#6c757d;--primary-color:#2196F3;--primary-color-text:#ffffff;--surface-0:#ffffff;--surface-50:#fafafa;--surface-100:#f5f5f5;--surface-200:#eeeeee;--surface-300:#e0e0e0;--surface-400:#bdbdbd;--surface-500:#9e9e9e;--surface-600:#757575;--surface-700:#616161;--surface-800:#424242;--surface-900:#212121;--gray-50:#fafafa;--gray-100:#f5f5f5;--gray-200:#eeeeee;--gray-300:#e0e0e0;--gray-400:#bdbdbd;--gray-500:#9e9e9e;--gray-600:#757575;--gray-700:#616161;--gray-800:#424242;--gray-900:#212121;--content-padding:1rem;--inline-spacing:.5rem;--border-radius:3px;--surface-ground:#f8f9fa;--surface-section:#ffffff;--surface-card:#ffffff;--surface-overlay:#ffffff;--surface-border:#dee2e6;--surface-hover:#e9ecef;--maskbg:rgba(0, 0, 0, .4);--highlight-bg:#E3F2FD;--highlight-text-color:#495057;--focus-ring:0 0 0 .2rem #a6d5fa;color-scheme:light}:root{--blue-50:#f4fafe;--blue-100:#cae6fc;--blue-200:#a0d2fa;--blue-300:#75bef8;--blue-400:#4baaf5;--blue-500:#2196f3;--blue-600:#1c80cf;--blue-700:#1769aa;--blue-800:#125386;--blue-900:#0d3c61;--green-50:#f6fbf6;--green-100:#d4ecd5;--green-200:#b2ddb4;--green-300:#90cd93;--green-400:#6ebe71;--green-500:#4caf50;--green-600:#419544;--green-700:#357b38;--green-800:#2a602c;--green-900:#1e4620;--yellow-50:#fffcf5;--yellow-100:#fef0cd;--yellow-200:#fde4a5;--yellow-300:#fdd87d;--yellow-400:#fccc55;--yellow-500:#fbc02d;--yellow-600:#d5a326;--yellow-700:#b08620;--yellow-800:#8a6a19;--yellow-900:#644d12;--cyan-50:#f2fcfd;--cyan-100:#c2eff5;--cyan-200:#91e2ed;--cyan-300:#61d5e4;--cyan-400:#30c9dc;--cyan-500:#00bcd4;--cyan-600:#00a0b4;--cyan-700:#008494;--cyan-800:#006775;--cyan-900:#004b55;--pink-50:#fef4f7;--pink-100:#fac9da;--pink-200:#f69ebc;--pink-300:#f1749e;--pink-400:#ed4981;--pink-500:#e91e63;--pink-600:#c61a54;--pink-700:#a31545;--pink-800:#801136;--pink-900:#5d0c28;--indigo-50:#f5f6fb;--indigo-100:#d1d5ed;--indigo-200:#acb4df;--indigo-300:#8893d1;--indigo-400:#6372c3;--indigo-500:#3f51b5;--indigo-600:#36459a;--indigo-700:#2c397f;--indigo-800:#232d64;--indigo-900:#192048;--teal-50:#f2faf9;--teal-100:#c2e6e2;--teal-200:#91d2cc;--teal-300:#61beb5;--teal-400:#30aa9f;--teal-500:#009688;--teal-600:#008074;--teal-700:#00695f;--teal-800:#00534b;--teal-900:#003c36;--orange-50:#fff8f2;--orange-100:#fde0c2;--orange-200:#fbc791;--orange-300:#f9ae61;--orange-400:#f79530;--orange-500:#f57c00;--orange-600:#d06900;--orange-700:#ac5700;--orange-800:#874400;--orange-900:#623200;--bluegray-50:#f7f9f9;--bluegray-100:#d9e0e3;--bluegray-200:#bbc7cd;--bluegray-300:#9caeb7;--bluegray-400:#7e96a1;--bluegray-500:#607d8b;--bluegray-600:#526a76;--bluegray-700:#435861;--bluegray-800:#35454c;--bluegray-900:#263238;--purple-50:#faf4fb;--purple-100:#e7cbec;--purple-200:#d4a2dd;--purple-300:#c279ce;--purple-400:#af50bf;--purple-500:#9c27b0;--purple-600:#852196;--purple-700:#6d1b7b;--purple-800:#561561;--purple-900:#3e1046;--red-50:#fff5f5;--red-100:#ffd1ce;--red-200:#ffada7;--red-300:#ff8980;--red-400:#ff6459;--red-500:#ff4032;--red-600:#d9362b;--red-700:#b32d23;--red-800:#8c231c;--red-900:#661a14;--primary-50:#f4fafe;--primary-100:#cae6fc;--primary-200:#a0d2fa;--primary-300:#75bef8;--primary-400:#4baaf5;--primary-500:#2196f3;--primary-600:#1c80cf;--primary-700:#1769aa;--primary-800:#125386;--primary-900:#0d3c61}@layer primeng{*{box-sizing:border-box}}@layer primeng{button{border-radius:0}}:root{--fa-style-family-brands:"Font Awesome 6 Brands";--fa-font-brands:normal 400 1em/1 "Font Awesome 6 Brands"}@font-face{font-family:"Font Awesome 6 Brands";font-style:normal;font-weight:400;font-display:block;src:url(fa-brands-400.87587a681474fe69.woff2) format("woff2"),url(fa-brands-400.5d18d427c08f12c3.ttf) format("truetype")}:root{--fa-style-family-classic:"Font Awesome 6 Free";--fa-font-regular:normal 400 1em/1 "Font Awesome 6 Free"}@font-face{font-family:"Font Awesome 6 Free";font-style:normal;font-weight:400;font-display:block;src:url(fa-regular-400.3ccdbd3d093918cb.woff2) format("woff2"),url(fa-regular-400.81482cd4d93fbfd4.ttf) format("truetype")}:root{--fa-style-family-classic:"Font Awesome 6 Free";--fa-font-solid:normal 900 1em/1 "Font Awesome 6 Free"}@font-face{font-family:"Font Awesome 6 Free";font-style:normal;font-weight:900;font-display:block;src:url(fa-solid-900.0b0cc8a6df2a4fc7.woff2) format("woff2"),url(fa-solid-900.69d3141ae4b2f721.ttf) format("truetype")}html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0}a{background-color:transparent}button,input{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button{text-transform:none}button{-webkit-appearance:button}button::-moz-focus-inner{border-style:none;padding:0}button:-moz-focusring{outline:1px dotted ButtonText}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-decoration{-webkit-appearance:none}body{color:#1b1b1b;background-color:#fff;overflow-x:hidden}input:not([disabled]):focus,button:not([disabled]):focus{outline:.25rem solid #2491ff;outline-offset:0}[href]:focus{outline:.25rem solid #2491ff;outline-offset:0}*,*:before,*:after{box-sizing:inherit}html{font-feature-settings:"kern" 1;font-kerning:normal;font-family:Roboto,sans-serif;font-size:100%}.usa-sr-only{position:absolute;left:-999em;right:auto}.usa-dark-background{-moz-osx-font-smoothing:grayscale;-webkit-font-smoothing:antialiased;background-color:#3d4551}.usa-dark-background p,.usa-dark-background span,.usa-dark-background a,.usa-dark-background a:visited{color:#fff}.usa-dark-background a:hover{color:#f0f0f0}.usa-icon{display:inline-block;fill:currentColor;height:1em;position:relative;width:1em}input[type=search]{box-sizing:border-box;appearance:none}[type=search]{padding-bottom:0;padding-top:0;border-bottom-right-radius:0;border-right:none;border-top-right-radius:0;box-sizing:border-box;float:left;font-size:.93rem;height:2rem;margin:0}:root{--ctgl-color-base-lightest:#f0f0f0;--ctgl-color-base-lighter:#dfe1e2;--ctgl-color-base-light:#a9aeb1;--ctgl-color-base:#71767a;--ctgl-color-base-dark:#565c65;--ctgl-color-base-darker:#3d4551;--ctgl-color-base-darkest:#1b1b1b;--ctgl-color-primary-lighter:#d9e8f6;--ctgl-color-primary-light:#73b3e7;--ctgl-color-primary:#0071bc;--ctgl-color-primary-vivid:#0050d8;--ctgl-color-primary-dark:#1a4480;--ctgl-color-primary-darker:#205493;--ctgl-color-primary-darkest:#112e51;--ctgl-color-secondary-lighter:#f3e1e4;--ctgl-color-secondary-light:#f2938c;--ctgl-color-secondary:#d83933;--ctgl-color-secondary-vivid:#e41d3d;--ctgl-color-secondary-dark:#b50909;--ctgl-color-secondary-darker:#8b0a03;--ctgl-color-accent-warm-lighter:#f2e4d4;--ctgl-color-accent-warm-light:#ffbc78;--ctgl-color-accent-warm:#fa9441;--ctgl-color-accent-warm-dark:#c05600;--ctgl-color-accent-warm-darker:#775540;--ctgl-color-accent-cool-lighter:#e1f3f8;--ctgl-color-accent-cool-light:#97d4ea;--ctgl-color-accent-cool:#00bde3;--ctgl-color-accent-cool-dark:#28a0cb;--ctgl-color-accent-cool-darker:#07648d;--ctgl-color-error-lighter:#f4e3db;--ctgl-color-error-light:#f39268;--ctgl-color-error:#d54309;--ctgl-color-error-dark:#b50909;--ctgl-color-error-darker:#6f3331;--ctgl-color-warning-lighter:#faf3d1;--ctgl-color-warning-light:#fee685;--ctgl-color-warning:#ffbe2e;--ctgl-color-warning-dark:#e5a000;--ctgl-color-warning-darker:#936f38;--ctgl-color-success-lighter:#ecf3ec;--ctgl-color-success-light:#70e17b;--ctgl-color-success:#00a91c;--ctgl-color-success-dark:#008817;--ctgl-color-success-darker:#216e1f;--ctgl-color-info-lighter:#e7f6f8;--ctgl-color-info-light:#99deea;--ctgl-color-info:#00bde3;--ctgl-color-info-dark:#009ec1;--ctgl-color-info-darker:#2e6276;--ctgl-color-disabled-light:#e6e6e6;--ctgl-color-disabled:#c9c9c9;--ctgl-color-disabled-dark:#adadad;--ctgl-color-emergency:#9c3d10;--ctgl-color-emergency-dark:#332d29;--ctgl-color-red-cool-5:#f8eff1;--ctgl-color-red-cool-10:#f3e1e4;--ctgl-color-red-cool-20:#ecbec6;--ctgl-color-red-cool-30:#e09aa6;--ctgl-color-red-cool-40:#e16b80;--ctgl-color-red-cool-50:#cd425b;--ctgl-color-red-cool-60:#9e394b;--ctgl-color-red-cool-70:#68363f;--ctgl-color-red-cool-80:#40282c;--ctgl-color-red-cool-90:#1e1517;--ctgl-color-red-cool-5v:#fff2f5;--ctgl-color-red-cool-10v:#f8dfe2;--ctgl-color-red-cool-20v:#f8b9c5;--ctgl-color-red-cool-30v:#fd8ba0;--ctgl-color-red-cool-40v:#f45d79;--ctgl-color-red-cool-50v:#e41d3d;--ctgl-color-red-cool-60v:#b21d38;--ctgl-color-red-cool-70v:#822133;--ctgl-color-red-cool-80v:#4f1c24;--ctgl-color-red-5:#f9eeee;--ctgl-color-red-10:#f8e1de;--ctgl-color-red-20:#f7bbb1;--ctgl-color-red-30:#f2938c;--ctgl-color-red-40:#e9695f;--ctgl-color-red-50:#d83933;--ctgl-color-red-60:#a23737;--ctgl-color-red-70:#6f3331;--ctgl-color-red-80:#3e2927;--ctgl-color-red-90:#1b1616;--ctgl-color-red-5v:#fff3f2;--ctgl-color-red-10v:#fde0db;--ctgl-color-red-20v:#fdb8ae;--ctgl-color-red-30v:#ff8d7b;--ctgl-color-red-40v:#fb5a47;--ctgl-color-red-50v:#e52207;--ctgl-color-red-60v:#b50909;--ctgl-color-red-70v:#8b0a03;--ctgl-color-red-80v:#5c1111;--ctgl-color-red-warm-5:#f6efea;--ctgl-color-red-warm-10:#f4e3db;--ctgl-color-red-warm-20:#ecc0a7;--ctgl-color-red-warm-30:#dca081;--ctgl-color-red-warm-40:#d27a56;--ctgl-color-red-warm-50:#c3512c;--ctgl-color-red-warm-60:#805039;--ctgl-color-red-warm-70:#524236;--ctgl-color-red-warm-80:#332d29;--ctgl-color-red-warm-90:#1f1c18;--ctgl-color-red-warm-5v:#fff5ee;--ctgl-color-red-warm-10v:#fce1d4;--ctgl-color-red-warm-20v:#f6bd9c;--ctgl-color-red-warm-30v:#f39268;--ctgl-color-red-warm-40v:#ef5e25;--ctgl-color-red-warm-50v:#d54309;--ctgl-color-red-warm-60v:#9c3d10;--ctgl-color-red-warm-70v:#63340f;--ctgl-color-red-warm-80v:#3e2a1e;--ctgl-color-orange-warm-5:#faeee5;--ctgl-color-orange-warm-10:#fbe0d0;--ctgl-color-orange-warm-20:#f7bca2;--ctgl-color-orange-warm-30:#f3966d;--ctgl-color-orange-warm-40:#e17141;--ctgl-color-orange-warm-50:#bd5727;--ctgl-color-orange-warm-60:#914734;--ctgl-color-orange-warm-70:#633a32;--ctgl-color-orange-warm-80:#3d2925;--ctgl-color-orange-warm-90:#1c1615;--ctgl-color-orange-warm-5v:#fff3ea;--ctgl-color-orange-warm-10v:#ffe2d1;--ctgl-color-orange-warm-20v:#fbbaa7;--ctgl-color-orange-warm-30v:#fc906d;--ctgl-color-orange-warm-40v:#ff580a;--ctgl-color-orange-warm-50v:#cf4900;--ctgl-color-orange-warm-60v:#a72f10;--ctgl-color-orange-warm-70v:#782312;--ctgl-color-orange-warm-80v:#3d231d;--ctgl-color-orange-5:#f6efe9;--ctgl-color-orange-10:#f2e4d4;--ctgl-color-orange-20:#f3bf90;--ctgl-color-orange-30:#f09860;--ctgl-color-orange-40:#dd7533;--ctgl-color-orange-50:#a86437;--ctgl-color-orange-60:#775540;--ctgl-color-orange-70:#524236;--ctgl-color-orange-80:#332d27;--ctgl-color-orange-90:#1b1614;--ctgl-color-orange-5v:#fef2e4;--ctgl-color-orange-10v:#fce2c5;--ctgl-color-orange-20v:#ffbc78;--ctgl-color-orange-30v:#fa9441;--ctgl-color-orange-40v:#e66f0e;--ctgl-color-orange-50v:#c05600;--ctgl-color-orange-60v:#8c471c;--ctgl-color-orange-70v:#5f3617;--ctgl-color-orange-80v:#352313;--ctgl-color-gold-5:#f5f0e6;--ctgl-color-gold-10:#f1e5cd;--ctgl-color-gold-20:#dec69a;--ctgl-color-gold-30:#c7a97b;--ctgl-color-gold-40:#ad8b65;--ctgl-color-gold-50:#8e704f;--ctgl-color-gold-60:#6b5947;--ctgl-color-gold-70:#4d4438;--ctgl-color-gold-80:#322d26;--ctgl-color-gold-90:#191714;--ctgl-color-gold-5v:#fef0c8;--ctgl-color-gold-10v:#ffe396;--ctgl-color-gold-20v:#ffbe2e;--ctgl-color-gold-30v:#e5a000;--ctgl-color-gold-40v:#c2850c;--ctgl-color-gold-50v:#936f38;--ctgl-color-gold-60v:#7a591a;--ctgl-color-gold-70v:#5c410a;--ctgl-color-gold-80v:#3b2b15;--ctgl-color-yellow-5:#faf3d1;--ctgl-color-yellow-10:#f5e6af;--ctgl-color-yellow-20:#e6c74c;--ctgl-color-yellow-30:#c9ab48;--ctgl-color-yellow-40:#a88f48;--ctgl-color-yellow-50:#8a7237;--ctgl-color-yellow-60:#6b5a39;--ctgl-color-yellow-70:#504332;--ctgl-color-yellow-80:#332d27;--ctgl-color-yellow-90:#1a1614;--ctgl-color-yellow-5v:#fff5c2;--ctgl-color-yellow-10v:#fee685;--ctgl-color-yellow-20v:#face00;--ctgl-color-yellow-30v:#ddaa01;--ctgl-color-yellow-40v:#b38c00;--ctgl-color-yellow-50v:#947100;--ctgl-color-yellow-60v:#776017;--ctgl-color-yellow-70v:#5c4809;--ctgl-color-yellow-80v:#422d19;--ctgl-color-green-warm-5:#f1f4d7;--ctgl-color-green-warm-10:#e7eab7;--ctgl-color-green-warm-20:#cbd17a;--ctgl-color-green-warm-30:#a6b557;--ctgl-color-green-warm-40:#8a984b;--ctgl-color-green-warm-50:#6f7a41;--ctgl-color-green-warm-60:#5a5f38;--ctgl-color-green-warm-70:#45472f;--ctgl-color-green-warm-80:#2d2f21;--ctgl-color-green-warm-90:#171712;--ctgl-color-green-warm-5v:#f5fbc1;--ctgl-color-green-warm-10v:#e7f434;--ctgl-color-green-warm-20v:#c5d30a;--ctgl-color-green-warm-30v:#a3b72c;--ctgl-color-green-warm-40v:#7e9c1d;--ctgl-color-green-warm-50v:#6a7d00;--ctgl-color-green-warm-60v:#5a6613;--ctgl-color-green-warm-70v:#4b4e10;--ctgl-color-green-warm-80v:#38380b;--ctgl-color-green-5:#eaf4dd;--ctgl-color-green-10:#dfeacd;--ctgl-color-green-20:#b8d293;--ctgl-color-green-30:#9bb672;--ctgl-color-green-40:#7d9b4e;--ctgl-color-green-50:#607f35;--ctgl-color-green-60:#4c6424;--ctgl-color-green-70:#3c4a29;--ctgl-color-green-80:#293021;--ctgl-color-green-90:#161814;--ctgl-color-green-5v:#ddf9c7;--ctgl-color-green-10v:#c5ee93;--ctgl-color-green-20v:#98d035;--ctgl-color-green-30v:#7fb135;--ctgl-color-green-40v:#719f2a;--ctgl-color-green-50v:#538200;--ctgl-color-green-60v:#466c04;--ctgl-color-green-70v:#2f4a0b;--ctgl-color-green-80v:#243413;--ctgl-color-green-cool-5:#ecf3ec;--ctgl-color-green-cool-10:#dbebde;--ctgl-color-green-cool-20:#b4d0b9;--ctgl-color-green-cool-30:#86b98e;--ctgl-color-green-cool-40:#5e9f69;--ctgl-color-green-cool-50:#4d8055;--ctgl-color-green-cool-60:#446443;--ctgl-color-green-cool-70:#37493b;--ctgl-color-green-cool-80:#28312a;--ctgl-color-green-cool-90:#1a1f1a;--ctgl-color-green-cool-5v:#e3f5e1;--ctgl-color-green-cool-10v:#b7f5bd;--ctgl-color-green-cool-20v:#70e17b;--ctgl-color-green-cool-30v:#21c834;--ctgl-color-green-cool-40v:#00a91c;--ctgl-color-green-cool-50v:#008817;--ctgl-color-green-cool-60v:#216e1f;--ctgl-color-green-cool-70v:#154c21;--ctgl-color-green-cool-80v:#19311e;--ctgl-color-mint-5:#dbf6ed;--ctgl-color-mint-10:#c7efe2;--ctgl-color-mint-20:#92d9bb;--ctgl-color-mint-30:#5abf95;--ctgl-color-mint-40:#34a37e;--ctgl-color-mint-50:#2e8367;--ctgl-color-mint-60:#286846;--ctgl-color-mint-70:#204e34;--ctgl-color-mint-80:#193324;--ctgl-color-mint-90:#0d1a12;--ctgl-color-mint-5v:#c9fbeb;--ctgl-color-mint-10v:#83fcd4;--ctgl-color-mint-20v:#0ceda6;--ctgl-color-mint-30v:#04c585;--ctgl-color-mint-40v:#00a871;--ctgl-color-mint-50v:#008659;--ctgl-color-mint-60v:#146947;--ctgl-color-mint-70v:#0c4e29;--ctgl-color-mint-80v:#0d351e;--ctgl-color-mint-cool-5:#e0f7f6;--ctgl-color-mint-cool-10:#c4eeeb;--ctgl-color-mint-cool-20:#9bd4cf;--ctgl-color-mint-cool-30:#6fbab3;--ctgl-color-mint-cool-40:#4f9e99;--ctgl-color-mint-cool-50:#40807e;--ctgl-color-mint-cool-60:#376462;--ctgl-color-mint-cool-70:#2a4b45;--ctgl-color-mint-cool-80:#203131;--ctgl-color-mint-cool-90:#111818;--ctgl-color-mint-cool-5v:#d5fbf3;--ctgl-color-mint-cool-10v:#7efbe1;--ctgl-color-mint-cool-20v:#29e1cb;--ctgl-color-mint-cool-30v:#1dc2ae;--ctgl-color-mint-cool-40v:#00a398;--ctgl-color-mint-cool-50v:#008480;--ctgl-color-mint-cool-60v:#0f6460;--ctgl-color-mint-cool-70v:#0b4b3f;--ctgl-color-mint-cool-80v:#123131;--ctgl-color-cyan-5:#e7f6f8;--ctgl-color-cyan-10:#ccecf2;--ctgl-color-cyan-20:#99deea;--ctgl-color-cyan-30:#5dc0d1;--ctgl-color-cyan-40:#449dac;--ctgl-color-cyan-50:#168092;--ctgl-color-cyan-60:#2a646d;--ctgl-color-cyan-70:#2c4a4e;--ctgl-color-cyan-80:#203133;--ctgl-color-cyan-90:#111819;--ctgl-color-cyan-5v:#e5faff;--ctgl-color-cyan-10v:#a8f2ff;--ctgl-color-cyan-20v:#52daf2;--ctgl-color-cyan-30v:#00bde3;--ctgl-color-cyan-40v:#009ec1;--ctgl-color-cyan-50v:#0081a1;--ctgl-color-cyan-60v:#00687d;--ctgl-color-cyan-70v:#0e4f5c;--ctgl-color-cyan-80v:#093b44;--ctgl-color-blue-cool-5:#e7f2f5;--ctgl-color-blue-cool-10:#dae9ee;--ctgl-color-blue-cool-20:#adcfdc;--ctgl-color-blue-cool-30:#82b4c9;--ctgl-color-blue-cool-40:#6499af;--ctgl-color-blue-cool-50:#3a7d95;--ctgl-color-blue-cool-60:#2e6276;--ctgl-color-blue-cool-70:#224a58;--ctgl-color-blue-cool-80:#14333d;--ctgl-color-blue-cool-90:#0f191c;--ctgl-color-blue-cool-5v:#e1f3f8;--ctgl-color-blue-cool-10v:#c3ebfa;--ctgl-color-blue-cool-20v:#97d4ea;--ctgl-color-blue-cool-30v:#59b9de;--ctgl-color-blue-cool-40v:#28a0cb;--ctgl-color-blue-cool-50v:#0d7ea2;--ctgl-color-blue-cool-60v:#07648d;--ctgl-color-blue-cool-70v:#074b69;--ctgl-color-blue-cool-80v:#002d3f;--ctgl-color-blue-5:#eff6fb;--ctgl-color-blue-10:#d9e8f6;--ctgl-color-blue-20:#aacdec;--ctgl-color-blue-30:#73b3e7;--ctgl-color-blue-40:#4f97d1;--ctgl-color-blue-50:#2378c3;--ctgl-color-blue-60:#2c608a;--ctgl-color-blue-70:#274863;--ctgl-color-blue-80:#1f303e;--ctgl-color-blue-90:#11181d;--ctgl-color-blue-5v:#e8f5ff;--ctgl-color-blue-10v:#cfe8ff;--ctgl-color-blue-20v:#a1d3ff;--ctgl-color-blue-30v:#58b4ff;--ctgl-color-blue-40v:#2491ff;--ctgl-color-blue-50v:#0076d6;--ctgl-color-blue-60v:#005ea2;--ctgl-color-blue-70v:#0b4778;--ctgl-color-blue-80v:#112f4e;--ctgl-color-blue-warm-5:#ecf1f7;--ctgl-color-blue-warm-10:#e1e7f1;--ctgl-color-blue-warm-20:#bbcae4;--ctgl-color-blue-warm-30:#98afd2;--ctgl-color-blue-warm-40:#7292c7;--ctgl-color-blue-warm-50:#4a77b4;--ctgl-color-blue-warm-60:#345d96;--ctgl-color-blue-warm-70:#2f4668;--ctgl-color-blue-warm-80:#252f3e;--ctgl-color-blue-warm-90:#13171f;--ctgl-color-blue-warm-5v:#edf5ff;--ctgl-color-blue-warm-10v:#d4e5ff;--ctgl-color-blue-warm-20v:#adcdff;--ctgl-color-blue-warm-30v:#81aefc;--ctgl-color-blue-warm-40v:#5994f6;--ctgl-color-blue-warm-50v:#2672de;--ctgl-color-blue-warm-60v:#0050d8;--ctgl-color-blue-warm-70v:#1a4480;--ctgl-color-blue-warm-80v:#162e51;--ctgl-color-indigo-cool-5:#eef0f9;--ctgl-color-indigo-cool-10:#e1e6f9;--ctgl-color-indigo-cool-20:#bbc8f5;--ctgl-color-indigo-cool-30:#96abee;--ctgl-color-indigo-cool-40:#6b8ee8;--ctgl-color-indigo-cool-50:#496fd8;--ctgl-color-indigo-cool-60:#3f57a6;--ctgl-color-indigo-cool-70:#374274;--ctgl-color-indigo-cool-80:#292d42;--ctgl-color-indigo-cool-90:#151622;--ctgl-color-indigo-cool-5v:#edf0ff;--ctgl-color-indigo-cool-10v:#dee5ff;--ctgl-color-indigo-cool-20v:#b8c8ff;--ctgl-color-indigo-cool-30v:#94adff;--ctgl-color-indigo-cool-40v:#628ef4;--ctgl-color-indigo-cool-50v:#4866ff;--ctgl-color-indigo-cool-60v:#3e4ded;--ctgl-color-indigo-cool-70v:#222fbf;--ctgl-color-indigo-cool-80v:#1b2b85;--ctgl-color-indigo-5:#efeff8;--ctgl-color-indigo-10:#e5e4fa;--ctgl-color-indigo-20:#c5c5f3;--ctgl-color-indigo-30:#a5a8eb;--ctgl-color-indigo-40:#8889db;--ctgl-color-indigo-50:#676cc8;--ctgl-color-indigo-60:#4d52af;--ctgl-color-indigo-70:#3d4076;--ctgl-color-indigo-80:#2b2c40;--ctgl-color-indigo-90:#16171f;--ctgl-color-indigo-5v:#f0f0ff;--ctgl-color-indigo-10v:#e0e0ff;--ctgl-color-indigo-20v:#ccceff;--ctgl-color-indigo-30v:#a3a7fa;--ctgl-color-indigo-40v:#8289ff;--ctgl-color-indigo-50v:#656bd7;--ctgl-color-indigo-60v:#4a50c4;--ctgl-color-indigo-70v:#3333a3;--ctgl-color-indigo-80v:#212463;--ctgl-color-indigo-warm-5:#f1eff7;--ctgl-color-indigo-warm-10:#e7e3fa;--ctgl-color-indigo-warm-20:#cbc4f2;--ctgl-color-indigo-warm-30:#afa5e8;--ctgl-color-indigo-warm-40:#9287d8;--ctgl-color-indigo-warm-50:#7665d1;--ctgl-color-indigo-warm-60:#5e519e;--ctgl-color-indigo-warm-70:#453c7b;--ctgl-color-indigo-warm-80:#2e2c40;--ctgl-color-indigo-warm-90:#18161d;--ctgl-color-indigo-warm-5v:#f5f2ff;--ctgl-color-indigo-warm-10v:#e4deff;--ctgl-color-indigo-warm-20v:#cfc4fd;--ctgl-color-indigo-warm-30v:#b69fff;--ctgl-color-indigo-warm-40v:#967efb;--ctgl-color-indigo-warm-50v:#745fe9;--ctgl-color-indigo-warm-60v:#5942d2;--ctgl-color-indigo-warm-70v:#3d2c9d;--ctgl-color-indigo-warm-80v:#261f5b;--ctgl-color-violet-5:#f4f1f9;--ctgl-color-violet-10:#ebe3f9;--ctgl-color-violet-20:#d0c3e9;--ctgl-color-violet-30:#b8a2e3;--ctgl-color-violet-40:#9d84d2;--ctgl-color-violet-50:#8168b3;--ctgl-color-violet-60:#665190;--ctgl-color-violet-70:#4c3d69;--ctgl-color-violet-80:#312b3f;--ctgl-color-violet-90:#18161d;--ctgl-color-violet-5v:#f7f2ff;--ctgl-color-violet-10v:#ede3ff;--ctgl-color-violet-20v:#d5bfff;--ctgl-color-violet-30v:#c39deb;--ctgl-color-violet-40v:#ad79e9;--ctgl-color-violet-50v:#9355dc;--ctgl-color-violet-60v:#783cb9;--ctgl-color-violet-70v:#54278f;--ctgl-color-violet-80v:#39215e;--ctgl-color-violet-warm-5:#f8f0f9;--ctgl-color-violet-warm-10:#f6dff8;--ctgl-color-violet-warm-20:#e2bee4;--ctgl-color-violet-warm-30:#d29ad8;--ctgl-color-violet-warm-40:#bf77c8;--ctgl-color-violet-warm-50:#b04abd;--ctgl-color-violet-warm-60:#864381;--ctgl-color-violet-warm-70:#5c395a;--ctgl-color-violet-warm-80:#382936;--ctgl-color-violet-warm-90:#1b151b;--ctgl-color-violet-warm-5v:#fef2ff;--ctgl-color-violet-warm-10v:#fbdcff;--ctgl-color-violet-warm-20v:#f4b2ff;--ctgl-color-violet-warm-30v:#ee83ff;--ctgl-color-violet-warm-40v:#d85bef;--ctgl-color-violet-warm-50v:#be32d0;--ctgl-color-violet-warm-60v:#93348c;--ctgl-color-violet-warm-70v:#711e6c;--ctgl-color-violet-warm-80v:#481441;--ctgl-color-magenta-5:#f9f0f2;--ctgl-color-magenta-10:#f6e1e8;--ctgl-color-magenta-20:#f0bbcc;--ctgl-color-magenta-30:#e895b3;--ctgl-color-magenta-40:#e0699f;--ctgl-color-magenta-50:#c84281;--ctgl-color-magenta-60:#8b4566;--ctgl-color-magenta-70:#66364b;--ctgl-color-magenta-80:#402731;--ctgl-color-magenta-90:#1b1617;--ctgl-color-magenta-5v:#fff2f5;--ctgl-color-magenta-10v:#ffddea;--ctgl-color-magenta-20v:#ffb4cf;--ctgl-color-magenta-30v:#ff87b2;--ctgl-color-magenta-40v:#fd4496;--ctgl-color-magenta-50v:#d72d79;--ctgl-color-magenta-60v:#ab2165;--ctgl-color-magenta-70v:#731f44;--ctgl-color-magenta-80v:#4f172e;--ctgl-color-gray-cool-1:#fbfcfd;--ctgl-color-gray-cool-2:#f7f9fa;--ctgl-color-gray-cool-3:#f5f6f7;--ctgl-color-gray-cool-4:#f1f3f6;--ctgl-color-gray-cool-5:#edeff0;--ctgl-color-gray-cool-10:#dfe1e2;--ctgl-color-gray-cool-20:#c6cace;--ctgl-color-gray-cool-30:#a9aeb1;--ctgl-color-gray-cool-40:#8d9297;--ctgl-color-gray-cool-50:#71767a;--ctgl-color-gray-cool-60:#565c65;--ctgl-color-gray-cool-70:#3d4551;--ctgl-color-gray-cool-80:#2d2e2f;--ctgl-color-gray-cool-90:#1c1d1f;--ctgl-color-gray-1:#fcfcfc;--ctgl-color-gray-2:#f9f9f9;--ctgl-color-gray-3:#f6f6f6;--ctgl-color-gray-4:#f3f3f3;--ctgl-color-gray-5:#f0f0f0;--ctgl-color-gray-10:#e6e6e6;--ctgl-color-gray-20:#c9c9c9;--ctgl-color-gray-30:#adadad;--ctgl-color-gray-40:#919191;--ctgl-color-gray-50:#757575;--ctgl-color-gray-60:#5c5c5c;--ctgl-color-gray-70:#454545;--ctgl-color-gray-80:#2e2e2e;--ctgl-color-gray-90:#1b1b1b;--ctgl-color-gray-100:#000000;--ctgl-color-gray-warm-1:#fcfcfb;--ctgl-color-gray-warm-2:#f9f9f7;--ctgl-color-gray-warm-3:#f6f6f2;--ctgl-color-gray-warm-4:#f5f5f0;--ctgl-color-gray-warm-5:#f0f0ec;--ctgl-color-gray-warm-10:#e6e6e2;--ctgl-color-gray-warm-20:#cac9c0;--ctgl-color-gray-warm-30:#afaea2;--ctgl-color-gray-warm-40:#929285;--ctgl-color-gray-warm-50:#76766a;--ctgl-color-gray-warm-60:#5d5d52;--ctgl-color-gray-warm-70:#454540;--ctgl-color-gray-warm-80:#2e2e2a;--ctgl-color-gray-warm-90:#171716;--ctgl-color-black-transparent-5:rgba(0, 0, 0, .01);--ctgl-color-black-transparent-10:rgba(0, 0, 0, .1);--ctgl-color-black-transparent-20:rgba(0, 0, 0, .2);--ctgl-color-black-transparent-30:rgba(0, 0, 0, .3);--ctgl-color-black-transparent-40:rgba(0, 0, 0, .4);--ctgl-color-black-transparent-50:rgba(0, 0, 0, .5);--ctgl-color-black-transparent-60:rgba(0, 0, 0, .6);--ctgl-color-black-transparent-70:rgba(0, 0, 0, .7);--ctgl-color-black-transparent-80:rgba(0, 0, 0, .8);--ctgl-color-black-transparent-90:rgba(0, 0, 0, .9);--ctgl-color-white-transparent-5:rgba(255, 255, 255, .01);--ctgl-color-white-transparent-10:rgba(255, 255, 255, .1);--ctgl-color-white-transparent-20:rgba(255, 255, 255, .2);--ctgl-color-white-transparent-30:rgba(255, 255, 255, .3);--ctgl-color-white-transparent-40:rgba(255, 255, 255, .4);--ctgl-color-white-transparent-50:rgba(255, 255, 255, .5);--ctgl-color-white-transparent-60:rgba(255, 255, 255, .6);--ctgl-color-white-transparent-70:rgba(255, 255, 255, .7);--ctgl-color-white-transparent-80:rgba(255, 255, 255, .8);--ctgl-color-white-transparent-90:rgba(255, 255, 255, .9)}:root{--ctgl-breakpoint-card:10rem;--ctgl-breakpoint-card-lg:15rem;--ctgl-breakpoint-mobile:20rem;--ctgl-breakpoint-mobile-lg:30rem;--ctgl-breakpoint-tablet:40rem;--ctgl-breakpoint-tablet-lg:55rem;--ctgl-breakpoint-desktop:64rem;--ctgl-breakpoint-desktop-lg:75rem;--ctgl-breakpoint-widescreen:87.5rem}:root{font-family:Roboto,sans-serif}html{--mat-ripple-color:rgba(0, 0, 0, .1)}html{--mat-option-selected-state-label-text-color:#0071bc;--mat-option-label-text-color:rgba(0, 0, 0, .87);--mat-option-hover-state-layer-color:rgba(0, 0, 0, .04);--mat-option-focus-state-layer-color:rgba(0, 0, 0, .04);--mat-option-selected-state-layer-color:rgba(0, 0, 0, .04)}html{--mat-optgroup-label-text-color:rgba(0, 0, 0, .87)}html{--mat-full-pseudo-checkbox-selected-icon-color:#448aff;--mat-full-pseudo-checkbox-selected-checkmark-color:#fafafa;--mat-full-pseudo-checkbox-unselected-icon-color:rgba(0, 0, 0, .54);--mat-full-pseudo-checkbox-disabled-selected-checkmark-color:#fafafa;--mat-full-pseudo-checkbox-disabled-unselected-icon-color:#b0b0b0;--mat-full-pseudo-checkbox-disabled-selected-icon-color:#b0b0b0;--mat-minimal-pseudo-checkbox-selected-checkmark-color:#448aff;--mat-minimal-pseudo-checkbox-disabled-selected-checkmark-color:#b0b0b0}html{--mat-app-background-color:#fafafa;--mat-app-text-color:rgba(0, 0, 0, .87)}html{--mdc-elevated-card-container-shape:4px;--mdc-outlined-card-container-shape:4px;--mdc-outlined-card-outline-width:1px}html{--mdc-elevated-card-container-color:white;--mdc-elevated-card-container-elevation:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-outlined-card-container-color:white;--mdc-outlined-card-outline-color:rgba(0, 0, 0, .12);--mdc-outlined-card-container-elevation:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mat-card-subtitle-text-color:rgba(0, 0, 0, .54)}html{--mdc-linear-progress-active-indicator-height:4px;--mdc-linear-progress-track-height:4px;--mdc-linear-progress-track-shape:0}html{--mdc-plain-tooltip-container-shape:4px;--mdc-plain-tooltip-supporting-text-line-height:16px}html{--mdc-plain-tooltip-container-color:#616161;--mdc-plain-tooltip-supporting-text-color:#fff}html{--mdc-filled-text-field-active-indicator-height:1px;--mdc-filled-text-field-focus-active-indicator-height:2px;--mdc-filled-text-field-container-shape:4px;--mdc-outlined-text-field-outline-width:1px;--mdc-outlined-text-field-focus-outline-width:2px;--mdc-outlined-text-field-container-shape:4px}html{--mdc-filled-text-field-caret-color:#0071bc;--mdc-filled-text-field-focus-active-indicator-color:#0071bc;--mdc-filled-text-field-focus-label-text-color:rgba(0, 113, 188, .87);--mdc-filled-text-field-container-color:whitesmoke;--mdc-filled-text-field-disabled-container-color:#fafafa;--mdc-filled-text-field-label-text-color:rgba(0, 0, 0, .6);--mdc-filled-text-field-hover-label-text-color:rgba(0, 0, 0, .6);--mdc-filled-text-field-disabled-label-text-color:rgba(0, 0, 0, .38);--mdc-filled-text-field-input-text-color:rgba(0, 0, 0, .87);--mdc-filled-text-field-disabled-input-text-color:rgba(0, 0, 0, .38);--mdc-filled-text-field-input-text-placeholder-color:rgba(0, 0, 0, .6);--mdc-filled-text-field-error-hover-label-text-color:#f44336;--mdc-filled-text-field-error-focus-label-text-color:#f44336;--mdc-filled-text-field-error-label-text-color:#f44336;--mdc-filled-text-field-error-caret-color:#f44336;--mdc-filled-text-field-active-indicator-color:rgba(0, 0, 0, .42);--mdc-filled-text-field-disabled-active-indicator-color:rgba(0, 0, 0, .06);--mdc-filled-text-field-hover-active-indicator-color:rgba(0, 0, 0, .87);--mdc-filled-text-field-error-active-indicator-color:#f44336;--mdc-filled-text-field-error-focus-active-indicator-color:#f44336;--mdc-filled-text-field-error-hover-active-indicator-color:#f44336;--mdc-outlined-text-field-caret-color:#0071bc;--mdc-outlined-text-field-focus-outline-color:#0071bc;--mdc-outlined-text-field-focus-label-text-color:rgba(0, 113, 188, .87);--mdc-outlined-text-field-label-text-color:rgba(0, 0, 0, .6);--mdc-outlined-text-field-hover-label-text-color:rgba(0, 0, 0, .6);--mdc-outlined-text-field-disabled-label-text-color:rgba(0, 0, 0, .38);--mdc-outlined-text-field-input-text-color:rgba(0, 0, 0, .87);--mdc-outlined-text-field-disabled-input-text-color:rgba(0, 0, 0, .38);--mdc-outlined-text-field-input-text-placeholder-color:rgba(0, 0, 0, .6);--mdc-outlined-text-field-error-caret-color:#f44336;--mdc-outlined-text-field-error-focus-label-text-color:#f44336;--mdc-outlined-text-field-error-label-text-color:#f44336;--mdc-outlined-text-field-error-hover-label-text-color:#f44336;--mdc-outlined-text-field-outline-color:rgba(0, 0, 0, .38);--mdc-outlined-text-field-disabled-outline-color:rgba(0, 0, 0, .06);--mdc-outlined-text-field-hover-outline-color:rgba(0, 0, 0, .87);--mdc-outlined-text-field-error-focus-outline-color:#f44336;--mdc-outlined-text-field-error-hover-outline-color:#f44336;--mdc-outlined-text-field-error-outline-color:#f44336;--mat-form-field-focus-select-arrow-color:rgba(0, 113, 188, .87);--mat-form-field-disabled-input-text-placeholder-color:rgba(0, 0, 0, .38);--mat-form-field-state-layer-color:rgba(0, 0, 0, .87);--mat-form-field-error-text-color:#f44336;--mat-form-field-select-option-text-color:inherit;--mat-form-field-select-disabled-option-text-color:GrayText;--mat-form-field-leading-icon-color:unset;--mat-form-field-disabled-leading-icon-color:unset;--mat-form-field-trailing-icon-color:unset;--mat-form-field-disabled-trailing-icon-color:unset;--mat-form-field-error-focus-trailing-icon-color:unset;--mat-form-field-error-hover-trailing-icon-color:unset;--mat-form-field-error-trailing-icon-color:unset;--mat-form-field-enabled-select-arrow-color:rgba(0, 0, 0, .54);--mat-form-field-disabled-select-arrow-color:rgba(0, 0, 0, .38);--mat-form-field-hover-state-layer-opacity:.04;--mat-form-field-focus-state-layer-opacity:.08}html{--mat-form-field-container-height:56px;--mat-form-field-filled-label-display:block;--mat-form-field-container-vertical-padding:16px;--mat-form-field-filled-with-label-container-padding-top:24px;--mat-form-field-filled-with-label-container-padding-bottom:8px}html{--mat-select-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12)}html{--mat-select-panel-background-color:white;--mat-select-enabled-trigger-text-color:rgba(0, 0, 0, .87);--mat-select-disabled-trigger-text-color:rgba(0, 0, 0, .38);--mat-select-placeholder-text-color:rgba(0, 0, 0, .6);--mat-select-enabled-arrow-color:rgba(0, 0, 0, .54);--mat-select-disabled-arrow-color:rgba(0, 0, 0, .38);--mat-select-focused-arrow-color:rgba(0, 113, 188, .87);--mat-select-invalid-arrow-color:rgba(244, 67, 54, .87)}html{--mat-select-arrow-transform:translateY(-8px)}html{--mat-autocomplete-container-shape:4px;--mat-autocomplete-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12)}html{--mat-autocomplete-background-color:white}html{--mdc-dialog-container-elevation-shadow:0px 11px 15px -7px rgba(0, 0, 0, .2), 0px 24px 38px 3px rgba(0, 0, 0, .14), 0px 9px 46px 8px rgba(0, 0, 0, .12);--mdc-dialog-container-shadow-color:#000;--mdc-dialog-container-shape:4px;--mat-dialog-container-max-width:80vw;--mat-dialog-container-small-max-width:80vw;--mat-dialog-container-min-width:0;--mat-dialog-actions-alignment:start;--mat-dialog-actions-padding:8px;--mat-dialog-content-padding:20px 24px;--mat-dialog-with-actions-content-padding:20px 24px;--mat-dialog-headline-padding:0 24px 9px}html{--mdc-dialog-container-color:white;--mdc-dialog-subhead-color:rgba(0, 0, 0, .87);--mdc-dialog-supporting-text-color:rgba(0, 0, 0, .6)}html{--mdc-switch-disabled-selected-icon-opacity:.38;--mdc-switch-disabled-track-opacity:.12;--mdc-switch-disabled-unselected-icon-opacity:.38;--mdc-switch-handle-height:20px;--mdc-switch-handle-shape:10px;--mdc-switch-handle-width:20px;--mdc-switch-selected-icon-size:18px;--mdc-switch-track-height:14px;--mdc-switch-track-shape:7px;--mdc-switch-track-width:36px;--mdc-switch-unselected-icon-size:18px;--mdc-switch-selected-focus-state-layer-opacity:.12;--mdc-switch-selected-hover-state-layer-opacity:.04;--mdc-switch-selected-pressed-state-layer-opacity:.1;--mdc-switch-unselected-focus-state-layer-opacity:.12;--mdc-switch-unselected-hover-state-layer-opacity:.04;--mdc-switch-unselected-pressed-state-layer-opacity:.1;--mat-switch-disabled-selected-handle-opacity:.38;--mat-switch-disabled-unselected-handle-opacity:.38;--mat-switch-unselected-handle-size:20px;--mat-switch-selected-handle-size:20px;--mat-switch-pressed-handle-size:20px;--mat-switch-with-icon-handle-size:20px;--mat-switch-selected-handle-horizontal-margin:0;--mat-switch-selected-with-icon-handle-horizontal-margin:0;--mat-switch-selected-pressed-handle-horizontal-margin:0;--mat-switch-unselected-handle-horizontal-margin:0;--mat-switch-unselected-with-icon-handle-horizontal-margin:0;--mat-switch-unselected-pressed-handle-horizontal-margin:0;--mat-switch-visible-track-opacity:1;--mat-switch-hidden-track-opacity:1;--mat-switch-visible-track-transition:transform 75ms 0ms cubic-bezier(0, 0, .2, 1);--mat-switch-hidden-track-transition:transform 75ms 0ms cubic-bezier(.4, 0, .6, 1);--mat-switch-track-outline-width:1px;--mat-switch-track-outline-color:transparent;--mat-switch-selected-track-outline-width:1px;--mat-switch-disabled-unselected-track-outline-width:1px;--mat-switch-disabled-unselected-track-outline-color:transparent}html{--mdc-switch-selected-focus-state-layer-color:#3949ab;--mdc-switch-selected-handle-color:#3949ab;--mdc-switch-selected-hover-state-layer-color:#3949ab;--mdc-switch-selected-pressed-state-layer-color:#3949ab;--mdc-switch-selected-focus-handle-color:#112e51;--mdc-switch-selected-hover-handle-color:#112e51;--mdc-switch-selected-pressed-handle-color:#112e51;--mdc-switch-selected-focus-track-color:#80b8dd;--mdc-switch-selected-hover-track-color:#80b8dd;--mdc-switch-selected-pressed-track-color:#80b8dd;--mdc-switch-selected-track-color:#80b8dd;--mdc-switch-disabled-selected-handle-color:#424242;--mdc-switch-disabled-selected-icon-color:#fff;--mdc-switch-disabled-selected-track-color:#424242;--mdc-switch-disabled-unselected-handle-color:#424242;--mdc-switch-disabled-unselected-icon-color:#fff;--mdc-switch-disabled-unselected-track-color:#424242;--mdc-switch-handle-surface-color:var(--mdc-theme-surface, #fff);--mdc-switch-handle-elevation-shadow:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-switch-handle-shadow-color:black;--mdc-switch-disabled-handle-elevation-shadow:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mdc-switch-selected-icon-color:#fff;--mdc-switch-unselected-focus-handle-color:#212121;--mdc-switch-unselected-focus-state-layer-color:#424242;--mdc-switch-unselected-focus-track-color:#e0e0e0;--mdc-switch-unselected-handle-color:#616161;--mdc-switch-unselected-hover-handle-color:#212121;--mdc-switch-unselected-hover-state-layer-color:#424242;--mdc-switch-unselected-hover-track-color:#e0e0e0;--mdc-switch-unselected-icon-color:#fff;--mdc-switch-unselected-pressed-handle-color:#212121;--mdc-switch-unselected-pressed-state-layer-color:#424242;--mdc-switch-unselected-pressed-track-color:#e0e0e0;--mdc-switch-unselected-track-color:#e0e0e0;--mdc-switch-disabled-label-text-color:rgba(0, 0, 0, .38)}html{--mdc-switch-state-layer-size:40px}html{--mdc-radio-disabled-selected-icon-opacity:.38;--mdc-radio-disabled-unselected-icon-opacity:.38;--mdc-radio-state-layer-size:40px}html{--mdc-radio-state-layer-size:40px;--mat-radio-touch-target-display:block}html{--mat-slider-value-indicator-width:auto;--mat-slider-value-indicator-height:32px;--mat-slider-value-indicator-caret-display:block;--mat-slider-value-indicator-border-radius:4px;--mat-slider-value-indicator-padding:0 12px;--mat-slider-value-indicator-text-transform:none;--mat-slider-value-indicator-container-transform:translateX(-50%);--mdc-slider-active-track-height:6px;--mdc-slider-active-track-shape:9999px;--mdc-slider-handle-height:20px;--mdc-slider-handle-shape:50%;--mdc-slider-handle-width:20px;--mdc-slider-inactive-track-height:4px;--mdc-slider-inactive-track-shape:9999px;--mdc-slider-with-overlap-handle-outline-width:1px;--mdc-slider-with-tick-marks-active-container-opacity:.6;--mdc-slider-with-tick-marks-container-shape:50%;--mdc-slider-with-tick-marks-container-size:2px;--mdc-slider-with-tick-marks-inactive-container-opacity:.6}html{--mdc-slider-handle-color:#0071bc;--mdc-slider-focus-handle-color:#0071bc;--mdc-slider-hover-handle-color:#0071bc;--mdc-slider-active-track-color:#0071bc;--mdc-slider-inactive-track-color:#0071bc;--mdc-slider-with-tick-marks-inactive-container-color:#0071bc;--mdc-slider-with-tick-marks-active-container-color:white;--mdc-slider-disabled-active-track-color:#000;--mdc-slider-disabled-handle-color:#000;--mdc-slider-disabled-inactive-track-color:#000;--mdc-slider-label-container-color:#000;--mdc-slider-label-label-text-color:#fff;--mdc-slider-with-overlap-handle-outline-color:#fff;--mdc-slider-with-tick-marks-disabled-container-color:#000;--mdc-slider-handle-elevation:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mat-slider-ripple-color:#0071bc;--mat-slider-hover-state-layer-color:rgba(0, 113, 188, .05);--mat-slider-focus-state-layer-color:rgba(0, 113, 188, .2);--mat-slider-value-indicator-opacity:.6}html{--mat-menu-container-shape:4px;--mat-menu-divider-bottom-spacing:0;--mat-menu-divider-top-spacing:0;--mat-menu-item-spacing:16px;--mat-menu-item-icon-size:24px;--mat-menu-item-leading-spacing:16px;--mat-menu-item-trailing-spacing:16px;--mat-menu-item-with-icon-leading-spacing:16px;--mat-menu-item-with-icon-trailing-spacing:16px}html{--mat-menu-item-label-text-color:rgba(0, 0, 0, .87);--mat-menu-item-icon-color:rgba(0, 0, 0, .87);--mat-menu-item-hover-state-layer-color:rgba(0, 0, 0, .04);--mat-menu-item-focus-state-layer-color:rgba(0, 0, 0, .04);--mat-menu-container-color:white;--mat-menu-divider-color:rgba(0, 0, 0, .12)}html{--mdc-list-list-item-container-shape:0;--mdc-list-list-item-leading-avatar-shape:50%;--mdc-list-list-item-container-color:transparent;--mdc-list-list-item-selected-container-color:transparent;--mdc-list-list-item-leading-avatar-color:transparent;--mdc-list-list-item-leading-icon-size:24px;--mdc-list-list-item-leading-avatar-size:40px;--mdc-list-list-item-trailing-icon-size:24px;--mdc-list-list-item-disabled-state-layer-color:transparent;--mdc-list-list-item-disabled-state-layer-opacity:0;--mdc-list-list-item-disabled-label-text-opacity:.38;--mdc-list-list-item-disabled-leading-icon-opacity:.38;--mdc-list-list-item-disabled-trailing-icon-opacity:.38;--mat-list-active-indicator-color:transparent;--mat-list-active-indicator-shape:4px}html{--mdc-list-list-item-label-text-color:rgba(0, 0, 0, .87);--mdc-list-list-item-supporting-text-color:rgba(0, 0, 0, .54);--mdc-list-list-item-leading-icon-color:rgba(0, 0, 0, .38);--mdc-list-list-item-trailing-supporting-text-color:rgba(0, 0, 0, .38);--mdc-list-list-item-trailing-icon-color:rgba(0, 0, 0, .38);--mdc-list-list-item-selected-trailing-icon-color:rgba(0, 0, 0, .38);--mdc-list-list-item-disabled-label-text-color:black;--mdc-list-list-item-disabled-leading-icon-color:black;--mdc-list-list-item-disabled-trailing-icon-color:black;--mdc-list-list-item-hover-label-text-color:rgba(0, 0, 0, .87);--mdc-list-list-item-hover-leading-icon-color:rgba(0, 0, 0, .38);--mdc-list-list-item-hover-trailing-icon-color:rgba(0, 0, 0, .38);--mdc-list-list-item-focus-label-text-color:rgba(0, 0, 0, .87);--mdc-list-list-item-hover-state-layer-color:black;--mdc-list-list-item-hover-state-layer-opacity:.04;--mdc-list-list-item-focus-state-layer-color:black;--mdc-list-list-item-focus-state-layer-opacity:.12}html{--mdc-list-list-item-one-line-container-height:48px;--mdc-list-list-item-two-line-container-height:64px;--mdc-list-list-item-three-line-container-height:88px;--mat-list-list-item-leading-icon-start-space:16px;--mat-list-list-item-leading-icon-end-space:32px}html{--mat-paginator-container-text-color:rgba(0, 0, 0, .87);--mat-paginator-container-background-color:white;--mat-paginator-enabled-icon-color:rgba(0, 0, 0, .54);--mat-paginator-disabled-icon-color:rgba(0, 0, 0, .12)}html{--mat-paginator-container-size:56px;--mat-paginator-form-field-container-height:40px;--mat-paginator-form-field-container-vertical-padding:8px}html{--mdc-tab-indicator-active-indicator-height:2px;--mdc-tab-indicator-active-indicator-shape:0;--mdc-secondary-navigation-tab-container-height:48px;--mat-tab-header-divider-color:transparent;--mat-tab-header-divider-height:0}html{--mdc-checkbox-disabled-selected-checkmark-color:#fff;--mdc-checkbox-selected-focus-state-layer-opacity:.16;--mdc-checkbox-selected-hover-state-layer-opacity:.04;--mdc-checkbox-selected-pressed-state-layer-opacity:.16;--mdc-checkbox-unselected-focus-state-layer-opacity:.16;--mdc-checkbox-unselected-hover-state-layer-opacity:.04;--mdc-checkbox-unselected-pressed-state-layer-opacity:.16}html{--mdc-checkbox-disabled-selected-icon-color:rgba(0, 0, 0, .38);--mdc-checkbox-disabled-unselected-icon-color:rgba(0, 0, 0, .38);--mdc-checkbox-selected-checkmark-color:white;--mdc-checkbox-selected-focus-icon-color:#448aff;--mdc-checkbox-selected-hover-icon-color:#448aff;--mdc-checkbox-selected-icon-color:#448aff;--mdc-checkbox-selected-pressed-icon-color:#448aff;--mdc-checkbox-unselected-focus-icon-color:#212121;--mdc-checkbox-unselected-hover-icon-color:#212121;--mdc-checkbox-unselected-icon-color:rgba(0, 0, 0, .54);--mdc-checkbox-unselected-pressed-icon-color:rgba(0, 0, 0, .54);--mdc-checkbox-selected-focus-state-layer-color:#448aff;--mdc-checkbox-selected-hover-state-layer-color:#448aff;--mdc-checkbox-selected-pressed-state-layer-color:#448aff;--mdc-checkbox-unselected-focus-state-layer-color:black;--mdc-checkbox-unselected-hover-state-layer-color:black;--mdc-checkbox-unselected-pressed-state-layer-color:black;--mat-checkbox-disabled-label-color:rgba(0, 0, 0, .38)}html{--mdc-checkbox-state-layer-size:40px;--mat-checkbox-touch-target-display:block}html{--mdc-text-button-container-shape:4px;--mdc-text-button-keep-touch-target:false;--mdc-filled-button-container-shape:4px;--mdc-filled-button-keep-touch-target:false;--mdc-protected-button-container-shape:4px;--mdc-protected-button-keep-touch-target:false;--mdc-outlined-button-keep-touch-target:false;--mdc-outlined-button-outline-width:1px;--mdc-outlined-button-container-shape:4px;--mat-text-button-horizontal-padding:8px;--mat-text-button-with-icon-horizontal-padding:8px;--mat-text-button-icon-spacing:8px;--mat-text-button-icon-offset:0;--mat-filled-button-horizontal-padding:16px;--mat-filled-button-icon-spacing:8px;--mat-filled-button-icon-offset:-4px;--mat-protected-button-horizontal-padding:16px;--mat-protected-button-icon-spacing:8px;--mat-protected-button-icon-offset:-4px;--mat-outlined-button-horizontal-padding:15px;--mat-outlined-button-icon-spacing:8px;--mat-outlined-button-icon-offset:-4px}html{--mdc-text-button-label-text-color:black;--mdc-text-button-disabled-label-text-color:rgba(0, 0, 0, .38);--mat-text-button-state-layer-color:black;--mat-text-button-disabled-state-layer-color:black;--mat-text-button-ripple-color:rgba(0, 0, 0, .1);--mat-text-button-hover-state-layer-opacity:.04;--mat-text-button-focus-state-layer-opacity:.12;--mat-text-button-pressed-state-layer-opacity:.12;--mdc-filled-button-container-color:white;--mdc-filled-button-label-text-color:black;--mdc-filled-button-disabled-container-color:rgba(0, 0, 0, .12);--mdc-filled-button-disabled-label-text-color:rgba(0, 0, 0, .38);--mat-filled-button-state-layer-color:black;--mat-filled-button-disabled-state-layer-color:black;--mat-filled-button-ripple-color:rgba(0, 0, 0, .1);--mat-filled-button-hover-state-layer-opacity:.04;--mat-filled-button-focus-state-layer-opacity:.12;--mat-filled-button-pressed-state-layer-opacity:.12;--mdc-protected-button-container-color:white;--mdc-protected-button-label-text-color:black;--mdc-protected-button-disabled-container-color:rgba(0, 0, 0, .12);--mdc-protected-button-disabled-label-text-color:rgba(0, 0, 0, .38);--mdc-protected-button-container-elevation-shadow:0px 3px 1px -2px rgba(0, 0, 0, .2), 0px 2px 2px 0px rgba(0, 0, 0, .14), 0px 1px 5px 0px rgba(0, 0, 0, .12);--mdc-protected-button-disabled-container-elevation-shadow:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mdc-protected-button-focus-container-elevation-shadow:0px 2px 4px -1px rgba(0, 0, 0, .2), 0px 4px 5px 0px rgba(0, 0, 0, .14), 0px 1px 10px 0px rgba(0, 0, 0, .12);--mdc-protected-button-hover-container-elevation-shadow:0px 2px 4px -1px rgba(0, 0, 0, .2), 0px 4px 5px 0px rgba(0, 0, 0, .14), 0px 1px 10px 0px rgba(0, 0, 0, .12);--mdc-protected-button-pressed-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-protected-button-container-shadow-color:#000;--mat-protected-button-state-layer-color:black;--mat-protected-button-disabled-state-layer-color:black;--mat-protected-button-ripple-color:rgba(0, 0, 0, .1);--mat-protected-button-hover-state-layer-opacity:.04;--mat-protected-button-focus-state-layer-opacity:.12;--mat-protected-button-pressed-state-layer-opacity:.12;--mdc-outlined-button-disabled-outline-color:rgba(0, 0, 0, .12);--mdc-outlined-button-disabled-label-text-color:rgba(0, 0, 0, .38);--mdc-outlined-button-label-text-color:black;--mdc-outlined-button-outline-color:rgba(0, 0, 0, .12);--mat-outlined-button-state-layer-color:black;--mat-outlined-button-disabled-state-layer-color:black;--mat-outlined-button-ripple-color:rgba(0, 0, 0, .1);--mat-outlined-button-hover-state-layer-opacity:.04;--mat-outlined-button-focus-state-layer-opacity:.12;--mat-outlined-button-pressed-state-layer-opacity:.12}html{--mdc-text-button-container-height:36px;--mdc-filled-button-container-height:36px;--mdc-outlined-button-container-height:36px;--mdc-protected-button-container-height:36px;--mat-text-button-touch-target-display:block;--mat-filled-button-touch-target-display:block;--mat-protected-button-touch-target-display:block;--mat-outlined-button-touch-target-display:block}html{--mdc-icon-button-icon-size:24px}html{--mdc-icon-button-icon-color:inherit;--mdc-icon-button-disabled-icon-color:rgba(0, 0, 0, .38);--mat-icon-button-state-layer-color:black;--mat-icon-button-disabled-state-layer-color:black;--mat-icon-button-ripple-color:rgba(0, 0, 0, .1);--mat-icon-button-hover-state-layer-opacity:.04;--mat-icon-button-focus-state-layer-opacity:.12;--mat-icon-button-pressed-state-layer-opacity:.12}html{--mat-icon-button-touch-target-display:block}html{--mdc-fab-container-shape:50%;--mdc-fab-icon-size:24px;--mdc-fab-small-container-shape:50%;--mdc-fab-small-icon-size:24px;--mdc-extended-fab-container-height:48px;--mdc-extended-fab-container-shape:24px}html{--mdc-fab-container-color:white;--mdc-fab-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-focus-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-pressed-container-elevation-shadow:0px 7px 8px -4px rgba(0, 0, 0, .2), 0px 12px 17px 2px rgba(0, 0, 0, .14), 0px 5px 22px 4px rgba(0, 0, 0, .12);--mdc-fab-container-shadow-color:#000;--mat-fab-foreground-color:black;--mat-fab-state-layer-color:black;--mat-fab-disabled-state-layer-color:black;--mat-fab-ripple-color:rgba(0, 0, 0, .1);--mat-fab-hover-state-layer-opacity:.04;--mat-fab-focus-state-layer-opacity:.12;--mat-fab-pressed-state-layer-opacity:.12;--mat-fab-disabled-state-container-color:rgba(0, 0, 0, .12);--mat-fab-disabled-state-foreground-color:rgba(0, 0, 0, .38);--mdc-fab-small-container-color:white;--mdc-fab-small-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-small-focus-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-small-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-small-pressed-container-elevation-shadow:0px 7px 8px -4px rgba(0, 0, 0, .2), 0px 12px 17px 2px rgba(0, 0, 0, .14), 0px 5px 22px 4px rgba(0, 0, 0, .12);--mdc-fab-small-container-shadow-color:#000;--mat-fab-small-foreground-color:black;--mat-fab-small-state-layer-color:black;--mat-fab-small-disabled-state-layer-color:black;--mat-fab-small-ripple-color:rgba(0, 0, 0, .1);--mat-fab-small-hover-state-layer-opacity:.04;--mat-fab-small-focus-state-layer-opacity:.12;--mat-fab-small-pressed-state-layer-opacity:.12;--mat-fab-small-disabled-state-container-color:rgba(0, 0, 0, .12);--mat-fab-small-disabled-state-foreground-color:rgba(0, 0, 0, .38);--mdc-extended-fab-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-extended-fab-focus-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-extended-fab-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-extended-fab-pressed-container-elevation-shadow:0px 7px 8px -4px rgba(0, 0, 0, .2), 0px 12px 17px 2px rgba(0, 0, 0, .14), 0px 5px 22px 4px rgba(0, 0, 0, .12);--mdc-extended-fab-container-shadow-color:#000}html{--mat-fab-touch-target-display:block;--mat-fab-small-touch-target-display:block}html{--mdc-snackbar-container-shape:4px}html{--mdc-snackbar-container-color:#333333;--mdc-snackbar-supporting-text-color:rgba(255, 255, 255, .87);--mat-snack-bar-button-color:#448aff}html{--mat-table-row-item-outline-width:1px}html{--mat-table-background-color:white;--mat-table-header-headline-color:rgba(0, 0, 0, .87);--mat-table-row-item-label-text-color:rgba(0, 0, 0, .87);--mat-table-row-item-outline-color:rgba(0, 0, 0, .12)}html{--mat-table-header-container-height:56px;--mat-table-footer-container-height:52px;--mat-table-row-item-container-height:52px}html{--mdc-circular-progress-active-indicator-width:4px;--mdc-circular-progress-size:48px}html{--mdc-circular-progress-active-indicator-color:#0071bc}html{--mat-badge-container-shape:50%;--mat-badge-container-size:unset;--mat-badge-small-size-container-size:unset;--mat-badge-large-size-container-size:unset;--mat-badge-legacy-container-size:22px;--mat-badge-legacy-small-size-container-size:16px;--mat-badge-legacy-large-size-container-size:28px;--mat-badge-container-offset:-11px 0;--mat-badge-small-size-container-offset:-8px 0;--mat-badge-large-size-container-offset:-14px 0;--mat-badge-container-overlap-offset:-11px;--mat-badge-small-size-container-overlap-offset:-8px;--mat-badge-large-size-container-overlap-offset:-14px;--mat-badge-container-padding:0;--mat-badge-small-size-container-padding:0;--mat-badge-large-size-container-padding:0}html{--mat-badge-background-color:#0071bc;--mat-badge-text-color:white;--mat-badge-disabled-state-background-color:#b9b9b9;--mat-badge-disabled-state-text-color:rgba(0, 0, 0, .38)}html{--mat-bottom-sheet-container-shape:4px}html{--mat-bottom-sheet-container-text-color:rgba(0, 0, 0, .87);--mat-bottom-sheet-container-background-color:white}html{--mat-legacy-button-toggle-height:36px;--mat-legacy-button-toggle-shape:2px;--mat-legacy-button-toggle-focus-state-layer-opacity:1;--mat-standard-button-toggle-shape:4px;--mat-standard-button-toggle-hover-state-layer-opacity:.04;--mat-standard-button-toggle-focus-state-layer-opacity:.12}html{--mat-legacy-button-toggle-text-color:rgba(0, 0, 0, .38);--mat-legacy-button-toggle-state-layer-color:rgba(0, 0, 0, .12);--mat-legacy-button-toggle-selected-state-text-color:rgba(0, 0, 0, .54);--mat-legacy-button-toggle-selected-state-background-color:#e0e0e0;--mat-legacy-button-toggle-disabled-state-text-color:rgba(0, 0, 0, .26);--mat-legacy-button-toggle-disabled-state-background-color:#eeeeee;--mat-legacy-button-toggle-disabled-selected-state-background-color:#bdbdbd;--mat-standard-button-toggle-text-color:rgba(0, 0, 0, .87);--mat-standard-button-toggle-background-color:white;--mat-standard-button-toggle-state-layer-color:black;--mat-standard-button-toggle-selected-state-background-color:#e0e0e0;--mat-standard-button-toggle-selected-state-text-color:rgba(0, 0, 0, .87);--mat-standard-button-toggle-disabled-state-text-color:rgba(0, 0, 0, .26);--mat-standard-button-toggle-disabled-state-background-color:white;--mat-standard-button-toggle-disabled-selected-state-text-color:rgba(0, 0, 0, .87);--mat-standard-button-toggle-disabled-selected-state-background-color:#bdbdbd;--mat-standard-button-toggle-divider-color:#e0e0e0}html{--mat-standard-button-toggle-height:48px}html{--mat-datepicker-calendar-container-shape:4px;--mat-datepicker-calendar-container-touch-shape:4px;--mat-datepicker-calendar-container-elevation-shadow:0px 2px 4px -1px rgba(0, 0, 0, .2), 0px 4px 5px 0px rgba(0, 0, 0, .14), 0px 1px 10px 0px rgba(0, 0, 0, .12);--mat-datepicker-calendar-container-touch-elevation-shadow:0px 11px 15px -7px rgba(0, 0, 0, .2), 0px 24px 38px 3px rgba(0, 0, 0, .14), 0px 9px 46px 8px rgba(0, 0, 0, .12)}html{--mat-datepicker-calendar-date-selected-state-text-color:white;--mat-datepicker-calendar-date-selected-state-background-color:#0071bc;--mat-datepicker-calendar-date-selected-disabled-state-background-color:rgba(0, 113, 188, .4);--mat-datepicker-calendar-date-today-selected-state-outline-color:white;--mat-datepicker-calendar-date-focus-state-background-color:rgba(0, 113, 188, .3);--mat-datepicker-calendar-date-hover-state-background-color:rgba(0, 113, 188, .3);--mat-datepicker-toggle-active-state-icon-color:#0071bc;--mat-datepicker-calendar-date-in-range-state-background-color:rgba(0, 113, 188, .2);--mat-datepicker-calendar-date-in-comparison-range-state-background-color:rgba(249, 171, 0, .2);--mat-datepicker-calendar-date-in-overlap-range-state-background-color:#a8dab5;--mat-datepicker-calendar-date-in-overlap-range-selected-state-background-color:#46a35e;--mat-datepicker-toggle-icon-color:rgba(0, 0, 0, .54);--mat-datepicker-calendar-body-label-text-color:rgba(0, 0, 0, .54);--mat-datepicker-calendar-period-button-text-color:black;--mat-datepicker-calendar-period-button-icon-color:rgba(0, 0, 0, .54);--mat-datepicker-calendar-navigation-button-icon-color:rgba(0, 0, 0, .54);--mat-datepicker-calendar-header-divider-color:rgba(0, 0, 0, .12);--mat-datepicker-calendar-header-text-color:rgba(0, 0, 0, .54);--mat-datepicker-calendar-date-today-outline-color:rgba(0, 0, 0, .38);--mat-datepicker-calendar-date-today-disabled-state-outline-color:rgba(0, 0, 0, .18);--mat-datepicker-calendar-date-text-color:rgba(0, 0, 0, .87);--mat-datepicker-calendar-date-outline-color:transparent;--mat-datepicker-calendar-date-disabled-state-text-color:rgba(0, 0, 0, .38);--mat-datepicker-calendar-date-preview-state-outline-color:rgba(0, 0, 0, .24);--mat-datepicker-range-input-separator-color:rgba(0, 0, 0, .87);--mat-datepicker-range-input-disabled-state-separator-color:rgba(0, 0, 0, .38);--mat-datepicker-range-input-disabled-state-text-color:rgba(0, 0, 0, .38);--mat-datepicker-calendar-container-background-color:white;--mat-datepicker-calendar-container-text-color:rgba(0, 0, 0, .87)}html{--mat-divider-width:1px}html{--mat-divider-color:rgba(0, 0, 0, .12)}html{--mat-expansion-container-shape:4px;--mat-expansion-legacy-header-indicator-display:inline-block;--mat-expansion-header-indicator-display:none}html{--mat-expansion-container-background-color:white;--mat-expansion-container-text-color:rgba(0, 0, 0, .87);--mat-expansion-actions-divider-color:rgba(0, 0, 0, .12);--mat-expansion-header-hover-state-layer-color:rgba(0, 0, 0, .04);--mat-expansion-header-focus-state-layer-color:rgba(0, 0, 0, .04);--mat-expansion-header-disabled-state-text-color:rgba(0, 0, 0, .26);--mat-expansion-header-text-color:rgba(0, 0, 0, .87);--mat-expansion-header-description-color:rgba(0, 0, 0, .54);--mat-expansion-header-indicator-color:rgba(0, 0, 0, .54)}html{--mat-expansion-header-collapsed-state-height:48px;--mat-expansion-header-expanded-state-height:64px}html{--mat-icon-color:inherit}html{--mat-sidenav-container-shape:0;--mat-sidenav-container-elevation-shadow:0px 8px 10px -5px rgba(0, 0, 0, .2), 0px 16px 24px 2px rgba(0, 0, 0, .14), 0px 6px 30px 5px rgba(0, 0, 0, .12);--mat-sidenav-container-width:auto}html{--mat-sidenav-container-divider-color:rgba(0, 0, 0, .12);--mat-sidenav-container-background-color:white;--mat-sidenav-container-text-color:rgba(0, 0, 0, .87);--mat-sidenav-content-background-color:#fafafa;--mat-sidenav-content-text-color:rgba(0, 0, 0, .87);--mat-sidenav-scrim-color:rgba(0, 0, 0, .6)}html{--mat-stepper-header-icon-foreground-color:white;--mat-stepper-header-selected-state-icon-background-color:#0071bc;--mat-stepper-header-selected-state-icon-foreground-color:white;--mat-stepper-header-done-state-icon-background-color:#0071bc;--mat-stepper-header-done-state-icon-foreground-color:white;--mat-stepper-header-edit-state-icon-background-color:#0071bc;--mat-stepper-header-edit-state-icon-foreground-color:white;--mat-stepper-container-color:white;--mat-stepper-line-color:rgba(0, 0, 0, .12);--mat-stepper-header-hover-state-layer-color:rgba(0, 0, 0, .04);--mat-stepper-header-focus-state-layer-color:rgba(0, 0, 0, .04);--mat-stepper-header-label-text-color:rgba(0, 0, 0, .54);--mat-stepper-header-optional-label-text-color:rgba(0, 0, 0, .54);--mat-stepper-header-selected-state-label-text-color:rgba(0, 0, 0, .87);--mat-stepper-header-error-state-label-text-color:#f44336;--mat-stepper-header-icon-background-color:rgba(0, 0, 0, .54);--mat-stepper-header-error-state-icon-foreground-color:#f44336;--mat-stepper-header-error-state-icon-background-color:transparent}html{--mat-stepper-header-height:72px}html{--mat-sort-arrow-color:#757575}html{--mat-toolbar-container-background-color:whitesmoke;--mat-toolbar-container-text-color:rgba(0, 0, 0, .87)}html{--mat-toolbar-standard-height:64px;--mat-toolbar-mobile-height:56px}html{--mat-tree-container-background-color:white;--mat-tree-node-text-color:rgba(0, 0, 0, .87)}html{--mat-tree-node-min-height:48px}p{line-height:1.62!important}html{box-sizing:border-box}*,*:after,*:before{box-sizing:inherit}@media print{.glossary{display:none}.hide-glossary .usa-icon{height:1.5rem;width:1.5rem;margin-top:4px}}:root{--ctg-removed-background-color:#f4a4b1;--ctg-added-background-color:#99cfa2}@charset "UTF-8";.glossary{background:#112e51;color:#fff;width:300px;position:fixed;top:0;bottom:0;right:0;overflow-y:auto;padding:2.4rem;transition:right .2s;z-index:10001}@media screen and (min-width: 481px){.glossary{width:364px}}.glossary ul{padding:0}.glossary input[type=search]{box-sizing:inherit;margin-bottom:4rem;min-width:220px}.glossary label{margin-top:2.6rem}.glossary a{color:#fff;text-decoration:underline}.glossary[aria-hidden=true]{right:-300px}@media screen and (min-width: 481px){.glossary[aria-hidden=true]{right:-364px}}.glossary-heading{display:inline;font-size:22px;margin-top:0}.js-glossary-toggle{border-bottom:none;color:#0071bc;font-size:1.5rem;font-weight:700;line-height:initial;width:initial}.js-glossary-toggle:hover{color:#205493}.js-glossary-toggle svg{margin-right:2px}.js-glossary-close{border:none;font-size:20px;background-color:transparent;float:right;width:initial}.js-glossary-search::-webkit-search-cancel-button{-webkit-appearance:searchfield-cancel-button!important}.usa-sr-only{position:absolute;left:-999em}.clearable-input{position:relative;display:inline-block}.clearable-input>input{padding-right:1.4em}.clearable-input>input::-ms-clear{display:none}</style><link rel="stylesheet" href="styles.83e3bba4c1055117.css" media="all" onload="this.media='all'"><noscript><link rel="stylesheet" href="styles.83e3bba4c1055117.css"></noscript><style type="text/css"></style><style>.hhsvdp[_ngcontent-ng-c3140640207]{text-align:center;margin-top:30px;font-size:10px}</style><script type="text/javascript" src="https://www.googletagmanager.com/gtag/js?id=G-CSLL4ZEK4L"></script><meta name="ncbi_pdid" content="show_study"><style>@media all and (min-width: 64em){.usa-accordion[_ngcontent-ng-c578623717]{margin-left:auto;margin-right:auto;max-width:87.5rem}}@media print{[_nghost-ng-c578623717]{display:none}}</style><style>.ncbi-alert__shutdown-outer{padding-left:max(28px,(100vw - 85rem) / 2)!important;padding-right:max(28px,(100vw - 85rem) / 2)!important;background-position:max(28px,(100vw - 85rem) / 2) 20px!important}  .close{right:max(28px,(100vw - 85rem) / 2)!important}</style><style>[_nghost-ng-c3790985285]{display:block}@media print{[_nghost-ng-c3790985285]{display:none}}.ncbi-logo[_ngcontent-ng-c3790985285]{width:286px}.prs-button[_ngcontent-ng-c3790985285]{font-weight:400;margin-right:0rem;color:var(--ctgl-color-disabled-light);box-shadow:0 0 0 1px var(--ctgl-color-disabled-light)}.prs-button[_ngcontent-ng-c3790985285]:hover{font-weight:700;color:var(--ctgl-color-base-lightest);box-shadow:0 0 0 2px var(--ctgl-color-base-lightest)}</style><style>.ctg-logo-image[_ngcontent-ng-c1485640015]{max-height:2.5rem}@media (min-width: 64rem){.ctg-logo-image[_ngcontent-ng-c1485640015]{max-height:4.5rem;height:85%;width:85%}}.block-inline[_ngcontent-ng-c1485640015]{margin-top:0}.reduce-indentation[_ngcontent-ng-c1485640015]{margin-left:-1rem}.adjust-mobile-menu[_ngcontent-ng-c1485640015]{display:flex;flex-direction:column;height:100%}@media (min-width: 64rem){.adjust-menu-margins[_ngcontent-ng-c1485640015]{margin-top:-16px;margin-bottom:4px}}.desktop-icon-style[_ngcontent-ng-c1485640015]{height:1.25em;width:1.25em;vertical-align:bottom}@media (min-width: 64rem){.last-item[_ngcontent-ng-c1485640015]{display:inline-flex;margin-left:auto;margin-right:-18px}}.mobile-my-list[_ngcontent-ng-c1485640015]{float:right;margin-top:2px;margin-right:-14px;height:1.25em;width:1.25em}@media (min-width: 64rem){.max-width[_ngcontent-ng-c1485640015]{width:100%!important}}.usa-nav-container[_ngcontent-ng-c1485640015]{padding-left:0;padding-right:0}.usa-menu-btn[_ngcontent-ng-c1485640015]{height:100%;font-size:14px;font-weight:700;background-color:var(--ctgl-color-primary-darkest);color:#fff;width:65px;text-transform:capitalize}.usa-menu-btn[_ngcontent-ng-c1485640015]:hover{background-color:var(--ctgl-color-primary-dark)}.usa-nav__primary[_ngcontent-ng-c1485640015]   button[_ngcontent-ng-c1485640015]:hover{background-color:var(--ctgl-color-primary-lighter)}.usa-nav__primary[_ngcontent-ng-c1485640015]   button[aria-expanded=true][_ngcontent-ng-c1485640015]{background-color:var(--ctgl-color-primary-light);color:var(--ctgl-color-base-darker)}.usa-nav__submenu[_ngcontent-ng-c1485640015]{background-color:#fff;color:var(--ctgl-color-base-darker);padding-left:0;font-size:16px;font-weight:400}.usa-nav__submenu[_ngcontent-ng-c1485640015]   a[_ngcontent-ng-c1485640015]{color:var(--ctgl-color-base-darker);padding-left:.5rem;padding-top:.5rem;padding-bottom:.5rem;border-left:5px solid white}.usa-nav__submenu[_ngcontent-ng-c1485640015]   li[_ngcontent-ng-c1485640015]   a[_ngcontent-ng-c1485640015]:hover, .usa-nav__submenu[_ngcontent-ng-c1485640015]   li[_ngcontent-ng-c1485640015]   a[_ngcontent-ng-c1485640015]:focus{border-left:5px solid blue}.usa-nav__link[_ngcontent-ng-c1485640015]:hover:after{background-color:transparent}.text-small[_ngcontent-ng-c1485640015]{font-family:Public Sans;font-size:22px;font-style:normal;font-weight:300;line-height:35.64px;letter-spacing:0;text-align:left;padding-top:24px}.ctg-header-content[_ngcontent-ng-c1485640015]{height:568px}.content-detail[_ngcontent-ng-c1485640015]{margin-top:2rem;margin-left:2em}.feature-buttons[_ngcontent-ng-c1485640015]{display:flex;flex-direction:column;padding-top:5px;padding-bottom:5px;margin-right:10%;color:#fff;background-color:transparent;box-shadow:inset 0 0 0 1px #fff}.ctg-content[_ngcontent-ng-c1485640015]{width:50%}.custom-button[_ngcontent-ng-c1485640015]{padding:20px}.header-right[_ngcontent-ng-c1485640015]{text-align:right;margin:15px}.ctg-placeholder[_ngcontent-ng-c1485640015]{margin-right:3em}.placeholder-logo[_ngcontent-ng-c1485640015], .ctg-placeholder-logo[_ngcontent-ng-c1485640015]{width:485px}.logo-menu[_ngcontent-ng-c1485640015]{justify-content:space-between}.local-menu[_ngcontent-ng-c1485640015]{margin-left:auto;padding:0}.local-menu[_ngcontent-ng-c1485640015]   img[_ngcontent-ng-c1485640015]{height:100%}@media screen and (min-width: 1024px){.usa-header[_ngcontent-ng-c1485640015]{border-bottom:1px solid var(--ctgl-color-primary-darker)}.usa-navbar[_ngcontent-ng-c1485640015]{height:64px}}.usa-nav[_ngcontent-ng-c1485640015]   .nav-close-button[_ngcontent-ng-c1485640015]{margin:-.75rem -.75rem 1rem auto}@media print{#local-menu-action[_ngcontent-ng-c1485640015], .usa-nav[_ngcontent-ng-c1485640015]{display:none}#local-menu-action-print[_ngcontent-ng-c1485640015]{display:block;padding-right:1rem}#basic-logo[_ngcontent-ng-c1485640015]{width:100%}.usa-header--basic[_ngcontent-ng-c1485640015]   .usa-navbar[_ngcontent-ng-c1485640015]{position:relative;width:100%}.usa-navbar[_ngcontent-ng-c1485640015]{border-bottom:none!important}}.no-underline[_ngcontent-ng-c1485640015]{text-decoration:none}.button-display[_ngcontent-ng-c1485640015]{width:100%;cursor:pointer}.button-display[_ngcontent-ng-c1485640015]   span[_ngcontent-ng-c1485640015]:after{content:none;background:none}</style><style>.usa-breadcrumb[_ngcontent-ng-c3661825414]{background-color:transparent}@media print{[_nghost-ng-c3661825414]{display:none}}</style><style>.error[_ngcontent-ng-c2928246094]{margin-top:20px;margin-bottom:56px}.red-error-title[_ngcontent-ng-c2928246094]{font-family:Roboto;font-style:normal;font-weight:700;font-size:42px;line-height:49px;color:var(--ctgl-color-error)}.error-footer[_ngcontent-ng-c2928246094]{margin-top:32px;font-family:Roboto;font-style:normal;font-weight:400;font-size:16px;line-height:24px;color:var(--ctgl-color-base-darkest)}.error-title[_ngcontent-ng-c2928246094]{font-style:normal;font-weight:700;font-size:56px;line-height:66px;color:var(--ctgl-color-primary)}.error-title-inline[_ngcontent-ng-c2928246094]{font-style:normal;font-weight:700;font-size:56px;line-height:66px;color:var(--ctgl-color-primary);font-size:2em;line-height:1.15}.error-body[_ngcontent-ng-c2928246094]{margin-top:26px;font-style:normal;font-weight:700;font-size:42px;line-height:49px;color:var(--ctgl-color-base-darkest);flex:none;order:1;align-self:stretch;flex-grow:0}.error-body-inline[_ngcontent-ng-c2928246094]{margin-top:26px;font-style:normal;font-weight:700;font-size:42px;line-height:49px;color:var(--ctgl-color-base-darkest);flex:none;order:1;align-self:stretch;flex-grow:0;font-size:1.5em;line-height:1.15}.home-button[_ngcontent-ng-c2928246094]{width:80px;height:40px;background:var(--ctgl-color-primary-darkest);margin-top:26px;margin-bottom:26px;text-align:center;font-family:Roboto;font-size:16px;font-weight:700;color:#fff}</style><style>.details[_ngcontent-ng-c2928246094]{background:var(--ctgl-color-blue-5);padding-bottom:32px}.tab-header[_ngcontent-ng-c2928246094]{background-color:var(--ctgl-color-primary-darker);display:flex;white-space:nowrap;overflow-x:scroll}@media (min-width: 64rem){.tab-header[_ngcontent-ng-c2928246094]{overflow-x:hidden}}.tab-header[_ngcontent-ng-c2928246094]   .tab-labels[_ngcontent-ng-c2928246094]{margin-left:auto;margin-right:auto;width:min(87.5rem,100vw);padding-left:.5rem;padding-right:.5rem}@media (min-width: 64rem){.tab-header[_ngcontent-ng-c2928246094]   .tab-labels[_ngcontent-ng-c2928246094]{padding-left:2rem;padding-right:2rem}}.tab-label[_ngcontent-ng-c2928246094]{height:48px;padding:0 24px;cursor:pointer;box-sizing:border-box;min-width:117px;text-align:center;display:inline-flex;justify-content:center;align-items:center;white-space:nowrap;border-top:6px solid var(--ctgl-color-blue-20);border-bottom:2px solid var(--ctgl-color-blue-warm-80v);border-left:0;border-right:0;margin-left:1px;margin-right:1px;font-weight:400;font-style:normal;font-size:17px;background-color:var(--ctgl-color-primary-lighter)}@media (min-width: 64rem){.tab-label[_ngcontent-ng-c2928246094]{font-size:22px;min-width:160px}}.tab-label.tab-label--active[_ngcontent-ng-c2928246094]{border-top-color:var(--ctgl-color-primary);border-bottom-color:var(--ctgl-color-blue-5);margin-bottom:0;font-weight:700;background-color:var(--ctgl-color-blue-5)}.tab-label[_ngcontent-ng-c2928246094]:disabled{color:var(--ctgl-color-gray-40);cursor:default}.tab-label[_ngcontent-ng-c2928246094]:not(:disabled):hover{border-top-color:var(--ctgl-color-blue-20);border-bottom-color:var(--ctgl-color-blue-warm-80v);background-color:var(--ctgl-color-blue-60v);font-weight:700;color:#fff;text-decoration:underline;text-decoration-thickness:1.5px;text-underline-offset:1.5px}.tab-label[_ngcontent-ng-c2928246094]:active, .tab-label[_ngcontent-ng-c2928246094]:focus{outline-offset:-.25rem}@media print{.tab-label[_ngcontent-ng-c2928246094]{display:none}.tab-label.tab-label--active[_ngcontent-ng-c2928246094]{display:block;border:none;padding-left:0;margin-top:10px;background-color:#fff;font-size:42px}.tab-label.tab-label--active[_ngcontent-ng-c2928246094]:after{content:" Tab"}.tab-header[_ngcontent-ng-c2928246094]{background:#fff;overflow:hidden}.details[_ngcontent-ng-c2928246094]{padding-bottom:0}.top-details[_ngcontent-ng-c2928246094]{margin-top:1rem}}.sticky-header[_ngcontent-ng-c2928246094]{top:0;position:sticky;position:-webkit-sticky;z-index:9997;background-color:var(--ctgl-color-primary);padding:.5rem 1rem}@media print{.sticky-header[_ngcontent-ng-c2928246094]{display:none}}</style><style>a[_ngcontent-ng-c2908842604]:hover{background-color:#277236;box-shadow:none;color:#fff}a[_ngcontent-ng-c2908842604]{background:no-repeat 1rem .875rem/1rem;color:#fff;position:fixed;z-index:99999;right:0;margin:0;box-shadow:0 0 .625rem #0000004d;transition:background-color .15s,box-shadow .3s;font-size:.88rem;height:2.75rem;line-height:1.71875rem;border-radius:0;-moz-osx-font-smoothing:grayscale;-webkit-font-smoothing:antialiased;appearance:none;border:0;cursor:pointer;display:inline-block;font-weight:700;padding:.625rem 1.2rem .625rem 2.5rem;text-align:left;text-decoration:none;width:9.9rem}a[_ngcontent-ng-c2908842604]:active, a[_ngcontent-ng-c2908842604]:hover{background-color:#277236;box-shadow:none;color:#fff;outline:0}a[_ngcontent-ng-c2908842604]:focus{outline:0}@media screen and (max-width: 600px){a[_ngcontent-ng-c2908842604]{text-indent:-1000px;overflow:hidden;padding:0;width:2.75rem;height:2.75rem;background-position:.75rem .8125rem;background-size:1.375rem}}</style><style>a[_ngcontent-ng-c2908842604]{z-index:9997;bottom:213px;transform:rotate(270deg);right:-47px;height:50px;font-size:1rem;width:9rem;background-size:21px;background-color:var(--ctgl-color-primary-darkest);background-image:url(/assets/images/arrow_forward.svg)}a[_ngcontent-ng-c2908842604]:hover{background-color:var(--ctgl-color-primary-darkest)}a[_ngcontent-ng-c2908842604]:focus{outline:.25rem solid var(--ctgl-color-blue-40v);outline-offset:0}.scroll-icon[_ngcontent-ng-c2908842604]{position:fixed;transform:rotate(0);background-color:transparent;padding:0;margin:0;bottom:170px;right:-1px;width:52px;background-color:var(--ctgl-color-primary-darkest);background-image:url(/assets/images/arrow_upward.svg)}@media print{[_nghost-ng-c2908842604]{display:none}}</style><style>.ctg-footer[_ngcontent-ng-c2717743177]{background-color:#20558a;color:#fff;padding-bottom:30px}.footer-grid-gap[_ngcontent-ng-c2717743177]{margin-right:5rem}.usa-list[_ngcontent-ng-c2717743177]{margin-top:16px}.ctg-footer[_ngcontent-ng-c2717743177]   a[_ngcontent-ng-c2717743177]:hover, .ctg-footer__primary-link[_ngcontent-ng-c2717743177]{color:#fff}.address[_ngcontent-ng-c2717743177]{font-size:14px}.ctg-footer-link-text[_ngcontent-ng-c2717743177]{color:var(--ctgl-color-base-lighter);text-decoration:underline;font-size:18px}.ctg-footer[_ngcontent-ng-c2717743177]   a[_ngcontent-ng-c2717743177]:visited{color:var(--ctgl-color-base-light)}.ctg-footer__logo[_ngcontent-ng-c2717743177]{width:30%}.column[_ngcontent-ng-c2717743177]{display:inline-block;margin-top:32px}.column-title[_ngcontent-ng-c2717743177]{font-size:20px;font-weight:700;line-height:26px;margin-bottom:16px}.column-content[_ngcontent-ng-c2717743177]{font-size:18px;line-height:21px;margin-bottom:16px}.social-title[_ngcontent-ng-c2717743177]{font-size:18px;font-weight:700;margin:16px 0}.separator[_ngcontent-ng-c2717743177]{width:38px;height:1px;border-top:1px solid white}.social-links[_ngcontent-ng-c2717743177]{margin-top:12px}.social-distance[_ngcontent-ng-c2717743177]{margin:0 8px 0 0;display:inline-block;width:38px;height:38px}.social-distance[_ngcontent-ng-c2717743177]:hover{background-color:transparent!important}.ctg-logo[_ngcontent-ng-c2717743177]{max-height:50px}.group-title[_ngcontent-ng-c2717743177]{background:none;border-width:0 0 1px 0;border-color:#a6a6a6;border-radius:0;border-style:solid;box-shadow:none;color:var(--ctgl-color-base-lighter);font-size:16px;font-weight:700;line-height:21px;padding:8px 0;text-align:left;width:100%;display:flex;align-items:center}.group-title[_ngcontent-ng-c2717743177]   i[_ngcontent-ng-c2717743177]{width:20px}.group-title[_ngcontent-ng-c2717743177]   span[_ngcontent-ng-c2717743177]{text-decoration:underline}.group-title[_ngcontent-ng-c2717743177]   .usa-icon[_ngcontent-ng-c2717743177]{width:20px;height:20px}.group[_ngcontent-ng-c2717743177]:first-child > .group-title[_ngcontent-ng-c2717743177]{border-top-width:1px;margin-top:8px}.group[_ngcontent-ng-c2717743177] > .group-content[_ngcontent-ng-c2717743177]{display:none}.group.group__expanded[_ngcontent-ng-c2717743177] > .group-content[_ngcontent-ng-c2717743177]{display:block}.group-content-row[_ngcontent-ng-c2717743177]{font-size:18px;line-height:21px;padding:8px 0 8px 40px}.group-content-row[_ngcontent-ng-c2717743177]:last-child{border-bottom:1px solid #a6a6a6}.footer-list[_ngcontent-ng-c2717743177]{display:none}.footer-accordion[_ngcontent-ng-c2717743177]{margin-bottom:16px}@media screen and (min-width: 640px){.footer-list[_ngcontent-ng-c2717743177]{display:none}.footer-accordion[_ngcontent-ng-c2717743177], .footer-contacts[_ngcontent-ng-c2717743177]{display:inline-block;vertical-align:top;width:50%}.footer-accordion[_ngcontent-ng-c2717743177]{padding:0 8px}}@media screen and (min-width: 1024px){.to-top[_ngcontent-ng-c2717743177], .footer-accordion[_ngcontent-ng-c2717743177]{display:none}.footer-list[_ngcontent-ng-c2717743177]{display:inline-block;vertical-align:top;padding:8px 16px 0 0;width:62%}.footer-contacts[_ngcontent-ng-c2717743177]{display:inline-block;vertical-align:top;margin-top:32px;width:38%;max-width:280px}.footer-contacts[_ngcontent-ng-c2717743177]   .address[_ngcontent-ng-c2717743177]{font-size:16px}}@media print{[_nghost-ng-c2717743177]{display:none}}</style><style>.hhs-footer[_ngcontent-ng-c2834835435]{background-color:var(--ctgl-color-blue-warm-80v);padding-right:1rem;color:#fff}.hhs-footer[_ngcontent-ng-c2834835435]   a[_ngcontent-ng-c2834835435]:hover{font-weight:700}.hhs-footer[_ngcontent-ng-c2834835435]   a[_ngcontent-ng-c2834835435]:visited{color:#fff}.usa-identifier__usagov-description[_ngcontent-ng-c2834835435]{margin-right:1ex}.usa-identifier__required-link[_ngcontent-ng-c2834835435]{font-weight:400!important}.usa-identifier__required-link[_ngcontent-ng-c2834835435]{color:var(--ctgl-color-base-light)!important}.usa-identifier__required-link[_ngcontent-ng-c2834835435]:hover, .usa-identifier__required-link[_ngcontent-ng-c2834835435]:visited{color:#fff!important}.usa-identifier__logos[_ngcontent-ng-c2834835435]{display:flex;align-items:center;max-width:354px;margin:0}@media screen and (min-width: 640px){.usa-identifier__logos[_ngcontent-ng-c2834835435]{margin-right:32px}}.version-info[_ngcontent-ng-c2834835435]{text-align:right;padding-right:10rem;margin:0;font-size:.75rem}@media screen and (max-width: 600px){.version-info[_ngcontent-ng-c2834835435]{padding-right:3rem}}@media print{[_nghost-ng-c2834835435]{display:none}}</style><style>.external-link[_ngcontent-ng-c2375699798]{text-decoration:underline;text-underline-position:under;color:var(--ctgl-color-blue-60v);cursor:pointer}.external-link[_ngcontent-ng-c2375699798]:hover{font-weight:700}.link-for-print[_ngcontent-ng-c2375699798]{display:none!important}@media print{.link-for-print[_ngcontent-ng-c2375699798]{display:inline!important;text-decoration:underline!important;padding-left:4px!important}}.publication-references[_ngcontent-ng-c2375699798]{margin:10px 0 18px}.tabular-publication-references[_ngcontent-ng-c2375699798]{margin:0 0 18px}.publication-retraction[_ngcontent-ng-c2375699798]{display:inline;margin-top:8px;margin-bottom:8px}.select-pub-link[_ngcontent-ng-c2375699798]{display:inline!important}.hhs-footer-usa-link[_ngcontent-ng-c2375699798]{color:var(--ctgl-color-base-lighter)!important}.usa-identifier__section--usagov[_ngcontent-ng-c2375699798]:visited, .hhs-footer-usa-link[_ngcontent-ng-c2375699798]:hover{color:#fff!important}.hhs-footer-usa-link[_ngcontent-ng-c2375699798]:visited{color:var(--ctgl-color-base-light)!important}</style><style>.header-banner[_ngcontent-ng-c2235860804]{background:var(--ctgl-color-blue-warm-80v)}.header-banner[_ngcontent-ng-c2235860804]   .constrained-width[_ngcontent-ng-c2235860804]{max-width:400px;font-weight:700}.header-banner[_ngcontent-ng-c2235860804]   .banner-content[_ngcontent-ng-c2235860804]{color:#fff}.header-banner[_ngcontent-ng-c2235860804]   .banner-content[_ngcontent-ng-c2235860804]   span[_ngcontent-ng-c2235860804]{color:var(--ctgl-color-base-lightest)}.header-banner[_ngcontent-ng-c2235860804]   .banner-content[_ngcontent-ng-c2235860804]   a[_ngcontent-ng-c2235860804]{color:var(--ctgl-color-base-lightest);text-decoration:underline}.header-banner[_ngcontent-ng-c2235860804]   .banner-content[_ngcontent-ng-c2235860804]   a[_ngcontent-ng-c2235860804]:hover{color:#fff}.header-banner[_ngcontent-ng-c2235860804]   .action-buttons[_ngcontent-ng-c2235860804]{font-weight:400}.header-banner[_ngcontent-ng-c2235860804]   .action-buttons[_ngcontent-ng-c2235860804]   .prev-next[_ngcontent-ng-c2235860804]{display:inline-flex}.header-banner[_ngcontent-ng-c2235860804]   .action-buttons[_ngcontent-ng-c2235860804]   .prev-next[_ngcontent-ng-c2235860804]   .usa-icon[_ngcontent-ng-c2235860804]{height:1.4rem;width:1.4rem}.header-banner[_ngcontent-ng-c2235860804]   .mobile-actions[_ngcontent-ng-c2235860804]{font-size:14px}.header-banner[_ngcontent-ng-c2235860804]   .mobile-actions[_ngcontent-ng-c2235860804]   .grid-row[_ngcontent-ng-c2235860804]{font-size:13px;font-weight:400}.header-banner[_ngcontent-ng-c2235860804]   .top-border[_ngcontent-ng-c2235860804]{border-top:2px solid white}.header-banner[_ngcontent-ng-c2235860804]   .right-border[_ngcontent-ng-c2235860804]{border-right:2px solid white;padding-right:16px;margin-right:20px}.header-banner[_ngcontent-ng-c2235860804]   .actions-right-border[_ngcontent-ng-c2235860804]{border-right:1px solid var(--ctgl-color-base);padding-right:10px;margin-right:10px}.actions-container[_ngcontent-ng-c2235860804]{display:inline-flex;justify-content:center}@media print{.no-print-view[_ngcontent-ng-c2235860804]{display:none}.header-banner[_ngcontent-ng-c2235860804]{margin-top:1rem}.header-banner[_ngcontent-ng-c2235860804], .constrained-width[_ngcontent-ng-c2235860804]{background:#fff;color:var(--ctgl-color-base-darkest)!important}}.disabled-link[_ngcontent-ng-c2235860804]{text-decoration:none!important}</style><script src="https://www.ncbi.nlm.nih.gov/core/alerts/alerts.js?_=1743969406891"></script><style>@keyframes mdc-circular-progress-container-rotate{to{transform:rotate(360deg)}}@keyframes mdc-circular-progress-spinner-layer-rotate{12.5%{transform:rotate(135deg)}25%{transform:rotate(270deg)}37.5%{transform:rotate(405deg)}50%{transform:rotate(540deg)}62.5%{transform:rotate(675deg)}75%{transform:rotate(810deg)}87.5%{transform:rotate(945deg)}100%{transform:rotate(1080deg)}}@keyframes mdc-circular-progress-color-1-fade-in-out{from{opacity:.99}25%{opacity:.99}26%{opacity:0}89%{opacity:0}90%{opacity:.99}to{opacity:.99}}@keyframes mdc-circular-progress-color-2-fade-in-out{from{opacity:0}15%{opacity:0}25%{opacity:.99}50%{opacity:.99}51%{opacity:0}to{opacity:0}}@keyframes mdc-circular-progress-color-3-fade-in-out{from{opacity:0}40%{opacity:0}50%{opacity:.99}75%{opacity:.99}76%{opacity:0}to{opacity:0}}@keyframes mdc-circular-progress-color-4-fade-in-out{from{opacity:0}65%{opacity:0}75%{opacity:.99}90%{opacity:.99}to{opacity:0}}@keyframes mdc-circular-progress-left-spin{from{transform:rotate(265deg)}50%{transform:rotate(130deg)}to{transform:rotate(265deg)}}@keyframes mdc-circular-progress-right-spin{from{transform:rotate(-265deg)}50%{transform:rotate(-130deg)}to{transform:rotate(-265deg)}}.mdc-circular-progress{display:inline-flex;position:relative;direction:ltr;line-height:0;transition:opacity 250ms 0ms cubic-bezier(0.4, 0, 0.6, 1)}.mdc-circular-progress__determinate-container,.mdc-circular-progress__indeterminate-circle-graphic,.mdc-circular-progress__indeterminate-container,.mdc-circular-progress__spinner-layer{position:absolute;width:100%;height:100%}.mdc-circular-progress__determinate-container{transform:rotate(-90deg)}.mdc-circular-progress__indeterminate-container{font-size:0;letter-spacing:0;white-space:nowrap;opacity:0}.mdc-circular-progress__determinate-circle-graphic,.mdc-circular-progress__indeterminate-circle-graphic{fill:rgba(0,0,0,0)}.mdc-circular-progress__determinate-circle{transition:stroke-dashoffset 500ms 0ms cubic-bezier(0, 0, 0.2, 1)}.mdc-circular-progress__gap-patch{position:absolute;top:0;left:47.5%;box-sizing:border-box;width:5%;height:100%;overflow:hidden}.mdc-circular-progress__gap-patch .mdc-circular-progress__indeterminate-circle-graphic{left:-900%;width:2000%;transform:rotate(180deg)}.mdc-circular-progress__circle-clipper{display:inline-flex;position:relative;width:50%;height:100%;overflow:hidden}.mdc-circular-progress__circle-clipper .mdc-circular-progress__indeterminate-circle-graphic{width:200%}.mdc-circular-progress__circle-right .mdc-circular-progress__indeterminate-circle-graphic{left:-100%}.mdc-circular-progress--indeterminate .mdc-circular-progress__determinate-container{opacity:0}.mdc-circular-progress--indeterminate .mdc-circular-progress__indeterminate-container{opacity:1}.mdc-circular-progress--indeterminate .mdc-circular-progress__indeterminate-container{animation:mdc-circular-progress-container-rotate 1568.2352941176ms linear infinite}.mdc-circular-progress--indeterminate .mdc-circular-progress__spinner-layer{animation:mdc-circular-progress-spinner-layer-rotate 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__color-1{animation:mdc-circular-progress-spinner-layer-rotate 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both,mdc-circular-progress-color-1-fade-in-out 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__color-2{animation:mdc-circular-progress-spinner-layer-rotate 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both,mdc-circular-progress-color-2-fade-in-out 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__color-3{animation:mdc-circular-progress-spinner-layer-rotate 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both,mdc-circular-progress-color-3-fade-in-out 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__color-4{animation:mdc-circular-progress-spinner-layer-rotate 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both,mdc-circular-progress-color-4-fade-in-out 5332ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__circle-left .mdc-circular-progress__indeterminate-circle-graphic{animation:mdc-circular-progress-left-spin 1333ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--indeterminate .mdc-circular-progress__circle-right .mdc-circular-progress__indeterminate-circle-graphic{animation:mdc-circular-progress-right-spin 1333ms cubic-bezier(0.4, 0, 0.2, 1) infinite both}.mdc-circular-progress--closed{opacity:0}.mat-mdc-progress-spinner .mdc-circular-progress__determinate-circle,.mat-mdc-progress-spinner .mdc-circular-progress__indeterminate-circle-graphic{stroke:var(--mdc-circular-progress-active-indicator-color)}@media screen and (forced-colors: active),(-ms-high-contrast: active){.mat-mdc-progress-spinner .mdc-circular-progress__determinate-circle,.mat-mdc-progress-spinner .mdc-circular-progress__indeterminate-circle-graphic{stroke:CanvasText}}.mat-mdc-progress-spinner circle{stroke-width:var(--mdc-circular-progress-active-indicator-width)}@media screen and (forced-colors: active),(-ms-high-contrast: active){.mat-mdc-progress-spinner .mdc-circular-progress--four-color .mdc-circular-progress__color-1 .mdc-circular-progress__indeterminate-circle-graphic{stroke:CanvasText}}@media screen and (forced-colors: active),(-ms-high-contrast: active){.mat-mdc-progress-spinner .mdc-circular-progress--four-color .mdc-circular-progress__color-2 .mdc-circular-progress__indeterminate-circle-graphic{stroke:CanvasText}}@media screen and (forced-colors: active),(-ms-high-contrast: active){.mat-mdc-progress-spinner .mdc-circular-progress--four-color .mdc-circular-progress__color-3 .mdc-circular-progress__indeterminate-circle-graphic{stroke:CanvasText}}@media screen and (forced-colors: active),(-ms-high-contrast: active){.mat-mdc-progress-spinner .mdc-circular-progress--four-color .mdc-circular-progress__color-4 .mdc-circular-progress__indeterminate-circle-graphic{stroke:CanvasText}}.mat-mdc-progress-spinner .mdc-circular-progress{width:var(--mdc-circular-progress-size) !important;height:var(--mdc-circular-progress-size) !important}.mat-mdc-progress-spinner{display:block;overflow:hidden;line-height:0}.mat-mdc-progress-spinner._mat-animation-noopable,.mat-mdc-progress-spinner._mat-animation-noopable .mdc-circular-progress__determinate-circle{transition:none}.mat-mdc-progress-spinner._mat-animation-noopable .mdc-circular-progress__indeterminate-circle-graphic,.mat-mdc-progress-spinner._mat-animation-noopable .mdc-circular-progress__spinner-layer,.mat-mdc-progress-spinner._mat-animation-noopable .mdc-circular-progress__indeterminate-container{animation:none}.mat-mdc-progress-spinner._mat-animation-noopable .mdc-circular-progress__indeterminate-container circle{stroke-dasharray:0 !important}.cdk-high-contrast-active .mat-mdc-progress-spinner .mdc-circular-progress__indeterminate-circle-graphic,.cdk-high-contrast-active .mat-mdc-progress-spinner .mdc-circular-progress__determinate-circle{stroke:currentColor;stroke:CanvasText}</style></head>
<body>
<div id="glossary" class="glossary usa-dark-background" aria-describedby="glossary-result" aria-hidden="true">
  <button title="Close glossary" class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled hide-glossary" tabindex="-1"><span class="usa-sr-only">Hide glossary</span>
    <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
      <use href="/assets/uswds/img/sprite.svg#close"></use>
    </svg>
  </button>
  <h4 class="glossary-heading">Glossary</h4>
  <p>
  Study record managers: refer to the <a href="/policy#data-element-definitions" tabindex="-1"><span style="text-decoration:underline">Data Element Definitions</span></a> if submitting registration or results information.
  </p>
  <p>
  <label for="glossary-search" class="label">Search for terms</label>
  </p>
  <span class="clearable-input">
  <input id="glossary-search" class="js-glossary-search" type="search" tabindex="-1">
  </span>
  <div class="glossary__content" id="glossary-result">
    <ul class="js-glossary-list"><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-0" aria-expanded="false">Accepts healthy volunteers</button><div class="glossary__definition" id="glossary-content-0" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span> that indicates whether people who do not have the <span class="term" data-term="condition/disease" tabindex="-1" title="opens glossary for condition/disease">condition/disease</span> being studied can participate in that clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-1" aria-expanded="false">Active comparator arm</button><div class="glossary__definition" id="glossary-content-1" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="opens glossary for arm type">arm type</span> in which a group of participants receives an <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> considered to be effective (or active) by health care providers.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-2" aria-expanded="false">Adverse event</button><div class="glossary__definition" id="glossary-content-2" aria-hidden="true" style="display: none;">An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-3" aria-expanded="false">Age or age group</button><div class="glossary__definition" id="glossary-content-3" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span> that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups:<p>The age groups are: </p><ul><li>Child (birth-17)</li><li>Adult (18-64)</li><li style="margin-bottom:-.4em;">Older Adult (65+)</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-4" aria-expanded="false">All-cause mortality</button><div class="glossary__definition" id="glossary-content-4" aria-hidden="true" style="display: none;">A measure of all deaths, due to any cause, that occur during a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-5" aria-expanded="false">Allocation</button><div class="glossary__definition" id="glossary-content-5" aria-hidden="true" style="display: none;">A method used to assign participants to an arm of a clinical study. The types of allocation are <span class="term" data-term="randomized allocation" tabindex="-1" title="opens glossary for randomized allocation">randomized allocation</span> and nonrandomized.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-6" aria-expanded="false">Arm</button><div class="glossary__definition" id="glossary-content-6" aria-hidden="true" style="display: none;">A group or subgroup of participants in a clinical trial that receives a specific <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span>, or no intervention, according to the trial's <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-7" aria-expanded="false">Arm type</button><div class="glossary__definition" id="glossary-content-7" aria-hidden="true" style="display: none;">A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include <span class="term" data-term="experimental arm" tabindex="-1" title="opens glossary for experimental arm">experimental arm</span>, <span class="term" data-term="active comparator arm" tabindex="-1" title="opens glossary for active comparator arm">active comparator arm</span>, <span class="term" data-term="placebo comparator arm" tabindex="-1" title="opens glossary for placebo comparator arm">placebo comparator arm</span>, <span class="term" data-term="sham comparator arm" tabindex="-1" title="opens glossary for sham comparator arm">sham comparator arm</span>, and <span class="term" data-term="no intervention arm" tabindex="-1" title="opens glossary for no intervention arm">no intervention arm</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-8" aria-expanded="false">Baseline characteristics</button><div class="glossary__definition" id="glossary-content-8" aria-hidden="true" style="display: none;">Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-9" aria-expanded="false">Canceled submission</button><div class="glossary__definition" id="glossary-content-9" aria-hidden="true" style="display: none;">Indicates that the study sponsor or investigator recalled a submission of <span class="term" data-term="study results" tabindex="-1" title="opens glossary for study results">study results</span> before <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> cannot be modified until QC review is completed, unless the submission is canceled.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-10" aria-expanded="false">Certain agreements</button><div class="glossary__definition" id="glossary-content-10" aria-hidden="true" style="display: none;">Information required by the <span class="term" data-term="food and drug administration amendments act of 2007, section 801 (fdaaa 801)" tabindex="-1" title="opens glossary for food and drug administration amendments act of 2007, section 801 (fdaaa 801)">Food and Drug Administration Amendments Act of 2007</span>. In general, this is a description of any agreement between the sponsor of a clinical study and the <span class="term" data-term="principal investigator (pi)" tabindex="-1" title="opens glossary for principal investigator (pi)">principal investigator</span> (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-11" aria-expanded="false">Certification</button><div class="glossary__definition" id="glossary-content-11" aria-hidden="true" style="display: none;">A sponsor or investigator may submit a certification to delay submission of results information if they are applying for FDA approval of a new drug or device, or new use of an already approved drug or device. A sponsor or investigator who submits a certification can delay results submission up to 2 years after the <span class="term" data-term="certification/extension first submitted" tabindex="-1" title="opens glossary for certification/extension first submitted">certification/extension first submitted</span> date, unless certain events occur sooner. See <a href="/policy/results-definitions#DelayResultsType" class="usa-link" tabindex="-1">Delay Results Type</a> in the Results Data Element definitions for more information about this certification.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-12" aria-expanded="false">Certification/extension first posted</button><div class="glossary__definition" id="glossary-content-12" aria-hidden="true" style="display: none;">The date on which information about a <span class="term" data-term="certification" tabindex="-1" title="opens glossary for certification">certification</span> to delay submission of results or an <span class="term" data-term="extension request" tabindex="-1" title="opens glossary for extension request">extension request</span> was first available on ClinicalTrials.gov. ClinicalTrials.gov does not indicate whether the submission was a certification or extension request. There is typically a delay between the date the study sponsor or investigator submitted the certification or extension request and the <span class="term" data-term="first posted" tabindex="-1" title="opens glossary for first posted">first posted date</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-13" aria-expanded="false">Certification/extension first submitted</button><div class="glossary__definition" id="glossary-content-13" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" tabindex="-1" title="opens glossary for certification">certification</span> or an <span class="term" data-term="extension request" tabindex="-1" title="opens glossary for extension request">extension request</span> to delay submission of results. A sponsor or investigator who submits a certification can delay results submission up to 2 years after this date, unless certain events occur sooner. There is typically a delay between the date the certification or extension request was submitted and the date the information is first available on ClinicalTrials.gov (<span class="term" data-term="certification/extension first posted" tabindex="-1" title="opens glossary for certification/extension first posted">certification/extension first posted</span>).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-14" aria-expanded="false">Certification/extension first submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-14" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" tabindex="-1" title="opens glossary for certification">certification</span> or an <span class="term" data-term="extension request" tabindex="-1" title="opens glossary for extension request">extension request</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a certification or extension request one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria. Meeting QC criteria for an extension request does not mean that the National Institutes of Health (NIH) has determined that the request demonstrates good cause. The process for review and granting of extension requests by the NIH is being developed.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-15" aria-expanded="false">City and distance</button><div class="glossary__definition" id="glossary-content-15" aria-hidden="true" style="display: none;">In the search feature, the City field is used to find clinical studies with locations in a specific city. The Distance field is used to find studies with locations within the specified distance from a city in number of miles. For example, if you choose Illinois as the <span class="term" data-term="state" tabindex="-1" title="opens glossary for state">state</span>, identifying "Chicago" as the city and "100 miles" as the distance will find all studies listing a location within 100 miles of Chicago.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-16" aria-expanded="false">Clinical study</button><div class="glossary__definition" id="glossary-content-16" aria-hidden="true" style="display: none;">A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="opens glossary for interventional study (clinical trial)">interventional studies</span> (also called clinical trials) and <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational studies</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-17" aria-expanded="false">Clinical trial</button><div class="glossary__definition" id="glossary-content-17" aria-hidden="true" style="display: none;">Another name for an <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="opens glossary for interventional study (clinical trial)">interventional study</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-18" aria-expanded="false">ClinicalTrials.gov identifier (NCT number)</button><div class="glossary__definition" id="glossary-content-18" aria-hidden="true" style="display: none;">The unique identification code given to each clinical study upon <span class="term" data-term="registration" tabindex="-1" title="opens glossary for registration">registration</span> at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-19" aria-expanded="false">Collaborator</button><div class="glossary__definition" id="glossary-content-19" aria-hidden="true" style="display: none;">An organization other than the <span class="term" data-term="sponsor" tabindex="-1" title="opens glossary for sponsor">sponsor</span> that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-20" aria-expanded="false">Condition/disease</button><div class="glossary__definition" id="glossary-content-20" aria-hidden="true" style="display: none;">The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-21" aria-expanded="false">Contact</button><div class="glossary__definition" id="glossary-content-21" aria-hidden="true" style="display: none;">The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-22" aria-expanded="false">Country</button><div class="glossary__definition" id="glossary-content-22" aria-hidden="true" style="display: none;">In the search feature, the Country field is used to find clinical studies with locations in a specific country. For example,  if you choose the United States, you can then narrow your search by selecting a <span class="term" data-term="state" tabindex="-1" title="opens glossary for state">state</span> and identifying a <span class="term" data-term="city and distance" tabindex="-1" title="opens glossary for city and distance">city and distance</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-23" aria-expanded="false">Cross-over assignment</button><div class="glossary__definition" id="glossary-content-23" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="opens glossary for intervention model">intervention model</span> describing a clinical trial in which groups of participants receive two or more interventions in a specific order. For example, two-by-two cross-over assignment involves two groups of participants. One group receives drug A during the initial phase of the trial, followed by drug B during a later phase. The other group receives drug B during the initial phase, followed by drug A. So during the trial, participants "cross over" to the other drug. All participants receive drug A and drug B at some point during the trial but in a different order, depending on the group to which they are assigned.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-24" aria-expanded="false">Data Monitoring Committee (DMC)</button><div class="glossary__definition" id="glossary-content-24" aria-hidden="true" style="display: none;">A group of independent scientists who monitor the safety and scientific integrity of a <span class="term" data-term="clinical trial" tabindex="-1" title="opens glossary for clinical trial">clinical trial</span>. The DMC can recommend to the sponsor that the trial be stopped if it is not effective, is harming participants, or is unlikely to serve its scientific purpose. Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-25" aria-expanded="false">Early Phase 1 (formerly listed as Phase 0)</button><div class="glossary__definition" id="glossary-content-25" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phase</span> of research used to describe exploratory trials conducted before traditional <span class="term" data-term="phase 1" tabindex="-1" title="opens glossary for phase 1">phase 1</span> trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-26" aria-expanded="false">Eligibility criteria</button><div class="glossary__definition" id="glossary-content-26" aria-hidden="true" style="display: none;">The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both <span class="term" data-term="inclusion criteria" tabindex="-1" title="opens glossary for inclusion criteria">inclusion criteria</span> (which are required for a person to participate in the study) and <span class="term" data-term="exclusion criteria" tabindex="-1" title="opens glossary for exclusion criteria">exclusion criteria</span> (which prevent a person from participating). Types of eligibility criteria include whether a study <span class="term" data-term="accepts healthy volunteers" tabindex="-1" title="opens glossary for accepts healthy volunteers"> accepts healthy volunteers</span>, has <span class="term" data-term="age or age group" tabindex="-1" title="opens glossary for age or age group">age or age group</span> requirements, or is limited by <span class="term" data-term="sex" tabindex="-1" title="opens glossary for sex">sex</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-27" aria-expanded="false">Enrollment</button><div class="glossary__definition" id="glossary-content-27" aria-hidden="true" style="display: none;">The number of participants in a clinical study. The "estimated" enrollment is the target number of participants that the researchers need for the study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-28" aria-expanded="false">Exclusion criteria</button><div class="glossary__definition" id="glossary-content-28" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span>. These are reasons that a person is not allowed to participate in a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-29" aria-expanded="false">Expanded access</button><div class="glossary__definition" id="glossary-content-29" aria-hidden="true" style="display: none;">A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">U.S. Food and Drug Administration (FDA)</span>. Also called compassionate use.  There are different <span class="term" data-term="expanded access type" tabindex="-1" title="opens glossary for expanded access type">expanded access types</span>. <p style="margin-bottom:-.4em;">For more information, see FDA <a href="https://www.fda.gov/news-events/public-health-focus/expanded-access" class="usa-link usa-link--external" title="Expanded Access: Information for Patients (opens in a new tab)" aria-label="Expanded Access: Information for Patients (opens in a new tab)" target="_blank" rel="noopener noreferrer" tabindex="-1">Expanded Access: Information for Patients</a>.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-30" aria-expanded="false">Expanded access status</button><div class="glossary__definition" id="glossary-content-30" aria-hidden="true" style="display: none;"><ul><li><strong>Available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="opens glossary for expanded access">Expanded access</span> is currently available for this investigational treatment, and patients who are not participants in the clinical study may be able to gain access to the drug, biologic, or medical device being studied.</li><li><strong>No longer available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="opens glossary for expanded access">Expanded access</span> was available for this intervention previously but is not currently available and will not be available in the future.</li><li><strong>Temporarily not available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="opens glossary for expanded access">Expanded access</span> is not currently available for this intervention but is expected to be available in the future.</li><li><strong>Approved for marketing:</strong> The intervention has been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)"> U.S. Food and Drug Administration</span> for use by the public.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-31" aria-expanded="false">Expanded access type</button><div class="glossary__definition" id="glossary-content-31" aria-hidden="true" style="display: none;">Describes the category of <span class="term" data-term="expanded access" tabindex="-1" title="opens glossary for expanded access">expanded access</span> under <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">U.S. Food and Drug Administration (FDA)</span> regulations. There are three types of expanded access: <ul><li><strong>Individual Patients</strong>: Allows a single patient, with a serious disease or condition who cannot participate in a clinical trial, access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">FDA</span>. This category also includes access in an emergency situation.</li><li><strong>Intermediate-size Population</strong>: Allows more than one patient (but generally fewer patients than through a Treatment IND/Protocol) access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">FDA</span>.  This type of expanded access is used when multiple patients with the same disease or condition seek access to a specific drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">FDA</span>.</li><li><strong><a id="treatment-ind" tabindex="-1"></a>Treatment IND/Protocol</strong>: Allows a large, widespread population access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">FDA</span>. This type of expanded access can only be provided if the product is already being developed for marketing for the same use as the expanded access use.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-32" aria-expanded="false">Experimental arm</button><div class="glossary__definition" id="glossary-content-32" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="opens glossary for arm type">arm type</span> in which a group of participants receives the <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> that is the focus of the clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-33" aria-expanded="false">Extension request</button><div class="glossary__definition" id="glossary-content-33" aria-hidden="true" style="display: none;">In certain circumstances, a sponsor or investigator may request an extension to delay the standard results submission deadline (generally one year after the <span class="term" data-term="primary completion date" tabindex="-1" title="opens glossary for primary completion date">primary completion date</span>). The request for an extension must demonstrate good cause (for example, the need to preserve the scientific integrity of an ongoing <span class="term" data-term="masking" tabindex="-1" title="opens glossary for masking">masked</span> trial). All requests must be reviewed and granted by the National Institutes of Health. This process for review and granting of extension requests is being developed. See <a href="/policy/results-definitions#DelayResultsType" class="usa-link" tabindex="-1">Delay Results Type</a> in the Results Data Element definitions for more information.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-34" aria-expanded="false">Factorial assignment</button><div class="glossary__definition" id="glossary-content-34" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="opens glossary for intervention model">intervention model</span> describing a clinical trial in which groups of participants receive one of several combinations of interventions. For example, two-by-two factorial assignment involves four groups of participants. Each group receives one of the following pairs of interventions: (1) drug A and drug B, (2) drug A and a placebo, (3) a placebo and drug B, or (4) a placebo and a placebo. So during the trial, all possible combinations of the two drugs (A and B) and the placebos are given to different groups of participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-35" aria-expanded="false">FDAAA 801 Violations</button><div class="glossary__definition" id="glossary-content-35" aria-hidden="true" style="display: none;">A FDAAA 801 Violation is shown on a study record when the U.S. Food and Drug Administration (FDA) has issued a Notice of Noncompliance to the responsible party of an applicable clinical trial. A Notice of Noncompliance indicates that the FDA has determined the responsible party was not in compliance with the registration or results reporting requirements for the clinical trial under the Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801).<p>The National Library of Medicine (NLM) is required by FDAAA 801 to add information to a study record about any FDAAA 801 Violation. This information is provided by the FDA. There are three categories of information that may be included:</p><ul><li>Violation: Shown when the FDA issues a Notice of Noncompliance and posts the Notice of Noncompliance on its designated webpage. There are three types of violations:<ul><li>Failure to submit required clinical trial information</li><li>Submission of false or misleading clinical trial information</li><li>Failure to submit primary and secondary outcomes</li></ul></li><li>Correction: Shown when the FDA confirms that the responsible party has updated the study record to correct the violation and posts the correction notice on its designated webpage.  Because of the time for FDA review and processing, there may be a delay between the date when the study record was updated and the addition of correction information to the FDAAA 801 Violation information. </li><li>Penalty: Shown when the FDA imposes a penalty for the violation and posts the penalty notice on its designated webpage.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-36" aria-expanded="false">First posted</button><div class="glossary__definition" id="glossary-content-36" aria-hidden="true" style="display: none;">The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) <a href="/submit-studies/prs-help/protocol-registration-quality-control-review-criteria" class="usa-link" tabindex="-1">quality control (QC) review</a> has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-37" aria-expanded="false">First submitted</button><div class="glossary__definition" id="glossary-content-37" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-38" aria-expanded="false">First submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-38" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-39" aria-expanded="false">Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)</button><div class="glossary__definition" id="glossary-content-39" aria-hidden="true" style="display: none;">U.S. Public Law 110-85, which was enacted on September 27, 2007. Section 801 of FDAAA amends Section 402 of the U.S. Public Health Service Act to expand ClinicalTrials.gov and create a clinical study <span class="term" data-term="results database" tabindex="-1" title="opens glossary for results database">results database</span>. For more information on FDAAA 801, see the <a href="/policy/reporting-requirements#final-rule" class="usa-link" tabindex="-1">Clinical Trial Reporting Requirements</a> page on this site.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-40" aria-expanded="false">Funder type</button><div class="glossary__definition" id="glossary-content-40" aria-hidden="true" style="display: none;">Describes the organization that provides funding or support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting. Organizations listed as <span class="term" data-term="sponsor" tabindex="-1" title="opens glossary for sponsor">sponsors</span> and <span class="term" data-term="collaborator" tabindex="-1" title="opens glossary for collaborator">collaborators</span> for a study are considered the funders of the study. ClinicalTrials.gov refers to four types of funders: <ul><li>U.S. National Institutes of Health</li><li>Other U.S. Federal agencies (for example, Food and Drug Administration, Centers for Disease Control and Prevention, or U.S. Department of Veterans Affairs)</li><li>Industry (for example: pharmaceutical and device companies)</li><li>All others (including individuals, universities, and community-based organizations)</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-41" aria-expanded="false">Gender-based eligibility</button><div class="glossary__definition" id="glossary-content-41" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span> that indicates whether eligibility to participate in a clinical study is based on a person's self-representation of gender identity. Gender identity refers to a person's own sense of gender, which may or may not be the same as their biological <span class="term" data-term="sex" tabindex="-1" title="opens glossary for sex">sex</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-42" aria-expanded="false">Group/cohort</button><div class="glossary__definition" id="glossary-content-42" aria-hidden="true" style="display: none;">A group or subgroup of participants in an <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational study</span> that is assessed for biomedical or health outcomes.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-43" aria-expanded="false">Human subjects protection review board</button><div class="glossary__definition" id="glossary-content-43" aria-hidden="true" style="display: none;">A group of people who review, approve, and monitor the clinical study's <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>. Their role is to protect the rights and welfare of people participating in a study (referred to as human research subjects), such as reviewing the <span class="term" data-term="informed consent form (icf)" tabindex="-1" title="opens glossary for informed consent form (icf)">informed consent form</span>. The group typically includes people with varying backgrounds, including a community member, to make sure that research activities conducted by an organization are completely and adequately reviewed. Also called an institutional review board, or IRB, or an ethics committee.<p>For more information, see <a href="/study-basics/learn-about-studies#q3" class="usa-link" tabindex="-1">Who can join clinical research?</a> on this site.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-44" aria-expanded="false">Inclusion criteria</button><div class="glossary__definition" id="glossary-content-44" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span>. These are the reasons that a person is allowed to participate in a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-45" aria-expanded="false">Informed consent</button><div class="glossary__definition" id="glossary-content-45" aria-hidden="true" style="display: none;">A process used by researchers to communicate to potential and enrolled participants the risks and potential benefits of participating in a clinical study. <p>For more information, see <a href="/study-basics/learn-about-studies#q3" class="usa-link" tabindex="-1">Who can join clinical research?</a> on this site.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-46" aria-expanded="false">Informed consent form (ICF)</button><div class="glossary__definition" id="glossary-content-46" aria-hidden="true" style="display: none;">The document used in the <span class="term" data-term="informed consent" tabindex="-1" title="opens glossary for informed consent">informed consent</span> or process.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-47" aria-expanded="false">Intervention model</button><div class="glossary__definition" id="glossary-content-47" aria-hidden="true" style="display: none;">The general design of the strategy for assigning interventions to participants in a clinical study. Types of intervention models include: <span class="term" data-term="single group assignment" tabindex="-1" title="opens glossary for single group assignment">single group assignment</span>, <span class="term" data-term="parallel assignment" tabindex="-1" title="opens glossary for parallel assignment">parallel assignment</span>, <span class="term" data-term="cross-over assignment" tabindex="-1" title="opens glossary for cross-over assignment">cross-over assignment</span>, and <span class="term" data-term="factorial assignment" tabindex="-1" title="opens glossary for factorial assignment">factorial assignment</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-48" aria-expanded="false">Intervention/treatment</button><div class="glossary__definition" id="glossary-content-48" aria-hidden="true" style="display: none;">A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-49" aria-expanded="false">Interventional study (clinical trial)</button><div class="glossary__definition" id="glossary-content-49" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="clinical study" tabindex="-1" title="opens glossary for clinical study">clinical study</span> in which participants are assigned to groups that receive one or more <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study's <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>. Participants may receive diagnostic, therapeutic, or other types of interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-50" aria-expanded="false">Investigator</button><div class="glossary__definition" id="glossary-content-50" aria-hidden="true" style="display: none;">A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study <span class="term" data-term="principal investigator (pi)" tabindex="-1" title="opens glossary for principal investigator (pi)">principal investigator</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-51" aria-expanded="false">Last update posted</button><div class="glossary__definition" id="glossary-content-51" aria-hidden="true" style="display: none;">The most recent date on which changes to a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the <span class="term" data-term="last update submitted" tabindex="-1" title="opens glossary for last update submitted">last update submitted</span> date) and the last update posted date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-52" aria-expanded="false">Last update submitted</button><div class="glossary__definition" id="glossary-content-52" aria-hidden="true" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the last update submitted date and when the date changes are posted on ClinicalTrials.gov (the <span class="term" data-term="last update posted" tabindex="-1" title="opens glossary for last update posted">last update posted</span> date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-53" aria-expanded="false">Last update submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-53" aria-hidden="true" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> that are consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-54" aria-expanded="false">Last verified</button><div class="glossary__definition" id="glossary-content-54" aria-hidden="true" style="display: none;">The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a <span class="term" data-term="recruitment status" tabindex="-1" title="opens glossary for recruitment status">recruitment status</span> of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's <span class="term" data-term="recruitment status" tabindex="-1" title="opens glossary for recruitment status">recruitment status</span> is shown as <span class="term" data-term="unknown" tabindex="-1" title="opens glossary for unknown">unknown</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-55" aria-expanded="false">Listed location countries</button><div class="glossary__definition" id="glossary-content-55" aria-hidden="true" style="display: none;">Countries in which research facilities for a study are located. A country is listed only once, even if there is more than one facility in the country. The list includes all countries as of the <span class="term" data-term="last update submitted" tabindex="-1" title="opens glossary for last update submitted">last update submitted</span> date; any country for which all facilities were removed from the <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> are listed under <span class="term" data-term="removed location countries" tabindex="-1" title="opens glossary for removed location countries">removed location countries</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-56" aria-expanded="false">Location terms</button><div class="glossary__definition" id="glossary-content-56" aria-hidden="true" style="display: none;">In the search feature, the Location terms field is used to narrow a search by location-related terms other than Country, State, and City or distance. For example, you may enter a specific facility name (such as National Institutes of Health Clinical Center) or a part of a facility name (such as Veteran for studies listing Veterans Hospital or Veteran Affairs in the facility name). Note: Not all <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study records</span> include this level of detail about locations.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-57" aria-expanded="false">Masking</button><div class="glossary__definition" id="glossary-content-57" aria-hidden="true" style="display: none;">A clinical trial design strategy in which one or more parties involved in the trial, such as the investigator or participants, do not know which participants have been assigned which interventions. Types of masking include: open label, single blind masking, and double-blind masking.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-58" aria-expanded="false">NCT number</button><div class="glossary__definition" id="glossary-content-58" aria-hidden="true" style="display: none;">A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the <span class="term" data-term="clinicaltrials.gov identifier (nct number)" tabindex="-1" title="opens glossary for clinicaltrials.gov identifier (nct number)">ClinicalTrials.gov identifier</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-59" aria-expanded="false">No intervention arm</button><div class="glossary__definition" id="glossary-content-59" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="opens glossary for arm type">arm type</span> in which a group of participants does not receive any <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> during the clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-60" aria-expanded="false">Observational study</button><div class="glossary__definition" id="glossary-content-60" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="clinical study" tabindex="-1" title="opens glossary for clinical study">clinical study</span> in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">interventions/treatment</span>.<p>A <span class="term" data-term="patient registry" tabindex="-1" title="opens glossary for patient registry">patient registry</span> is a type of observational study.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-61" aria-expanded="false">Observational study model</button><div class="glossary__definition" id="glossary-content-61" aria-hidden="true" style="display: none;">The general design of the strategy for identifying and following up with participants during an <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational study</span>. Types of observational study models include cohort, case-control, case-only, case-cross-over, ecologic or community studies, family-based, and other.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-62" aria-expanded="false">Other adverse event</button><div class="glossary__definition" id="glossary-content-62" aria-hidden="true" style="display: none;">An <span class="term" data-term="adverse event" tabindex="-1" title="opens glossary for adverse event">adverse event</span> that is not a <span class="term" data-term="serious adverse event" tabindex="-1" title="opens glossary for serious adverse event">serious adverse event</span>, meaning that it does not result in death, is not life-threatening, does not require inpatient hospitalization or extend a current hospital stay, does not result in an ongoing or significant incapacity or interfere substantially with normal life functions, and does not cause a congenital anomaly or birth defect; it also does not put the participant in danger and does not require medical or surgical intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-63" aria-expanded="false">Other study IDs</button><div class="glossary__definition" id="glossary-content-63" aria-hidden="true" style="display: none;">Identifiers or ID numbers other than the <span class="term" data-term="nct number" tabindex="-1" title="opens glossary for nct number">NCT number</span> that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-64" aria-expanded="false">Other terms</button><div class="glossary__definition" id="glossary-content-64" aria-hidden="true" style="display: none;">In the search feature, the Other terms field is used to narrow a search. For example, you may enter the name of a drug or the NCT number of a clinical study to limit the search to <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study records</span> that contain these words.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-65" aria-expanded="false">Outcome measure</button><div class="glossary__definition" id="glossary-content-65" aria-hidden="true" style="display: none;">For <span class="term" data-term="clinical trial" tabindex="-1" title="opens glossary for clinical trial">clinical trials</span>, a planned measurement described in the protocol that is used to determine the effect of an <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> on participants. For <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational studies</span>, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include <span class="term" data-term="primary outcome measure" tabindex="-1" title="opens glossary for primary outcome measure">primary outcome measure</span> and <span class="term" data-term="secondary outcome measure" tabindex="-1" title="opens glossary for secondary outcome measure">secondary outcome measure</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-66" aria-expanded="false">Parallel assignment</button><div class="glossary__definition" id="glossary-content-66" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="opens glossary for intervention model">intervention model</span> describing a clinical trial in which two or more groups of participants receive different interventions. For example, a two-arm parallel assignment involves two groups of participants. One group receives drug A, and the other group receives drug B. So during the trial, participants in one group receive drug A "in parallel" to participants in the other group, who receive drug B.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-67" aria-expanded="false">Participant flow</button><div class="glossary__definition" id="glossary-content-67" aria-hidden="true" style="display: none;">A summary of the progress of participants through each stage of a clinical study, by study <span class="term" data-term="arm" tabindex="-1" title="opens glossary for arm">arm</span> or <span class="term" data-term="group/cohort" tabindex="-1" title="opens glossary for group/cohort">group/cohort</span>. This includes the number of participants who started, completed, and dropped out of the study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-68" aria-expanded="false">Patient registry</button><div class="glossary__definition" id="glossary-content-68" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational study</span> that collects information about patients' medical conditions and/or treatments to better understand how a condition or treatment affects patients in the real world.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-69" aria-expanded="false">Phase</button><div class="glossary__definition" id="glossary-content-69" aria-hidden="true" style="display: none;">The stage of a clinical trial studying a drug or biological product, based on definitions developed by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="opens glossary for u.s. food and drug administration (fda)">U.S. Food and Drug Administration (FDA)</span>. The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: <span class="term" data-term="early phase 1 (formerly listed as phase 0)" tabindex="-1" title="opens glossary for early phase 1 (formerly listed as phase 0)">Early Phase 1 (formerly listed as Phase 0)</span>, <span class="term" data-term="phase 1" tabindex="-1" title="opens glossary for phase 1">Phase 1</span>, <span class="term" data-term="phase 2" tabindex="-1" title="opens glossary for phase 2">Phase 2</span>, <span class="term" data-term="phase 3" tabindex="-1" title="opens glossary for phase 3">Phase 3</span>, and <span class="term" data-term="phase 4" tabindex="-1" title="opens glossary for phase 4">Phase 4</span>. <span class="term" data-term="phase not applicable" tabindex="-1" title="opens glossary for phase not applicable">Not Applicable</span> is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-70" aria-expanded="false">Phase 1</button><div class="glossary__definition" id="glossary-content-70" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phase</span> of research to describe clinical trials that focus on the safety of a drug. They are usually conducted with healthy volunteers, and the goal is to determine the drug's most frequent and <span class="term" data-term="serious adverse event" tabindex="-1" title="opens glossary for serious adverse event">serious adverse events</span> and, often, how the drug is broken down and excreted by the body. These trials usually involve a small number of participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-71" aria-expanded="false">Phase 2</button><div class="glossary__definition" id="glossary-content-71" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phase</span> of research to describe clinical trials that gather preliminary data on whether a drug works in people who have a certain <span class="term" data-term="condition/disease" tabindex="-1" title="opens glossary for condition/disease">condition/disease</span> (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a <span class="term" data-term="placebo" tabindex="-1" title="opens glossary for placebo">placebo</span>) or a different drug. Safety continues to be evaluated, and short-term <span class="term" data-term="adverse event" tabindex="-1" title="opens glossary for adverse event">adverse events</span> are studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-72" aria-expanded="false">Phase 3</button><div class="glossary__definition" id="glossary-content-72" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phase</span> of research to describe clinical trials that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-73" aria-expanded="false">Phase 4</button><div class="glossary__definition" id="glossary-content-73" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phase</span> of research to describe clinical trials occurring after FDA has approved a drug for marketing. They include postmarket requirement and commitment studies that are required of or agreed to by the study sponsor. These trials gather additional information about a drug's safety, efficacy, or optimal use.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-74" aria-expanded="false">Phase Not Applicable</button><div class="glossary__definition" id="glossary-content-74" aria-hidden="true" style="display: none;">Describes trials without FDA-defined <span class="term" data-term="phase" tabindex="-1" title="opens glossary for phase">phases</span>, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-75" aria-expanded="false">Placebo</button><div class="glossary__definition" id="glossary-content-75" aria-hidden="true" style="display: none;">An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-76" aria-expanded="false">Placebo comparator arm</button><div class="glossary__definition" id="glossary-content-76" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="opens glossary for arm type">arm type</span> in which a group of participants receives a <span class="term" data-term="placebo" tabindex="-1" title="opens glossary for placebo">placebo</span> during a clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-77" aria-expanded="false">Primary completion date</button><div class="glossary__definition" id="glossary-content-77" aria-hidden="true" style="display: none;">The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the <span class="term" data-term="primary outcome measure" tabindex="-1" title="opens glossary for primary outcome measure">primary outcome measure</span>. Whether the clinical study ended according to the <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span> or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "estimated" primary completion date is the date that the researchers think will be the primary completion date for the study. </div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-78" aria-expanded="false">Primary outcome measure</button><div class="glossary__definition" id="glossary-content-78" aria-hidden="true" style="display: none;">In a clinical study's <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>, the planned outcome measure that is the most important for evaluating the effect of an <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span>. Most clinical studies have one primary outcome measure, but some have more than one.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-79" aria-expanded="false">Primary purpose</button><div class="glossary__definition" id="glossary-content-79" aria-hidden="true" style="display: none;">The main reason for the <span class="term" data-term="clinical trial" tabindex="-1" title="opens glossary for clinical trial">clinical trial</span>. The types of primary purpose are: treatment, prevention, diagnostic, supportive care, screening, health services research, basic science, and other.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-80" aria-expanded="false">Principal investigator (PI)</button><div class="glossary__definition" id="glossary-content-80" aria-hidden="true" style="display: none;">The person who is responsible for the scientific and technical direction of the entire clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-81" aria-expanded="false">Protocol</button><div class="glossary__definition" id="glossary-content-81" aria-hidden="true" style="display: none;">The written description of a clinical study. It includes the study's objectives, design, and methods. It may also include relevant scientific background and statistical information.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-82" aria-expanded="false">Quality control (QC) review</button><div class="glossary__definition" id="glossary-content-82" aria-hidden="true" style="display: none;">National Library of Medicine (NLM) staff perform a limited review of submitted <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study records</span> for apparent errors, deficiencies, or inconsistencies. NLM staff identify potential major and advisory issues and provide comments directly to the study sponsor or investigator. Major issues identified in QC review must be addressed or corrected (see <span class="term" data-term="first submitted that met qc criteria" tabindex="-1" title="opens glossary for first submitted that met qc criteria">First submitted that met QC criteria</span> and <span class="term" data-term="results first submitted that met qc criteria" tabindex="-1" title="opens glossary for results first submitted that met qc criteria">Results first submitted that met QC criteria</span>). Advisory issues are suggestions to help improve the clarity of the record. NLM staff do not verify the scientific validity or relevance of the submitted information. The study sponsor or investigator is responsible for ensuring that the studies follow all applicable laws and regulations.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-83" aria-expanded="false">Randomized allocation</button><div class="glossary__definition" id="glossary-content-83" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="allocation" tabindex="-1" title="opens glossary for allocation">allocation</span> strategy in which participants are assigned to the <span class="term" data-term="arm" tabindex="-1" title="opens glossary for arm">arms</span> of a clinical trial by chance.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-84" aria-expanded="false">Recruitment status</button><div class="glossary__definition" id="glossary-content-84" aria-hidden="true" style="display: none;"><ul><li><strong>Not yet recruiting:</strong> The study has not started recruiting participants.</li><li><strong>Recruiting:</strong> The study is currently recruiting participants.</li><li><strong>Enrolling by invitation:</strong> The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.</li><li><strong>Active, not recruiting:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.</li><li><strong>Suspended:</strong> The study has stopped early but may start again.</li><li><strong>Terminated:</strong> The study has stopped early and will not start again. Participants are no longer being examined or treated.</li><li><strong>Completed:</strong> The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).</li><li><strong>Withdrawn:</strong> The study stopped early, before enrolling its first participant.</li><li><strong>Unknown:</strong> A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been <span class="term" data-term="last verified" tabindex="-1" title="opens glossary for last verified">last verified</span> within the past 2 years.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-85" aria-expanded="false">Registration</button><div class="glossary__definition" id="glossary-content-85" aria-hidden="true" style="display: none;">The process of submitting and updating summary information about a clinical study and its <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>, from its beginning to end, to a structured, public Web-based <span class="term" data-term="study registry" tabindex="-1" title="opens glossary for study registry">study registry</span> that is accessible to the public, such as ClinicalTrials.gov.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-86" aria-expanded="false">Removed location countries</button><div class="glossary__definition" id="glossary-content-86" aria-hidden="true" style="display: none;">Countries that appeared under <span class="term" data-term="listed location countries" tabindex="-1" title="opens glossary for listed location countries">listed location countries</span> but were removed from the <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> by the sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-87" aria-expanded="false">Reporting group</button><div class="glossary__definition" id="glossary-content-87" aria-hidden="true" style="display: none;">A grouping of participants in a clinical study that is used for summarizing the data collected during the study. This grouping may be the same as or different from a study arm or group.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-88" aria-expanded="false">Responsible party</button><div class="glossary__definition" id="glossary-content-88" aria-hidden="true" style="display: none;">The person responsible for submitting information about a clinical study to ClinicalTrials.gov and updating that information. Usually the study sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-89" aria-expanded="false">Results database</button><div class="glossary__definition" id="glossary-content-89" aria-hidden="true" style="display: none;">A structured online system, such as the ClinicalTrials.gov results database, that provides the public with access to registration and summary results information for completed or terminated clinical studies. A study with results available on ClinicalTrials.gov is described as having the results "posted." <p><strong>Note:</strong> The ClinicalTrials.gov results database became available in September 2008. Older studies are unlikely to have results available in the database.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-90" aria-expanded="false">Results delayed</button><div class="glossary__definition" id="glossary-content-90" aria-hidden="true" style="display: none;">Indicates that the sponsor or investigator submitted a <span class="term" data-term="certification" tabindex="-1" title="opens glossary for certification">certification</span> or <span class="term" data-term="extension request" tabindex="-1" title="opens glossary for extension request">extension request</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-91" aria-expanded="false">Results first posted</button><div class="glossary__definition" id="glossary-content-91" aria-hidden="true" style="display: none;">The date on which summary results information was first available on ClinicalTrials.gov after National Library of Medicine (NLM) <a href="submit-studies/prs-help/results-quality-control-review-criteria" class="usa-link" tabindex="-1">quality control (QC) review</a> has concluded. There is typically a delay between the date the study sponsor or investigator first submits summary results information (the results first submitted date) and the results first posted date. Some results information may be available at an earlier date if <span class="term" data-term="results first posted with qc comments" tabindex="-1" title="opens glossary for results first posted with qc comments">Results First Posted with QC Comments</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-92" aria-expanded="false">Results first posted with QC comments</button><div class="glossary__definition" id="glossary-content-92" aria-hidden="true" style="display: none;">The date on which summary results information was first available on ClinicalTrials.gov with quality control review comments from the National Library of Medicine (NLM) identifying major issues that must be addressed by the sponsor or investigator. As of January 1, 2020, initial results submissions for applicable clinical trials (ACTs) that do not meet <a href="/submit-studies/prs-help/results-quality-control-review-criteria" class="usa-link" tabindex="-1">quality control review criteria</a> will be publicly posted on ClinicalTrials.gov with brief standardized major comments. Accordingly, the Results First Posted with QC Comments date may be earlier than the Results First Posted date for an ACT with summary results information that is not consistent with NLM quality control review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-93" aria-expanded="false">Results first submitted</button><div class="glossary__definition" id="glossary-content-93" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> with summary results information. There is typically a delay between the results first submitted date and when summary results information becomes available on ClinicalTrials.gov (the <span class="term" data-term="results first posted" tabindex="-1" title="opens glossary for results first posted">results first posted</span> date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-94" aria-expanded="false">Results first submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-94" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> with summary results information that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit results information one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-95" aria-expanded="false">Results returned after quality control review</button><div class="glossary__definition" id="glossary-content-95" aria-hidden="true" style="display: none;">The date on which the National Library of Medicine provided <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> comments to the study sponsor or investigator. The sponsor or investigator must address major issues identified in the review comments. If there is a date listed for results returned after quality control review, but there is not a subsequent date listed for <span class="term" data-term="results submitted to clinicaltrials.gov" tabindex="-1" title="opens glossary for results submitted to clinicaltrials.gov">results submitted to ClinicalTrials.gov</span>, this means that the submission is pending changes by the sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-96" aria-expanded="false">Results submitted to ClinicalTrials.gov</button><div class="glossary__definition" id="glossary-content-96" aria-hidden="true" style="display: none;">Indicates that the study sponsor or investigator has submitted summary results information for a clinical study to ClinicalTrials.gov but the <span class="term" data-term="quality control (qc) review" tabindex="-1" title="opens glossary for quality control (qc) review">quality control (QC) review</span> process has not concluded.<p>The results submitted date indicates when the study sponsor or investigator first submitted summary results information or submitted changes to summary results information. Submissions with changes are typically in response to  QC review comments from the National Library of Medicine (NLM). If there is a date listed for results submitted to ClinicalTrials.gov, but there is not a subsequent date listed for <span class="term" data-term="results returned after quality control review" tabindex="-1" title="opens glossary for results returned after quality control review">results returned after quality control review</span>, this means that the submission is pending review by NLM.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-97" aria-expanded="false">Secondary outcome measure</button><div class="glossary__definition" id="glossary-content-97" aria-hidden="true" style="display: none;">In a clinical study's <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-98" aria-expanded="false">Serious adverse event</button><div class="glossary__definition" id="glossary-content-98" aria-hidden="true" style="display: none;">An <span class="term" data-term="adverse event" tabindex="-1" title="opens glossary for adverse event">adverse event</span> that results in death, is life-threatening, requires inpatient hospitalization or extends a current hospital stay, results in an ongoing or significant incapacity or interferes substantially with normal life functions, or causes a congenital anomaly or birth defect. Medical events that do not result in death, are not life-threatening, or do not require hospitalization may be considered serious adverse events if they put the participant in danger or require medical or surgical intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-99" aria-expanded="false">Sex</button><div class="glossary__definition" id="glossary-content-99" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="opens glossary for eligibility criteria">eligibility criteria</span> that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person's classification as female or male based on biological distinctions. Sex is distinct from <span class="term" data-term="gender-based eligibility" tabindex="-1" title="opens glossary for gender-based eligibility">gender-based eligibility</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-100" aria-expanded="false">Sham comparator arm</button><div class="glossary__definition" id="glossary-content-100" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="opens glossary for arm type">arm type</span> in which a group of participants receives a procedure or device that appears to be the same as the actual procedure or device being studied but does not contain active processes or components.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-101" aria-expanded="false">Single group assignment</button><div class="glossary__definition" id="glossary-content-101" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="opens glossary for intervention model">intervention model</span> describing a clinical trial in which all participants receive the same intervention/treatment.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-102" aria-expanded="false">Sort studies by</button><div class="glossary__definition" id="glossary-content-102" aria-hidden="true" style="display: none;">The Sort studies by option is used to change the order of studies listed on the Search Results page. You can sort by Relevance or Newest First: <ul><li>Relevance: Studies that best match your search terms appear higher in the search results list. This is the default display for all searches.</li><li>Newest First: Studies with the most recent <span class="term" data-term="first posted" tabindex="-1" title="opens glossary for first posted">First posted</span> dates appear higher in the search results list.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-103" aria-expanded="false">Sponsor</button><div class="glossary__definition" id="glossary-content-103" aria-hidden="true" style="display: none;">The organization or person who initiates the study and who has authority and control over the study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-104" aria-expanded="false">State</button><div class="glossary__definition" id="glossary-content-104" aria-hidden="true" style="display: none;">In the search feature, the State field is used to find clinical studies with locations in a specific state within the United States. If you choose United States in the <span class="term" data-term="country" tabindex="-1" title="opens glossary for country">Country</span> field, you can search for studies with locations in a specific state.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-105" aria-expanded="false">Statistical analysis plan (SAP)</button><div class="glossary__definition" id="glossary-content-105" aria-hidden="true" style="display: none;">The written description of the statistical considerations and methods for analyzing the data collected in the <span class="term" data-term="clinical study" tabindex="-1" title="opens glossary for clinical study">clinical study</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-106" aria-expanded="false">Status</button><div class="glossary__definition" id="glossary-content-106" aria-hidden="true" style="display: none;">Indicates the current <span class="term" data-term="recruitment status" tabindex="-1" title="opens glossary for recruitment status">recruitment status</span> or the <span class="term" data-term="expanded access status" tabindex="-1" title="opens glossary for expanded access status">expanded access status</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-107" aria-expanded="false">Study completion date</button><div class="glossary__definition" id="glossary-content-107" aria-hidden="true" style="display: none;">The date on which the last participant in a clinical study was examined or received an <span class="term" data-term="intervention/treatment" tabindex="-1" title="opens glossary for intervention/treatment">intervention/treatment</span> to collect final data for the <span class="term" data-term="primary outcome measure" tabindex="-1" title="opens glossary for primary outcome measure">primary outcome measures</span>, <span class="term" data-term="secondary outcome measure" tabindex="-1" title="opens glossary for secondary outcome measure">secondary outcome measures</span>, and <span class="term" data-term="adverse event" tabindex="-1" title="opens glossary for adverse event">adverse events</span> (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-108" aria-expanded="false">Study design</button><div class="glossary__definition" id="glossary-content-108" aria-hidden="true" style="display: none;">The investigative methods and strategies used in the clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-109" aria-expanded="false">Study documents</button><div class="glossary__definition" id="glossary-content-109" aria-hidden="true" style="display: none;">Refers to the type of documents that the study sponsor or principal investigator may add to their <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span>. These include a study <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span>, <span class="term" data-term="statistical analysis plan (sap)" tabindex="-1" title="opens glossary for statistical analysis plan (sap)">statistical analysis plan</span>, and <span class="term" data-term="informed consent form (icf)" tabindex="-1" title="opens glossary for informed consent form (icf)">informed consent form</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-110" aria-expanded="false">Study IDs</button><div class="glossary__definition" id="glossary-content-110" aria-hidden="true" style="display: none;">Identifiers that are assigned to a clinical study by the study's <span class="term" data-term="sponsor" tabindex="-1" title="opens glossary for sponsor">sponsor</span>, funders, or others. They include unique identifiers from other trial <span class="term" data-term="study registry" tabindex="-1" title="opens glossary for study registry">study registries</span> and National Institutes of Health grant numbers. Note: ClinicalTrials.gov assigns a unique identification code to each clinical study registered on ClinicalTrials.gov. Also called the <span class="term" data-term="nct number" tabindex="-1" title="opens glossary for nct number">NCT number</span>, the format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-111" aria-expanded="false">Study record</button><div class="glossary__definition" id="glossary-content-111" aria-hidden="true" style="display: none;">An entry on ClinicalTrials.gov that contains a summary of a clinical study's protocol information, including the <span class="term" data-term="recruitment status" tabindex="-1" title="opens glossary for recruitment status">recruitment status</span>; eligibility criteria; contact information; and, in some cases, summary results. Each study record is assigned a ClinicalTrials.gov identifier, or <span class="term" data-term="nct number" tabindex="-1" title="opens glossary for nct number">NCT number</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-112" aria-expanded="false">Study registry</button><div class="glossary__definition" id="glossary-content-112" aria-hidden="true" style="display: none;">A structured online system, such as ClinicalTrials.gov, that provides the public with access to summary information about ongoing and completed clinical studies.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-113" aria-expanded="false">Study results</button><div class="glossary__definition" id="glossary-content-113" aria-hidden="true" style="display: none;">A <span class="term" data-term="study record" tabindex="-1" title="opens glossary for study record">study record</span> that includes the summary results posted in the ClinicalTrials.gov <span class="term" data-term="results database" tabindex="-1" title="opens glossary for results database">results database</span>. Summary results information includes <span class="term" data-term="participant flow" tabindex="-1" title="opens glossary for participant flow">participant flow</span>, <span class="term" data-term="baseline characteristics" tabindex="-1" title="opens glossary for baseline characteristics">baseline characteristics</span>, <span class="term" data-term="outcome measure" tabindex="-1" title="opens glossary for outcome measure">outcome measures</span>, and <span class="term" data-term="adverse event" tabindex="-1" title="opens glossary for adverse event">adverse events</span> (including <span class="term" data-term="serious adverse event" tabindex="-1" title="opens glossary for serious adverse event">serious adverse events</span>).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-114" aria-expanded="false">Study start date</button><div class="glossary__definition" id="glossary-content-114" aria-hidden="true" style="display: none;">The actual date on which the first participant was enrolled in a clinical study. The "estimated" study start date is the date that the researchers think will be the study start date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-115" aria-expanded="false">Study type</button><div class="glossary__definition" id="glossary-content-115" aria-hidden="true" style="display: none;">Describes the nature of a <span class="term" data-term="clinical study" tabindex="-1" title="opens glossary for clinical study">clinical study</span>. Study types include <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="opens glossary for interventional study (clinical trial)">interventional studies</span> (also called clinical trials), <span class="term" data-term="observational study" tabindex="-1" title="opens glossary for observational study">observational studies</span> (including <span class="term" data-term="patient registry" tabindex="-1" title="opens glossary for patient registry">patient registries</span>), and <span class="term" data-term="expanded access" tabindex="-1" title="opens glossary for expanded access">expanded access</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-116" aria-expanded="false">Submitted date</button><div class="glossary__definition" id="glossary-content-116" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator submitted a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-117" aria-expanded="false">Title</button><div class="glossary__definition" id="glossary-content-117" aria-hidden="true" style="display: none;">The official title of a <span class="term" data-term="protocol" tabindex="-1" title="opens glossary for protocol">protocol</span> used to identify a clinical study or a short title written in language intended for the lay public.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-118" aria-expanded="false">Title acronym</button><div class="glossary__definition" id="glossary-content-118" aria-hidden="true" style="display: none;">The acronym or initials used to identify a clinical study (not all studies have one). For example, the title acronym for the Women's Health Initiative is "WHI."</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-119" aria-expanded="false">Type of intervention</button><div class="glossary__definition" id="glossary-content-119" aria-hidden="true" style="display: none;">A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-120" aria-expanded="false">U.S. Agency for Healthcare Research and Quality (AHRQ)</button><div class="glossary__definition" id="glossary-content-120" aria-hidden="true" style="display: none;">An agency within the U.S. Department of Health and Human Services. AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-121" aria-expanded="false">U.S. Food and Drug Administration (FDA)</button><div class="glossary__definition" id="glossary-content-121" aria-hidden="true" style="display: none;">An agency within the U.S. Department of Health and Human Services. The FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the Nation's food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-122" aria-expanded="false">Unknown</button><div class="glossary__definition" id="glossary-content-122" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="recruitment status" tabindex="-1" title="opens glossary for recruitment status">recruitment status</span>. It identifies a study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been verified within the past 2 years. Studies with an unknown status are considered closed studies.</div></li></ul>
  </div>
</div>

<app-root _nghost-ng-c3140640207="" ng-version="17.3.10"><ctg-header _ngcontent-ng-c3140640207="" _nghost-ng-c1668052511=""><ctg-official-gov-banner _ngcontent-ng-c1668052511="" _nghost-ng-c578623717=""><section _ngcontent-ng-c578623717="" aria-label="Official government website,," class="usa-banner site-banner"><div _ngcontent-ng-c578623717="" class="usa-accordion"><header _ngcontent-ng-c578623717="" class="usa-banner__header"><div _ngcontent-ng-c578623717="" class="usa-banner__inner" style="margin-left: 0;"><div _ngcontent-ng-c578623717="" class="grid-col-auto"><img _ngcontent-ng-c578623717="" src="assets/images/favicon-57.png" alt="U.S. flag" class="usa-banner__header-flag"></div><div _ngcontent-ng-c578623717="" class="grid-col-fill tablet:grid-col-auto"><p _ngcontent-ng-c578623717="" class="usa-banner__header-text">An official website of the United States government </p><p _ngcontent-ng-c578623717="" aria-hidden="true" class="usa-banner__header-action">Here's how you know </p></div><button _ngcontent-ng-c578623717="" aria-expanded="false" aria-controls="gov-banner" class="usa-accordion__button usa-banner__button"><span _ngcontent-ng-c578623717="" class="usa-banner__button-text">Here's how you know </span></button></div></header><div _ngcontent-ng-c578623717="" id="gov-banner" hidden="" class="usa-banner__content usa-accordion__content"><div _ngcontent-ng-c578623717="" class="grid-row grid-gap-lg"><div _ngcontent-ng-c578623717="" class="usa-banner__guidance tablet:grid-col-6"><img _ngcontent-ng-c578623717="" src="assets/images/icon-dot-gov.svg" alt="Dot gov" class="usa-banner__icon usa-media-block__img"><div _ngcontent-ng-c578623717="" class="usa-media-block__body"><p _ngcontent-ng-c578623717="" class="font-body-xs"><strong _ngcontent-ng-c578623717="">Official websites use .gov </strong><br _ngcontent-ng-c578623717=""> A <strong _ngcontent-ng-c578623717="">.gov </strong> website belongs to an official government organization in the United States. </p></div></div><div _ngcontent-ng-c578623717="" class="usa-banner__guidance tablet:grid-col-6"><img _ngcontent-ng-c578623717="" src="assets/images/icon-https.svg" alt="Https" class="usa-banner__icon usa-media-block__img"><div _ngcontent-ng-c578623717="" class="usa-media-block__body"><p _ngcontent-ng-c578623717="" class="font-body-xs"><strong _ngcontent-ng-c578623717="">Secure .gov websites use HTTPS </strong><br _ngcontent-ng-c578623717=""> A <strong _ngcontent-ng-c578623717="">lock </strong> ( <span _ngcontent-ng-c578623717="" class="icon-lock"><svg _ngcontent-ng-c578623717="" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 52 64" role="img" aria-labelledby="banner-lock-title banner-lock-description" class="usa-banner__lock-image"><title _ngcontent-ng-c578623717="" id="banner-lock-title">Lock </title><desc _ngcontent-ng-c578623717="" id="banner-lock-description">A locked padlock </desc><path _ngcontent-ng-c578623717="" fill="#ffffff" fill-rule="evenodd" d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z"></path></svg></span>) or <strong _ngcontent-ng-c578623717="">https:// </strong> means youve safely connected to the .gov website. Share sensitive information only on official, secure websites. </p></div></div></div></div></div></section></ctg-official-gov-banner><a _ngcontent-ng-c1668052511="" href="#main-content" class="usa-skipnav">Skip to main page content</a><ctg-ncbi-global-alert-banner _ngcontent-ng-c1668052511="" _nghost-ng-c2321451106=""><section _ngcontent-ng-c2321451106="" data-section="Alerts"><div _ngcontent-ng-c2321451106="" class="ncbi-alerts-placeholder"></div></section></ctg-ncbi-global-alert-banner><ctg-ncbi-header _ngcontent-ng-c1668052511="" _nghost-ng-c3790985285=""><header _ngcontent-ng-c3790985285="" role="banner" data-section="Header" class="bg-primary-darker padding-y-1"><div _ngcontent-ng-c3790985285="" class="grid-container-widescreen"><div _ngcontent-ng-c3790985285="" class="grid-row flex-align-center"><div _ngcontent-ng-c3790985285="" class="mobile-lg:grid-col-8 text-left"><a _ngcontent-ng-c3790985285="" href="https://ncbi.nlm.nih.gov" target="_blank" rel="noopener noreferrer" class="logo block-inline" title="NIH National Library of Medicine, National Center for Biotechnology Information (opens in a new tab)"><img _ngcontent-ng-c3790985285="" src="assets/main/img/AgencyLogo.svg" class="ncbi-logo" alt="NIH National Library of Medicine, National Center for Biotechnology Information (opens in a new tab)"></a></div><div _ngcontent-ng-c3790985285="" class="mobile-lg:grid-col-4 text-right display-none mobile-lg:display-block"><button _ngcontent-ng-c3790985285="" aria-label="PRS Login" class="usa-button usa-button--outline usa-button--inverse font-ui-md prs-button"> PRS Login </button></div></div></div></header></ctg-ncbi-header><ctg-ctgl-header _ngcontent-ng-c1668052511="" _nghost-ng-c1485640015=""><div _ngcontent-ng-c1485640015="" class="usa-overlay"></div><header _ngcontent-ng-c1485640015="" class="usa-header"><div _ngcontent-ng-c1485640015="" class="desktop:grid-container-widescreen"><div _ngcontent-ng-c1485640015="" class="usa-nav-container maxw-none"><div _ngcontent-ng-c1485640015="" class="usa-navbar logo-menu max-width"><div _ngcontent-ng-c1485640015="" id="basic-logo" class="desktop:margin-top-105 mobile-lg:margin-y-1 display-flex"><a _ngcontent-ng-c1485640015="" href="/" class="usa-logo block-inline" title="ClinicalTrials.gov return to the CTG homepage"><img _ngcontent-ng-c1485640015="" src="assets/images/ctg-header-logo.svg" class="ctg-logo-image" alt="ClinicalTrials.gov return to the CTG homepage"></a><a _ngcontent-ng-c1485640015="" id="local-menu-action-print" class="usa-logo block-inline"><img _ngcontent-ng-c1485640015="" src="../../../assets/images/nih-nlm-ncbi-logo.png"></a></div><button _ngcontent-ng-c1485640015="" title="Menu button" aria-label="Menu button" id="local-menu-action" class="usa-menu-btn"> Menu </button></div><div _ngcontent-ng-c1485640015="" class="flex-justify-start reduce-indentation"><nav _ngcontent-ng-c1485640015="" aria-label="Primary navigation" class="max-width usa-nav flex-align-self-stretch" style="height: 100%;"><button _ngcontent-ng-c1485640015="" title="Menu close button" aria-label="Menu close button" class="usa-nav__close nav-close-button"><img _ngcontent-ng-c1485640015="" src="/assets/images/close.png" role="img" alt="close"></button><ul _ngcontent-ng-c1485640015="" class="usa-nav__primary usa-accordion adjust-menu-margins adjust-mobile-menu"><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="Find Studies" aria-label="Find Studies" aria-controls="basic-nav-section-five" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">Find Studies</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-five" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/expert-search">Expert Search</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/find-studies/how-to-search">How to Search</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/find-studies/how-to-use-search-results">How to Use Search Results</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/find-studies/how-to-search-for-studies-with-results">How to Search for Studies with Results</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/find-studies/constructing-complex-search-queries">Constructing Complex Search Queries</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/find-studies/rss">RSS Feeds</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="Study Basics" aria-label="Study Basics" aria-controls="basic-nav-section-two" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">Study Basics</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-two" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" routerlink="/study-basics/learn-about-studies" href="/study-basics/learn-about-studies">Learn About Studies</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/study-basics/how-to-read-study-record">How to Read a Study Record</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/study-basics/how-to-read-study-results">How to Read Study Results</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" routerlink="/study-basics/glossary" href="/study-basics/glossary">Glossary</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" routerlink="/study-basics/patient-resources" href="/study-basics/patient-resources">Patient Resources</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="Submit Studies" aria-label="Submit Studies" aria-controls="basic-nav-section-four" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">Submit Studies</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-four" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/submit-studies/prs-accounts">PRS Accounts</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/submit-studies/prs-help">PRS Help Resources</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="Data and API" aria-label="Data About Studies" aria-controls="basic-nav-section-three" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">Data and API</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-three" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/data-api/api">ClinicalTrials.gov API</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/data-api/about-api">About the API</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/data-api/how-download-study-records">How to Download Study Records</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/data-api/fhir">Access Data in FHIR</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="Policy" aria-label="Policy" aria-controls="basic-nav-section-six" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">Policy</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-six" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/faq">FAQs</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/reporting-requirements">Clinical Trial Reporting Requirements</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/fdaaa-801-final-rule">FDAAA 801 and the Final Rule</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/protocol-definitions">Protocol Registration Definitions</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/results-definitions">Results Definitions</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/policy/expanded-access-definitions">Expanded Access Definitions</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item"><button _ngcontent-ng-c1485640015="" aria-expanded="false" title="About This Site" aria-label="About This Site" aria-controls="basic-nav-section-one" class="usa-accordion__button usa-nav__link"><span _ngcontent-ng-c1485640015="" class="font-ui-md">About</span></button><ul _ngcontent-ng-c1485640015="" id="basic-nav-section-one" class="usa-nav__submenu shadow-1" hidden=""><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/news-and-updates">News and Updates</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/about-ctg">About ClinicalTrials.gov</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/trends-charts">Trends and Charts</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/modernization">Modernization</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/modernization-top-questions">Modernization Top Questions</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/selected-publications">Selected Publications</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/release-notes">Release Notes</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/planned-features">Planned Features on ClinicalTrials.gov</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/disclaimer">Disclaimer</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/terms-conditions">Terms and Conditions</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/linking-to">Linking to This Site</a></li><li _ngcontent-ng-c1485640015="" class="usa-nav__submenu-item"><a _ngcontent-ng-c1485640015="" href="/about-site/accessibility">Accessibility</a></li></ul></li><li _ngcontent-ng-c1485640015="" class="usa-nav__primary-item last-item"><a _ngcontent-ng-c1485640015="" title="Go to My Saved Studies page" aria-label="Go to My Saved Studies page" routerlink="/search/my-saved-studies" class="usa-link" href="/search/my-saved-studies"><span _ngcontent-ng-c1485640015="" class="font-ui-md">My Saved Studies (0 )</span><span _ngcontent-ng-c1485640015=""><svg _ngcontent-ng-c1485640015="" aria-hidden="true" focusable="false" role="img" class="usa-icon mobile-my-list"><use _ngcontent-ng-c1485640015="" xlink:href="/assets/uswds/img/sprite.svg#arrow_forward"></use></svg></span></a><!----><!----></li></ul></nav></div></div></div></header></ctg-ctgl-header><ctg-results-navigation _ngcontent-ng-c1668052511="" _nghost-ng-c2235860804=""><div _ngcontent-ng-c2235860804="" class="header-banner font-body-2xs desktop:font-body-sm"><div _ngcontent-ng-c2235860804="" class="grid-container"><div _ngcontent-ng-c2235860804="" class="grid-row"><div _ngcontent-ng-c2235860804="" class="grid-col-12"><div _ngcontent-ng-c2235860804="" class="banner-content mobile-actions"><div _ngcontent-ng-c2235860804="" class="margin-y-1"><div _ngcontent-ng-c2235860804="" class="constrained-width right-border"> Record 1 of 0 </div><!----></div><div _ngcontent-ng-c2235860804="" class="grid-row margin-bottom-1 no-print-view"><div _ngcontent-ng-c2235860804="" class="actions-right-border"><a _ngcontent-ng-c2235860804="" class="display-flex flex-justify disabled-link"><div _ngcontent-ng-c2235860804=""> Previous Study </div></a></div><div _ngcontent-ng-c2235860804="" class="actions-right-border"><div _ngcontent-ng-c2235860804="" class="display-flex flex-justify-center flex-align-self-strech"><a _ngcontent-ng-c2235860804="" href="javascript:void(0)">Return to Search</a></div></div><div _ngcontent-ng-c2235860804=""><a _ngcontent-ng-c2235860804="" class="display-flex flex-justify disabled-link"><div _ngcontent-ng-c2235860804=""> Next Study </div></a></div></div></div><!----><!----></div></div></div><!----><!----></div><!----><!----><!----></ctg-results-navigation><!----><ctg-breadcrumbs _ngcontent-ng-c1668052511="" _nghost-ng-c3661825414=""><div _ngcontent-ng-c3661825414="" class="grid-container desktop:grid-container-widescreen"><div _ngcontent-ng-c3661825414="" class="grid-row"><div _ngcontent-ng-c3661825414="" class="mobile-lg:grid-col-8 text-left"><nav _ngcontent-ng-c3661825414="" aria-label="Breadcrumbs" class="usa-breadcrumb"><ol _ngcontent-ng-c3661825414="" class="usa-breadcrumb__list"><li _ngcontent-ng-c3661825414="" class="usa-breadcrumb__list-item"><a _ngcontent-ng-c3661825414="" class="usa-breadcrumb__link" href="/"><span _ngcontent-ng-c3661825414="">Home</span></a><!----><!----></li><li _ngcontent-ng-c3661825414="" class="usa-breadcrumb__list-item"><a _ngcontent-ng-c3661825414="" class="usa-breadcrumb__link" href="/search?cond=pulmonary&amp;rank=1"><span _ngcontent-ng-c3661825414="">Search Results</span></a><!----><!----></li><li _ngcontent-ng-c3661825414="" class="usa-breadcrumb__list-item usa-current" aria-current="page"><!----><span _ngcontent-ng-c3661825414="">Study Record</span><!----></li><!----></ol></nav></div></div></div><!----><!----><!----></ctg-breadcrumbs></ctg-header><!----><main _ngcontent-ng-c3140640207="" id="main-content"><router-outlet _ngcontent-ng-c3140640207=""></router-outlet><ctg-study-details _nghost-ng-c2928246094=""><mat-spinner _ngcontent-ng-c2928246094="" role="progressbar" tabindex="-1" diameter="40" class="mat-mdc-progress-spinner mdc-circular-progress mat-primary mdc-circular-progress--indeterminate" aria-valuemin="0" aria-valuemax="100" mode="indeterminate" style="width: 40px; height: 40px; --mdc-circular-progress-size: 40px; --mdc-circular-progress-active-indicator-width: 40px;"><!----><div aria-hidden="true" class="mdc-circular-progress__determinate-container"><svg xmlns="http://www.w3.org/2000/svg" focusable="false" class="mdc-circular-progress__determinate-circle-graphic" viewBox="0 0 34 34"><circle cx="50%" cy="50%" class="mdc-circular-progress__determinate-circle" r="15" style="stroke-dasharray: 94.2478px; stroke-width: 10%;"></circle></svg></div><div aria-hidden="true" class="mdc-circular-progress__indeterminate-container"><div class="mdc-circular-progress__spinner-layer"><div class="mdc-circular-progress__circle-clipper mdc-circular-progress__circle-left"><svg xmlns="http://www.w3.org/2000/svg" focusable="false" class="mdc-circular-progress__indeterminate-circle-graphic" viewBox="0 0 34 34"><circle cx="50%" cy="50%" r="15" style="stroke-dasharray: 94.2478px; stroke-dashoffset: 47.1239px; stroke-width: 10%;"></circle></svg><!----></div><div class="mdc-circular-progress__gap-patch"><svg xmlns="http://www.w3.org/2000/svg" focusable="false" class="mdc-circular-progress__indeterminate-circle-graphic" viewBox="0 0 34 34"><circle cx="50%" cy="50%" r="15" style="stroke-dasharray: 94.2478px; stroke-dashoffset: 47.1239px; stroke-width: 10%;"></circle></svg><!----></div><div class="mdc-circular-progress__circle-clipper mdc-circular-progress__circle-right"><svg xmlns="http://www.w3.org/2000/svg" focusable="false" class="mdc-circular-progress__indeterminate-circle-graphic" viewBox="0 0 34 34"><circle cx="50%" cy="50%" r="15" style="stroke-dasharray: 94.2478px; stroke-dashoffset: 47.1239px; stroke-width: 10%;"></circle></svg><!----></div></div></div></mat-spinner><!----><!----><!----><!----></ctg-study-details><!----></main><ctg-footer _ngcontent-ng-c3140640207=""><ctg-ctg-footer _nghost-ng-c2717743177=""><div _ngcontent-ng-c2717743177="" class="usa-footer__primary-section ctg-footer"><div _ngcontent-ng-c2717743177="" class="grid-container-widescreen"><div _ngcontent-ng-c2717743177="" class="grid-row grid-gap"><div _ngcontent-ng-c2717743177="" class="mobile-lg:grid-col footer-accordion"><section _ngcontent-ng-c2717743177="" class="group"><button _ngcontent-ng-c2717743177="" class="group-title"><!----><svg _ngcontent-ng-c2717743177="" aria-hidden="true" focusable="false" role="img" class="usa-icon"><use _ngcontent-ng-c2717743177="" xlink:href="/assets/uswds/img/sprite.svg#add"></use></svg><!----><span _ngcontent-ng-c2717743177="">About</span></button><div _ngcontent-ng-c2717743177="" class="group-content"><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="About ClinicalTrials.gov (opens in a new tab)" href="/about-site/about-ctg" title="About ClinicalTrials.gov (opens in a new tab)">About ClinicalTrials.gov</a><!----><!----></div><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="Release Notes (opens in a new tab)" href="/about-site/release-notes" title="Release Notes (opens in a new tab)">Release Notes</a><!----><!----></div><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="Site Map (opens in a new tab)" href="/site-map" title="Site Map (opens in a new tab)">Site Map</a><!----><!----></div><!----></div></section><section _ngcontent-ng-c2717743177="" class="group"><button _ngcontent-ng-c2717743177="" class="group-title"><!----><svg _ngcontent-ng-c2717743177="" aria-hidden="true" focusable="false" role="img" class="usa-icon"><use _ngcontent-ng-c2717743177="" xlink:href="/assets/uswds/img/sprite.svg#add"></use></svg><!----><span _ngcontent-ng-c2717743177="">Help</span></button><div _ngcontent-ng-c2717743177="" class="group-content"><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="https://nlmenterprise.co1.qualtrics.com/jfe/form/SV_5iL6W3r2A7vY52R?ncbi_app=ctgov2&amp;CurrentPage=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03054870%3Fcond%3Dpulmonary%26rank%3D1">Give us feedback</a><!----><!----></div><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="Glossary (opens in a new tab)" href="/study-basics/glossary" title="Glossary (opens in a new tab)">Glossary</a><!----><!----></div><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov">Customer Support</a><!----><!----></div><!----></div></section><section _ngcontent-ng-c2717743177="" class="group"><button _ngcontent-ng-c2717743177="" class="group-title"><!----><svg _ngcontent-ng-c2717743177="" aria-hidden="true" focusable="false" role="img" class="usa-icon"><use _ngcontent-ng-c2717743177="" xlink:href="/assets/uswds/img/sprite.svg#add"></use></svg><!----><span _ngcontent-ng-c2717743177="">Legal</span></button><div _ngcontent-ng-c2717743177="" class="group-content"><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="Disclaimer (opens in a new tab)" href="/about-site/disclaimer" title="Disclaimer (opens in a new tab)">Disclaimer</a><!----><!----></div><div _ngcontent-ng-c2717743177="" class="group-content-row"><a _ngcontent-ng-c2717743177="" target="_blank" rel="noopener noreferrer" class="ctg-footer-link-text" aria-label="Terms and Conditions (opens in a new tab)" href="/about-site/terms-conditions" title="Terms and Conditions (opens in a new tab)">Terms and Conditions</a><!----><!----></div><!----></div></section><!----></div><div _ngcontent-ng-c2717743177="" class="grid-row desktop:display-flex desktop:flex-justify width-full"><div _ngcontent-ng-c2717743177="" class="footer-list"><nav _ngcontent-ng-c2717743177="" aria-label="Footer navigation" class="mobile-lg:grid-col-11"><div _ngcontent-ng-c2717743177="" class="grid-row"><div _ngcontent-ng-c2717743177="" class="mobile-lg:grid-col-4"><section _ngcontent-ng-c2717743177="" class="column usa-footer__primary-content"><div _ngcontent-ng-c2717743177="" class="column-title">About</div><div _ngcontent-ng-c2717743177="" class="separator"></div><ul _ngcontent-ng-c2717743177="" class="usa-list usa-list--unstyled"><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/about-site/about-ctg">About ClinicalTrials.gov</a><!----><!----><!----></li><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/about-site/release-notes">Release Notes</a><!----><!----><!----></li><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/site-map">Site Map</a><!----><!----><!----></li><!----></ul></section><!----></div><div _ngcontent-ng-c2717743177="" class="mobile-lg:grid-col-4"><section _ngcontent-ng-c2717743177="" class="column usa-footer__primary-content"><div _ngcontent-ng-c2717743177="" class="column-title">Help</div><div _ngcontent-ng-c2717743177="" class="separator"></div><ul _ngcontent-ng-c2717743177="" class="usa-list usa-list--unstyled"><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="https://nlmenterprise.co1.qualtrics.com/jfe/form/SV_5iL6W3r2A7vY52R?ncbi_app=ctgov2&amp;CurrentPage=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03054870%3Fcond%3Dpulmonary%26rank%3D1" aria-label="Give us feedback">Give us feedback</a><!----><!----><!----></li><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/study-basics/glossary">Glossary</a><!----><!----><!----></li><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov" aria-label="Customer Support">Customer Support</a><!----><!----><!----></li><!----></ul></section><!----></div><div _ngcontent-ng-c2717743177="" class="mobile-lg:grid-col-4"><section _ngcontent-ng-c2717743177="" class="column usa-footer__primary-content"><div _ngcontent-ng-c2717743177="" class="column-title">Legal</div><div _ngcontent-ng-c2717743177="" class="separator"></div><ul _ngcontent-ng-c2717743177="" class="usa-list usa-list--unstyled"><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/about-site/disclaimer">Disclaimer</a><!----><!----><!----></li><li _ngcontent-ng-c2717743177="" class="usa-footer__secondary-link"><a _ngcontent-ng-c2717743177="" class="ctg-footer-link-text" href="/about-site/terms-conditions">Terms and Conditions</a><!----><!----><!----></li><!----></ul></section><!----></div></div></nav></div><div _ngcontent-ng-c2717743177="" class="tablet:grid-col mobile-lg:grid-col footer-contacts"><img _ngcontent-ng-c2717743177="" src="assets/images/ctg-footer-logo.svg" alt="ClinicalTrials.gov logo" class="ctg-logo"><div _ngcontent-ng-c2717743177="" class="address"> National Library of Medicine<br _ngcontent-ng-c2717743177=""> 8600 Rockville Pike, Bethesda, MD 20894 </div></div></div></div></div></div><!----></ctg-ctg-footer><ctg-hhs-footer _nghost-ng-c2834835435=""><div _ngcontent-ng-c2834835435="" class="usa-identifier hhs-footer"><section _ngcontent-ng-c2834835435="" aria-label="Agency identifier" class="usa-identifier__section usa-identifier__section--masthead"><div _ngcontent-ng-c2834835435="" class="grid-container-widescreen"><div _ngcontent-ng-c2834835435="" class="grid-row grid-gap"><div _ngcontent-ng-c2834835435="" class="desktop:grid-col usa-identifier__logos"><a _ngcontent-ng-c2834835435="" href="https://ncbi.nlm.nih.gov" target="_blank" rel="noopener noreferrer" class="usa-identifier__logo" style="flex: 1;" title="NIH National Library of Medicine, National Center for Biotechnology Information (opens in a new tab)"><img _ngcontent-ng-c2834835435="" src="assets/main/img/AgencyLogo.svg" role="img" class="usa-identifier__logo-img" style="width: 100%;" alt="NIH National Library of Medicine, National Center for Biotechnology Information (opens in a new tab)"></a></div><div _ngcontent-ng-c2834835435="" aria-label="Agency description" class="desktop:grid-col" style="padding-top: 15px;"><p _ngcontent-ng-c2834835435="" class="usa-identifier__identity-domain">ClinicalTrials.gov</p><p _ngcontent-ng-c2834835435="" class="usa-identifier__identity-disclaimer">An official website of the <ctg-external-link-ref _ngcontent-ng-c2834835435="" href="https://www.hhs.gov" linktext="U.S. Department of Health and Human Services" class="hhs-footer-usa-link" _nghost-ng-c2375699798=""><a _ngcontent-ng-c2375699798="" target="_blank" class="hhs-footer-usa-link usa-link" href="https://www.hhs.gov" rel="noopener noreferrer " title="U.S. Department of Health and Human Services (opens in a new tab)" aria-label="U.S. Department of Health and Human Services (opens in a new tab)">U.S. Department of Health and Human Services</a><span _ngcontent-ng-c2375699798="" class="link-for-print">(https://www.hhs.gov)</span></ctg-external-link-ref>, <ctg-external-link-ref _ngcontent-ng-c2834835435="" href="https://www.nih.gov" linktext="National Institutes of Health" class="hhs-footer-usa-link" _nghost-ng-c2375699798=""><a _ngcontent-ng-c2375699798="" target="_blank" class="hhs-footer-usa-link usa-link" href="https://www.nih.gov" rel="noopener noreferrer " title="National Institutes of Health (opens in a new tab)" aria-label="National Institutes of Health (opens in a new tab)">National Institutes of Health</a><span _ngcontent-ng-c2375699798="" class="link-for-print">(https://www.nih.gov)</span></ctg-external-link-ref>, <ctg-external-link-ref _ngcontent-ng-c2834835435="" href="https://www.nlm.nih.gov" linktext="National Library of Medicine" class="hhs-footer-usa-link" _nghost-ng-c2375699798=""><a _ngcontent-ng-c2375699798="" target="_blank" class="hhs-footer-usa-link usa-link" href="https://www.nlm.nih.gov" rel="noopener noreferrer " title="National Library of Medicine (opens in a new tab)" aria-label="National Library of Medicine (opens in a new tab)">National Library of Medicine</a><span _ngcontent-ng-c2375699798="" class="link-for-print">(https://www.nlm.nih.gov)</span></ctg-external-link-ref>, and <ctg-external-link-ref _ngcontent-ng-c2834835435="" href="https://www.ncbi.nlm.nih.gov" linktext="National Center for Biotechnology Information" class="hhs-footer-usa-link" _nghost-ng-c2375699798=""><a _ngcontent-ng-c2375699798="" target="_blank" class="hhs-footer-usa-link usa-link" href="https://www.ncbi.nlm.nih.gov" rel="noopener noreferrer " title="National Center for Biotechnology Information (opens in a new tab)" aria-label="National Center for Biotechnology Information (opens in a new tab)">National Center for Biotechnology Information</a><span _ngcontent-ng-c2375699798="" class="link-for-print">(https://www.ncbi.nlm.nih.gov)</span></ctg-external-link-ref>. </p></div></div></div></section><nav _ngcontent-ng-c2834835435="" aria-label="Important links" class="usa-identifier__section usa-identifier__section--required-links"><div _ngcontent-ng-c2834835435="" class="grid-container-widescreen"><ul _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-list"><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="About HHS (opens in a new tab)" href="https://www.hhs.gov/about/index.html" title="About HHS (opens in a new tab)">About HHS</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="About NIH (opens in a new tab)" href="https://www.nih.gov/about-nih" title="About NIH (opens in a new tab)">About NIH</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="About NLM (opens in a new tab)" href="https://www.nlm.nih.gov/about" title="About NLM (opens in a new tab)">About NLM</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="About NCBI (opens in a new tab)" href="https://www.ncbi.nlm.nih.gov/home/about" title="About NCBI (opens in a new tab)">About NCBI</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="Accessibility support (opens in a new tab)" href="https://www.nlm.nih.gov/accessibility.html" title="Accessibility support (opens in a new tab)">Accessibility support</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="FOIA requests (opens in a new tab)" href="https://www.nih.gov/icd/od/foia/index.htm" title="FOIA requests (opens in a new tab)">FOIA requests</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="No FEAR Act data (opens in a new tab)" href="https://www.edi.nih.gov/no-fear-act" title="No FEAR Act data (opens in a new tab)">No FEAR Act data</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="Office of the Inspector General (opens in a new tab)" href="https://oig.hhs.gov" title="Office of the Inspector General (opens in a new tab)">Office of the Inspector General</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="Privacy policy (opens in a new tab)" href="https://www.nlm.nih.gov/privacy.html" title="Privacy policy (opens in a new tab)">Privacy policy</a></li><li _ngcontent-ng-c2834835435="" class="usa-identifier__required-links-item padding-y-05 margin-bottom-0"><a _ngcontent-ng-c2834835435="" target="_blank" rel="noopener noreferrer" class="usa-identifier__required-link usa-link" aria-label="HHS Vulnerability Disclosure (opens in a new tab)" href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" title="HHS Vulnerability Disclosure (opens in a new tab)" id="vdp">HHS Vulnerability Disclosure</a></li><!----></ul></div></nav><section _ngcontent-ng-c2834835435="" aria-label="Government information and services" class="usa-identifier__section usa-identifier__section--usagov"><div _ngcontent-ng-c2834835435="" class="grid-container-widescreen"><div _ngcontent-ng-c2834835435="" class="usa-identifier__usagov-description">Looking for U.S. government information and services?</div><ctg-external-link-ref _ngcontent-ng-c2834835435="" href="https://www.usa.gov/" linktext="Visit USA.gov" class="usa-identifier__section--usagov hhs-footer-usa-link" _nghost-ng-c2375699798=""><a _ngcontent-ng-c2375699798="" target="_blank" class="hhs-footer-usa-link usa-identifier__section--usagov usa-link" href="https://www.usa.gov/" rel="noopener noreferrer " title="Visit USA.gov (opens in a new tab)" aria-label="Visit USA.gov (opens in a new tab)">Visit USA.gov</a><span _ngcontent-ng-c2375699798="" class="link-for-print">(https://www.usa.gov/)</span></ctg-external-link-ref></div></section><section _ngcontent-ng-c2834835435=""><div _ngcontent-ng-c2834835435="" class="margin-0"><p _ngcontent-ng-c2834835435="" class="version-info text-base-light">Revision: v2.14.4</p></div></section></div></ctg-hhs-footer></ctg-footer><ctg-scroll-top _ngcontent-ng-c3140640207="" _nghost-ng-c2908842604=""><!----></ctg-scroll-top><!----><!----><!----><!----></app-root>

<script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"></script><div id="ZN_dikYWqsjiUWN0Q5"></div>

<script src="runtime.e658a911ee08f211.js" type="module"></script><script src="polyfills.779d77443fdc493d.js" type="module"></script><script src="scripts.a415e2a2b3a92985.js" defer=""></script><script src="main.63f39b9480651a2c.js" type="module"></script>



<script src="https://code.jquery.com/jquery-3.5.1.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous">
</script>
<script>
  var fallbackJquery = "https://www.ncbi.nlm.nih.gov/style-guide/static/base/js/jquery-3.5.0.min.js";
  window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
</script>



<!--<script  type="text/javascript" src="assets/core/alerts/alerts.js"> </script>-->

<!--<script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>-->


<!-- - - - - -

- - - - - -->

<script type="text/javascript">
  var alertsUrl = "/core/alerts/alerts.js";
  if (typeof ncbiBaseUrl !== 'undefined') {
    alertsUrl = ncbiBaseUrl + alertsUrl;
  } else {
    alertsUrl = "https://www.ncbi.nlm.nih.gov" + alertsUrl;
  }
</script>

<!--
<script src="https://www.ncbi.nlm.nih.gov/coreutils/ncbi-banner/ncbi-banner-experiment.js"></script>
-->


<script id="_fed_an_ua_tag" text="" charset="" type="text/javascript" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=NCBI%20-%20ncbi.nlm.nih.gov&amp;sitetopic=NCBI%20Pinger%200.39.3&amp;siteplatform=NCBI%20Pinger%200.39.3"></script><script type="text/javascript" src="https://zndikYWqsjiUWN0Q5-nlmenterprise.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_dikYWqsjiUWN0Q5"></script></body><!-- JavaScript --></html>